data_2jnw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jnw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.92 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.727 ' H ' HG11 ' A' ' 103' ' ' VAL . 1.9 t -98.07 137.58 20.86 Favored Pre-proline 0 C--N 1.292 -1.908 0 O-C-N 120.13 -1.606 . . . . 40.0 110.374 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.16 -9.34 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 124.013 1.533 . . . . 40.0 108.918 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.552 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.6 ttp180 -84.26 0.79 47.6 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 106.479 -1.674 . . . . 40.0 106.479 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 104' ' ' SER . 6.9 tp60 -108.55 -0.17 20.5 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.454 0.645 . . . . 40.0 109.584 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.701 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -53.0 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.982 -1.074 . . . . 40.0 108.81 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 56.28 -74.8 0.01 OUTLIER Glycine 0 C--N 1.288 -2.113 0 N-CA-C 108.773 -1.731 . . . . 40.0 108.773 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.72 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 12.6 t-20 -23.24 112.08 0.17 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.387 -1.066 . . . . 40.0 111.918 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.462 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 38.4 Cg_endo -64.76 -14.25 43.76 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.392 2.061 . . . . 40.0 113.0 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.72 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.05 -35.4 34.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 119.911 -1.743 . . . . 40.0 109.503 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.462 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.42 33.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.513 ' CD1' ' C ' ' A' ' 140' ' ' PHE . 1.1 t80 -104.34 137.01 42.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.746 -1.221 . . . . 40.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.25 1.2 tp -138.85 103.37 4.79 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.0 -1.481 . . . . 40.0 107.0 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 142' ' ' SER . 25.9 t . . . . . 0 N--CA 1.527 3.386 0 N-CA-C 115.269 1.581 . . . . 40.0 115.269 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.694 ' C ' ' H ' ' A' ' 152' ' ' TYR . 51.8 Cg_endo . . . . . 0 C--O 1.209 -0.967 0 N-CA-C 107.232 -1.872 . . . . 40.0 107.232 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 18.8 t0 61.71 -26.17 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 O-C-N 120.612 -1.305 . . . . 40.0 109.494 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.694 ' H ' ' C ' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -62.48 -45.47 92.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.072 -1.825 . . . . 40.0 106.072 177.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -61.67 -36.94 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 115.937 -2.305 . . . . 40.0 109.814 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.581 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.699 0.761 . . . . 40.0 110.723 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.562 HG22 ' NZ ' ' B' ' 67' ' ' LYS . 13.3 tt -126.35 59.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.515 -0.92 . . . . 40.0 108.515 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.581 HG13 ' HD3' ' B' ' 67' ' ' LYS . 8.3 mt . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 40.0 110.624 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.51 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.735 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -103.22 138.53 19.57 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 119.646 -1.909 . . . . 40.0 110.578 176.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -59.8 -13.61 23.12 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.656 1.345 . . . . 40.0 109.142 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -76.19 -7.46 54.87 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 105.797 -1.927 . . . . 40.0 105.797 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 104' ' ' SER . 9.0 tp60 -106.92 3.28 26.0 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.2 0.524 . . . . 40.0 110.05 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.9 -157.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.663 -1.273 . . . . 40.0 109.472 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.593 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 49.4 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 107.806 -2.118 . . . . 40.0 107.806 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 108' ' ' ARG . 5.6 t-20 -4.9 109.15 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.692 0 O-C-N 121.825 -0.809 . . . . 40.0 112.986 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.533 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 38.2 Cg_endo -63.05 -12.36 29.4 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 122.268 1.979 . . . . 40.0 114.794 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.32 -35.4 36.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 O-C-N 119.315 -2.116 . . . . 40.0 109.503 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.533 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.97 33.84 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.8 t80 -102.99 138.61 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 40.0 110.904 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 2.7 tp -140.86 102.82 4.36 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.774 -1.565 . . . . 40.0 106.774 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 142' ' ' SER . 28.0 t . . . . . 0 N--CA 1.527 3.416 0 C-N-CA 117.608 -1.637 . . . . 40.0 115.013 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 152' ' ' TYR . 54.0 Cg_endo . . . . . 0 C--O 1.209 -0.963 0 N-CA-C 113.051 0.366 . . . . 40.0 113.051 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 39.1 t0 -34.47 -19.08 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 119.387 0.994 . . . . 40.0 113.501 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 150' ' ' PRO . 9.1 t80 -54.45 -48.59 71.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.626 -1.296 . . . . 40.0 111.361 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -63.19 -36.94 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.321 -1.752 . . . . 40.0 109.814 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.447 ' CD ' ' CD1' ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 121.683 0.754 . . . . 40.0 110.728 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.462 HG23 ' N ' ' B' ' 69' ' ' ILE 0.252 0.1 OUTLIER -107.25 -40.75 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 122.015 0.912 . . . . 40.0 110.996 -178.277 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.462 ' N ' HG23 ' B' ' 68' ' ' ILE . 8.0 mt . . . . . 0 N--CA 1.517 2.9 0 CA-C-N 114.67 -1.15 . . . . 40.0 113.676 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.729 ' H ' HG11 ' A' ' 103' ' ' VAL . 2.4 t -99.32 138.53 20.54 Favored Pre-proline 0 C--N 1.289 -2.063 0 O-C-N 120.352 -1.468 . . . . 40.0 110.319 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.29 -9.14 9.86 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 124.115 1.587 . . . . 40.0 108.539 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.447 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 1.6 ttp180 -80.47 -2.78 47.32 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 106.204 -1.776 . . . . 40.0 106.204 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.57 ' HG2' ' OH ' ' A' ' 130' ' ' TYR . 8.5 tp60 -108.83 0.48 20.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.253 0.549 . . . . 40.0 110.249 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -52.23 -172.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.911 -1.118 . . . . 40.0 108.566 178.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.585 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 58.75 -80.03 0.01 OUTLIER Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.764 -1.734 . . . . 40.0 108.764 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 108' ' ' ARG . 34.6 t30 -16.72 106.27 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.463 0 O-C-N 121.418 -1.048 . . . . 40.0 112.253 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.441 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 37.4 Cg_endo -61.22 -14.85 36.36 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.296 1.997 . . . . 40.0 113.247 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 140' ' ' PHE . 53.6 t -54.79 -35.4 33.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 O-C-N 119.83 -1.794 . . . . 40.0 109.503 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 131.77 32.08 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.9 t80 -102.44 138.97 38.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 40.0 110.427 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.25 1.6 tp -141.49 103.82 4.46 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.147 -1.427 . . . . 40.0 107.147 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.525 3.299 0 O-C-N 120.231 -1.543 . . . . 40.0 114.655 -176.38 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 45.7 Cg_endo . . . . . 0 CA--C 1.542 0.898 0 N-CA-C 107.359 -1.823 . . . . 40.0 107.359 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.645 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 26.4 t0 70.55 -22.79 0.17 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.647 -1.283 . . . . 40.0 109.443 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.516 ' H ' ' C ' ' A' ' 150' ' ' PRO . 2.1 t80 -65.72 -52.64 49.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 105.794 -1.928 . . . . 40.0 105.794 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -59.9 -36.94 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.461 -1.696 . . . . 40.0 109.814 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.565 ' CE ' ' H ' ' B' ' 68' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 122.087 0.946 . . . . 40.0 110.942 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.685 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -107.43 68.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.312 -0.996 . . . . 40.0 108.312 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' B' ' 67' ' ' LYS . 9.4 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 40.0 110.894 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.3 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.753 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -104.13 141.14 21.89 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 119.38 -2.075 . . . . 40.0 110.209 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.02 -14.33 27.59 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.779 1.41 . . . . 40.0 108.866 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.09 -2.19 23.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.036 -1.839 . . . . 40.0 106.036 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 104' ' ' SER . 7.8 tp60 -109.0 -5.01 16.23 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.148 0.499 . . . . 40.0 110.851 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 110' ' ' ASN . 35.7 ttm180 -55.06 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.524 -1.36 . . . . 40.0 109.055 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 67.78 -72.49 0.26 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 107.61 -2.196 . . . . 40.0 107.61 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.779 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 9.9 t-20 -27.31 111.31 0.23 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.593 -0.945 . . . . 40.0 111.282 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.456 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 37.7 Cg_endo -63.37 -13.52 36.56 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.131 1.888 . . . . 40.0 113.172 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.779 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.7 -35.4 39.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 O-C-N 119.891 -1.755 . . . . 40.0 109.503 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.456 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.58 33.27 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 t80 -103.13 139.13 39.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.609 -0.837 . . . . 40.0 110.364 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.252 0.7 OUTLIER -143.16 102.58 4.01 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.671 -1.604 . . . . 40.0 106.671 179.23 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.527 3.386 0 N-CA-C 115.473 1.656 . . . . 40.0 115.473 -175.801 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 152' ' ' TYR . 51.0 Cg_endo . . . . . 0 C--O 1.209 -0.963 0 CA-C-O 119.186 -0.422 . . . . 40.0 112.898 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 25.2 t0 -29.35 -22.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.502 0 CA-C-N 119.293 0.951 . . . . 40.0 113.546 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.706 ' N ' ' O ' ' A' ' 150' ' ' PRO . 10.3 t80 -50.52 -49.56 55.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.892 -1.13 . . . . 40.0 111.158 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -63.77 -36.94 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.251 -1.78 . . . . 40.0 109.814 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.709 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.574 0.702 . . . . 40.0 110.801 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -119.91 28.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.225 -0.922 . . . . 40.0 110.414 -178.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.709 HG13 ' HD3' ' B' ' 67' ' ' LYS . 7.5 mt . . . . . 0 N--CA 1.503 2.209 0 O-C-N 121.145 -0.972 . . . . 40.0 111.583 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.93 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.747 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -101.67 137.86 19.69 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 119.607 -1.933 . . . . 40.0 110.438 175.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -59.93 -9.71 10.51 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.69 1.363 . . . . 40.0 108.745 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.441 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -78.74 -2.46 39.53 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 105.696 -1.965 . . . . 40.0 105.696 175.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.8 tp-100 -109.37 -0.01 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.107 0.48 . . . . 40.0 110.487 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -54.63 -163.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.583 -1.323 . . . . 40.0 109.507 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 53.57 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 107.092 -2.403 . . . . 40.0 107.092 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 108' ' ' ARG . 24.3 t-20 -7.74 109.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.621 0 O-C-N 121.651 -0.911 . . . . 40.0 112.879 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.496 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 39.8 Cg_endo -64.44 -13.81 40.63 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.043 1.828 . . . . 40.0 114.21 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.427 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.64 -35.4 38.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 119.48 -2.012 . . . . 40.0 109.503 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 130.73 30.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.0 OUTLIER -109.98 124.31 51.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.552 -1.259 . . . . 40.0 109.798 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -130.85 104.81 7.37 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 106.262 -1.755 . . . . 40.0 106.262 178.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.507 2.414 0 C-N-CA 116.374 -2.131 . . . . 40.0 107.236 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 152' ' ' TYR . 55.9 Cg_endo . . . . . 0 C--O 1.21 -0.881 0 N-CA-C 113.949 0.711 . . . . 40.0 113.949 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -30.54 -22.34 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 113.775 1.028 . . . . 40.0 113.775 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 150' ' ' PRO . 2.5 t80 -52.12 -46.85 65.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.808 -1.182 . . . . 40.0 111.009 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -63.39 -36.94 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 116.455 -2.098 . . . . 40.0 109.814 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 152' ' ' TYR . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.762 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 121.513 0.673 . . . . 40.0 110.627 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.574 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -125.36 39.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.331 -0.855 . . . . 40.0 109.596 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.762 HG13 ' HD3' ' B' ' 67' ' ' LYS . 9.5 mt . . . . . 0 N--CA 1.501 2.107 0 O-C-N 121.456 -0.777 . . . . 40.0 111.47 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.68 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.721 ' H ' HG11 ' A' ' 103' ' ' VAL . 5.0 t -102.57 142.82 25.36 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.338 -1.476 . . . . 40.0 110.708 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.1 Cg_endo -63.21 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 107.789 -1.658 . . . . 40.0 107.789 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm-85 -72.64 -8.44 55.3 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 105.952 -1.87 . . . . 40.0 105.952 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.568 ' NE2' ' OH ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -105.47 1.89 28.06 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 115.867 -0.606 . . . . 40.0 109.51 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -54.91 -164.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.268 -0.895 . . . . 40.0 110.128 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 47.89 -126.92 14.55 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 104.136 -3.585 . . . . 40.0 104.136 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 109' ' ' GLY . 38.4 t-20 39.37 105.54 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 118.872 1.336 . . . . 40.0 113.701 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.545 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 40.3 Cg_endo -63.35 -13.38 35.62 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.818 1.679 . . . . 40.0 114.551 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 140' ' ' PHE . 53.6 t -58.49 -35.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 119.516 -1.99 . . . . 40.0 109.503 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.545 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.67 33.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 t80 -107.07 129.66 54.79 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.326 -1.484 . . . . 40.0 111.819 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 7.5 tp -127.74 104.69 7.98 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.372 -1.344 . . . . 40.0 107.372 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.526 3.336 0 C-N-CA 117.302 -1.759 . . . . 40.0 113.785 -177.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 CA--C 1.544 1.022 0 N-CA-C 112.404 0.117 . . . . 40.0 112.404 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 66.5 t0 -49.77 -19.43 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.591 -1.318 . . . . 40.0 112.237 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -54.07 -56.96 13.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.77 -1.207 . . . . 40.0 111.915 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -63.23 -36.94 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.259 -1.376 . . . . 40.0 109.814 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.424 ' HZ2' HG13 ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.525 0.202 . . . . 40.0 110.941 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.41 72.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 CA-C-O 122.026 0.917 . . . . 40.0 111.02 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.424 HG13 ' HZ2' ' B' ' 67' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 123.052 1.406 . . . . 40.0 111.144 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.98 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.755 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -97.75 138.98 21.07 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 119.869 -1.769 . . . . 40.0 111.236 176.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.47 -10.72 17.08 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.689 1.363 . . . . 40.0 109.272 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -88.01 6.67 34.9 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 105.931 -1.877 . . . . 40.0 105.931 176.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.661 ' HB2' ' O ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -110.7 -3.97 15.58 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.968 -0.753 . . . . 40.0 108.968 177.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -50.86 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.832 -1.167 . . . . 40.0 110.13 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.651 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 50.59 -97.38 0.02 OUTLIER Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.584 -2.206 . . . . 40.0 107.584 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.651 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.2 t30 -0.57 108.92 0.02 OUTLIER Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 121.791 -0.829 . . . . 40.0 112.459 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.54 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 39.0 Cg_endo -63.18 -11.49 25.46 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 122.334 2.022 . . . . 40.0 114.831 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.649 ' HB ' HD22 ' A' ' 110' ' ' ASN . 53.6 t -56.63 -35.4 45.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 O-C-N 119.352 -2.092 . . . . 40.0 109.503 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.54 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.44 33.07 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.3 t80 -106.25 132.24 52.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 40.0 111.34 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -135.43 103.46 5.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.968 -1.493 . . . . 40.0 106.968 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.48 ' O ' ' OG ' ' A' ' 142' ' ' SER . 14.9 t . . . . . 0 N--CA 1.525 3.302 0 O-C-N 120.228 -1.545 . . . . 40.0 114.765 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 152' ' ' TYR . 56.2 Cg_endo . . . . . 0 CA--C 1.55 1.295 0 N-CA-C 113.666 0.602 . . . . 40.0 113.666 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -39.24 -18.93 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.265 0 O-C-N 120.562 -1.336 . . . . 40.0 112.901 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 150' ' ' PRO . 8.9 t80 -53.3 -50.18 65.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.14 . . . . 40.0 111.634 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -62.92 -36.94 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.276 -1.77 . . . . 40.0 109.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.674 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.603 0.716 . . . . 40.0 110.715 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.513 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -124.99 33.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.403 -0.811 . . . . 40.0 110.521 -178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.674 HG13 ' HD3' ' B' ' 67' ' ' LYS . 7.4 mt . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.154 -0.966 . . . . 40.0 111.122 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 104' ' ' SER . 87.2 t -115.84 172.15 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.796 ' H ' HG11 ' A' ' 103' ' ' VAL . 1.3 t -98.28 142.8 25.17 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 120.36 -1.462 . . . . 40.0 111.206 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 -12.22 34.76 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 N-CA-C 107.771 -1.665 . . . . 40.0 107.771 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.67 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -82.73 -2.13 53.38 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 105.984 -1.858 . . . . 40.0 105.984 176.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.662 ' HB3' ' O ' ' A' ' 104' ' ' SER . 4.7 tp-100 -107.42 6.64 28.45 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.163 -1.051 . . . . 40.0 108.163 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.612 ' HG2' ' CZ ' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -52.65 -166.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 40.0 110.062 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 46.52 -110.59 0.54 Allowed Glycine 0 C--O 1.208 -1.521 0 N-CA-C 105.618 -2.993 . . . . 40.0 105.618 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.626 ' ND2' ' HB ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER 25.59 97.36 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 117.662 0.731 . . . . 40.0 112.768 176.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.477 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 36.2 Cg_endo -57.86 -13.39 14.72 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.84 1.693 . . . . 40.0 114.125 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.626 ' HB ' ' ND2' ' A' ' 110' ' ' ASN . 53.6 t -58.1 -35.4 52.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 O-C-N 119.783 -1.823 . . . . 40.0 109.503 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.612 ' CZ ' ' HG2' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.83 33.63 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 2.6 t80 -103.52 143.67 32.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.915 -1.116 . . . . 40.0 111.022 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.547 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 3.3 tp -146.24 101.04 3.46 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.594 -1.261 . . . . 40.0 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.517 2.9 0 O-C-N 120.228 -1.545 . . . . 40.0 114.124 -176.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 152' ' ' TYR . 47.0 Cg_endo . . . . . 0 CA--C 1.54 0.801 0 N-CA-C 107.605 -1.729 . . . . 40.0 107.605 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.604 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 66.3 t0 67.98 -23.95 0.12 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.29 -1.506 . . . . 40.0 108.441 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.63 ' H ' ' C ' ' A' ' 150' ' ' PRO . 8.0 t80 -66.24 -54.38 25.7 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.936 -1.505 . . . . 40.0 106.936 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -60.15 -36.94 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.102 -1.439 . . . . 40.0 109.814 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.533 ' NH1' ' OH ' ' A' ' 152' ' ' TYR . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.499 ' HE3' ' CD1' ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 121.918 0.866 . . . . 40.0 110.826 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 15.7 tt -130.3 71.75 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 40.0 109.315 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.499 ' CD1' ' HE3' ' B' ' 67' ' ' LYS . 29.2 mt . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.1 -1.0 . . . . 40.0 110.888 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.747 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -103.43 143.09 25.92 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 119.29 -2.131 . . . . 40.0 109.982 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.9 -10.25 14.16 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.697 1.367 . . . . 40.0 108.556 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.489 ' NH2' ' HE1' ' A' ' 152' ' ' TYR . 1.4 ttp180 -76.85 -3.83 40.53 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.085 -1.821 . . . . 40.0 106.085 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 104' ' ' SER . 2.3 mm-40 -106.86 -7.47 17.1 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.064 0.459 . . . . 40.0 110.186 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -51.58 -177.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.992 -1.067 . . . . 40.0 109.439 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 64.27 -66.84 0.06 OUTLIER Glycine 0 C--N 1.288 -2.087 0 N-CA-C 108.576 -1.81 . . . . 40.0 108.576 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.621 ' N ' ' O ' ' A' ' 108' ' ' ARG . 33.8 t-20 -31.12 113.08 0.32 Allowed Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.265 -1.138 . . . . 40.0 112.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.444 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 38.1 Cg_endo -63.68 -15.49 49.06 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.825 1.683 . . . . 40.0 112.815 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.581 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.51 -35.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.732 -1.855 . . . . 40.0 109.503 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.444 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.23 32.75 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 7.4 t80 -103.12 143.43 32.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.037 -1.039 . . . . 40.0 110.976 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.255 1.7 tp -146.4 92.16 2.14 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.367 -0.975 . . . . 40.0 108.367 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 142' ' ' SER . 6.7 t . . . . . 0 N--CA 1.531 3.622 0 O-C-N 120.357 -1.464 . . . . 40.0 114.873 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 152' ' ' TYR . 52.0 Cg_endo . . . . . 0 CA--C 1.545 1.058 0 N-CA-C 113.53 0.55 . . . . 40.0 113.53 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.484 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -44.38 -16.47 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 120.417 -1.427 . . . . 40.0 111.961 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.489 ' HE1' ' NH2' ' A' ' 106' ' ' ARG . 4.1 t80 -55.93 -50.91 69.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 40.0 111.5 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -62.07 -36.94 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.648 -1.621 . . . . 40.0 109.814 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.626 ' HE3' HG13 ' B' ' 69' ' ' ILE . 1.3 ttpp . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 121.804 0.811 . . . . 40.0 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.49 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 13.1 tt -119.6 52.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.499 -0.926 . . . . 40.0 108.499 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.626 HG13 ' HE3' ' B' ' 67' ' ' LYS . 5.9 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 40.0 110.645 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.94 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.745 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -101.96 139.76 20.6 Favored Pre-proline 0 C--N 1.289 -2.058 0 O-C-N 119.491 -2.005 . . . . 40.0 109.994 175.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.46 -15.57 36.77 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 108.195 -1.502 . . . . 40.0 108.195 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.56 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.5 ttm180 -72.6 -10.2 59.51 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 105.533 -2.025 . . . . 40.0 105.533 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.632 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.7 tp-100 -103.32 1.14 32.38 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.038 -0.528 . . . . 40.0 110.062 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.24 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.93 -1.106 . . . . 40.0 108.928 178.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 52.33 -89.92 0.01 OUTLIER Glycine 0 C--N 1.295 -1.736 0 N-CA-C 108.316 -1.914 . . . . 40.0 108.316 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.606 ' C ' ' O ' ' A' ' 109' ' ' GLY . 21.6 t-20 -6.18 115.18 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 121.604 -0.939 . . . . 40.0 112.954 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.419 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 42.1 Cg_endo -66.82 -14.66 44.64 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 122.29 1.994 . . . . 40.0 113.81 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.601 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.75 -35.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 119.834 -1.791 . . . . 40.0 109.503 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.419 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.509 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 131.18 31.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.4 t80 -98.64 136.63 38.44 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.233 1.016 . . . . 40.0 109.217 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.307 0.5 OUTLIER -140.11 94.03 2.71 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 107.541 -1.281 . . . . 40.0 107.541 -178.817 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.515 ' O ' ' CD2' ' A' ' 141' ' ' LEU . 20.7 t . . . . . 0 N--CA 1.513 2.699 0 C-N-CA 115.147 -2.621 . . . . 40.0 106.916 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.597 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 53.3 Cg_endo . . . . . 0 C--O 1.214 -0.679 0 N-CA-C 106.68 -2.084 . . . . 40.0 106.68 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 37.6 t0 67.77 -25.44 0.12 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.752 -1.217 . . . . 40.0 109.383 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.575 ' H ' ' C ' ' A' ' 150' ' ' PRO . 3.5 t80 -63.32 -53.16 57.05 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.723 -1.954 . . . . 40.0 105.723 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -62.08 -36.94 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.368 -1.733 . . . . 40.0 109.814 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.748 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.293 0.568 . . . . 40.0 110.237 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.646 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -122.94 73.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 122.042 0.925 . . . . 40.0 108.924 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.748 HG13 ' HD3' ' B' ' 67' ' ' LYS . 18.8 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 40.0 109.562 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.92 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.727 ' H ' HG11 ' A' ' 103' ' ' VAL . 1.9 t -98.07 137.58 20.86 Favored Pre-proline 0 C--N 1.292 -1.908 0 O-C-N 120.13 -1.606 . . . . 40.0 110.374 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.16 -9.34 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 124.013 1.533 . . . . 40.0 108.918 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.552 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.6 ttp180 -84.26 0.79 47.6 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 106.479 -1.674 . . . . 40.0 106.479 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 104' ' ' SER . 6.9 tp60 -108.55 -0.17 20.5 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.454 0.645 . . . . 40.0 109.584 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.701 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -53.0 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.982 -1.074 . . . . 40.0 108.81 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 56.28 -74.8 0.01 OUTLIER Glycine 0 C--N 1.288 -2.113 0 N-CA-C 108.773 -1.731 . . . . 40.0 108.773 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.72 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 12.6 t-20 -23.24 112.08 0.17 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.387 -1.066 . . . . 40.0 111.918 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.462 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 38.4 Cg_endo -64.76 -14.25 43.76 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.392 2.061 . . . . 40.0 113.0 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.72 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.05 -35.4 34.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 119.911 -1.743 . . . . 40.0 109.503 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.462 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.42 33.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.513 ' CD1' ' C ' ' A' ' 140' ' ' PHE . 1.1 t80 -104.34 137.01 42.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.746 -1.221 . . . . 40.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.534 ' HA ' ' HA3' ' B' ' 74' ' ' GLY 0.25 1.2 tp -138.85 103.37 4.79 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.0 -1.481 . . . . 40.0 107.0 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.701 ' O ' ' N ' ' A' ' 144' ' ' ARG . 25.9 t -70.13 17.04 0.06 Allowed 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 115.269 1.581 . . . . 40.0 115.269 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.813 ' O ' ' N ' ' A' ' 146' ' ' HIS . 1.1 tt 49.33 -67.85 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.561 0 O-C-N 120.478 -1.389 . . . . 40.0 112.138 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.701 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -43.28 -47.69 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 119.769 -1.832 . . . . 40.0 106.678 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.784 ' CE1' ' CE1' ' A' ' 149' ' ' HIS . 51.9 t80 -67.46 -29.4 68.84 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.82 -1.548 . . . . 40.0 106.82 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.813 ' N ' ' O ' ' A' ' 143' ' ' LEU . 63.6 t60 -50.59 -37.0 37.61 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.803 -0.759 . . . . 40.0 110.676 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 144' ' ' ARG . 0.7 OUTLIER -67.71 -62.15 1.55 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.335 -1.728 . . . . 40.0 106.335 177.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.628 ' C ' ' CD2' ' A' ' 149' ' ' HIS . 5.1 mp -52.75 104.93 0.1 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.622 -1.251 . . . . 40.0 107.622 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.784 ' CE1' ' CE1' ' A' ' 145' ' ' TYR . 4.9 p80 43.09 96.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.593 -0.73 . . . . 40.0 112.455 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.694 ' C ' ' H ' ' A' ' 152' ' ' TYR . 51.8 Cg_endo -96.88 -148.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.209 -0.967 0 C-N-CA 123.296 2.664 . . . . 40.0 107.232 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 18.8 t0 61.71 -26.17 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 O-C-N 120.612 -1.305 . . . . 40.0 109.494 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.694 ' H ' ' C ' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -62.48 -45.47 92.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.072 -1.825 . . . . 40.0 106.072 177.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -61.67 -36.94 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 115.937 -2.305 . . . . 40.0 109.814 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.581 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.699 0.761 . . . . 40.0 110.723 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.562 HG22 ' NZ ' ' B' ' 67' ' ' LYS . 13.3 tt -126.35 59.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.515 -0.92 . . . . 40.0 108.515 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.591 ' O ' ' C ' ' B' ' 70' ' ' ASP . 8.3 mt -109.85 38.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 40.0 110.624 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.591 ' C ' ' O ' ' B' ' 69' ' ' ILE . 2.6 t0 -29.46 106.03 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.686 1.232 . . . . 40.0 111.409 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 5.6 p -82.52 -132.6 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.254 -1.387 . . . . 40.0 107.254 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.512 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -129.47 134.53 7.97 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.036 -1.626 . . . . 40.0 109.036 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.456 ' HA2' ' HH ' ' A' ' 152' ' ' TYR . . . 152.52 25.66 0.05 OUTLIER Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.202 -0.999 . . . . 40.0 111.709 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 52.91 58.18 12.32 Favored Glycine 0 N--CA 1.504 3.182 0 O-C-N 120.477 -1.602 . . . . 40.0 109.622 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.661 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.8 OUTLIER -172.09 131.25 0.64 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.103 -1.439 . . . . 40.0 110.424 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.66 HG13 ' HB3' ' A' ' 144' ' ' ARG . 13.3 mm -71.4 130.5 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 113.279 0.844 . . . . 40.0 113.279 -176.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.56 ' HB3' ' HA ' ' B' ' 70' ' ' ASP . 10.7 tp . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.432 -0.794 . . . . 40.0 111.527 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.51 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.735 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -103.22 138.53 19.57 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 119.646 -1.909 . . . . 40.0 110.578 176.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -59.8 -13.61 23.12 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.656 1.345 . . . . 40.0 109.142 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 3.0 ttm-85 -76.19 -7.46 54.87 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 105.797 -1.927 . . . . 40.0 105.797 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 104' ' ' SER . 9.0 tp60 -106.92 3.28 26.0 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.2 0.524 . . . . 40.0 110.05 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.9 -157.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.663 -1.273 . . . . 40.0 109.472 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.593 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 49.4 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 107.806 -2.118 . . . . 40.0 107.806 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.695 ' HB2' ' CD2' ' B' ' 75' ' ' PHE . 5.6 t-20 -4.9 109.15 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.692 0 O-C-N 121.825 -0.809 . . . . 40.0 112.986 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 38.2 Cg_endo -63.05 -12.36 29.4 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 122.268 1.979 . . . . 40.0 114.794 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.32 -35.4 36.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 O-C-N 119.315 -2.116 . . . . 40.0 109.503 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.533 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.97 33.84 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.8 t80 -102.99 138.61 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 40.0 110.904 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 2.7 tp -140.86 102.82 4.36 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.774 -1.565 . . . . 40.0 106.774 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 144' ' ' ARG . 28.0 t -71.02 17.15 0.08 Allowed 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 117.608 -1.637 . . . . 40.0 115.013 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.789 ' O ' ' N ' ' A' ' 146' ' ' HIS . 1.0 OUTLIER 49.75 -67.58 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.718 -1.239 . . . . 40.0 112.244 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.75 ' HB3' HG13 ' B' ' 76' ' ' ILE . 0.0 OUTLIER -43.19 -42.54 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 119.986 -1.696 . . . . 40.0 106.714 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.827 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 86.9 t80 -71.66 -32.67 68.14 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.701 -1.592 . . . . 40.0 106.701 175.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.789 ' N ' ' O ' ' A' ' 143' ' ' LEU . 72.7 t60 -48.69 -33.81 10.77 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.011 -0.676 . . . . 40.0 111.202 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -64.52 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.589 ' C ' ' ND1' ' A' ' 149' ' ' HIS . 4.2 mp -54.42 113.66 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.827 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 8.0 p-80 42.24 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.647 0 O-C-N 121.179 -0.95 . . . . 40.0 109.829 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 152' ' ' TYR . 54.0 Cg_endo -94.72 -53.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.068 1.845 . . . . 40.0 113.051 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 39.1 t0 -34.47 -19.08 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 119.387 0.994 . . . . 40.0 113.501 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 150' ' ' PRO . 9.1 t80 -54.45 -48.59 71.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.626 -1.296 . . . . 40.0 111.361 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -63.19 -36.94 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.321 -1.752 . . . . 40.0 109.814 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.447 ' CD ' ' CD1' ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 121.683 0.754 . . . . 40.0 110.728 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.724 ' O ' ' N ' ' B' ' 70' ' ' ASP 0.252 0.1 OUTLIER -107.25 -40.75 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 122.015 0.912 . . . . 40.0 110.996 -178.277 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.462 ' N ' HG23 ' B' ' 68' ' ' ILE . 8.0 mt -26.59 65.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 CA-C-N 114.67 -1.15 . . . . 40.0 113.676 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.724 ' N ' ' O ' ' B' ' 68' ' ' ILE . 1.0 OUTLIER -68.16 111.7 4.66 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 117.363 -1.735 . . . . 40.0 108.781 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.468 HG22 ' CD1' ' B' ' 77' ' ' LEU . 3.3 p -83.66 -138.65 0.05 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.389 -1.337 . . . . 40.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.706 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -123.71 141.59 13.69 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.284 -1.527 . . . . 40.0 109.284 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.588 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 147.92 16.43 0.12 Allowed Glycine 0 N--CA 1.508 3.44 0 C-N-CA 120.29 -0.957 . . . . 40.0 111.965 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 57.78 61.16 7.77 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.014 -1.635 . . . . 40.0 109.014 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.695 ' CD2' ' HB2' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -171.86 129.3 0.63 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.446 -1.302 . . . . 40.0 110.115 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.75 HG13 ' HB3' ' A' ' 144' ' ' ARG . 18.8 mm -72.16 123.22 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.651 -0.656 . . . . 40.0 112.231 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.562 ' HG ' ' CZ ' ' B' ' 75' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 CA-C-O 117.884 -1.055 . . . . 40.0 111.308 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.729 ' H ' HG11 ' A' ' 103' ' ' VAL . 2.4 t -99.32 138.53 20.54 Favored Pre-proline 0 C--N 1.289 -2.063 0 O-C-N 120.352 -1.468 . . . . 40.0 110.319 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.29 -9.14 9.86 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 124.115 1.587 . . . . 40.0 108.539 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' B' ' 72' ' ' GLY . 1.6 ttp180 -80.47 -2.78 47.32 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 106.204 -1.776 . . . . 40.0 106.204 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.57 ' HG2' ' OH ' ' A' ' 130' ' ' TYR . 8.5 tp60 -108.83 0.48 20.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.253 0.549 . . . . 40.0 110.249 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -52.23 -172.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.911 -1.118 . . . . 40.0 108.566 178.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.585 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 58.75 -80.03 0.01 OUTLIER Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.764 -1.734 . . . . 40.0 108.764 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 108' ' ' ARG . 34.6 t30 -16.72 106.27 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.463 0 O-C-N 121.418 -1.048 . . . . 40.0 112.253 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.441 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 37.4 Cg_endo -61.22 -14.85 36.36 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.296 1.997 . . . . 40.0 113.247 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 140' ' ' PHE . 53.6 t -54.79 -35.4 33.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 O-C-N 119.83 -1.794 . . . . 40.0 109.503 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 131.77 32.08 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.9 t80 -102.44 138.97 38.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 40.0 110.427 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' A' ' 146' ' ' HIS 0.25 1.6 tp -141.49 103.82 4.46 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.147 -1.427 . . . . 40.0 107.147 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.686 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 24.8 t -70.45 10.53 0.46 Allowed 'General case' 0 N--CA 1.525 3.299 0 O-C-N 120.231 -1.543 . . . . 40.0 114.655 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.829 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.3 OUTLIER 56.35 -66.35 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.658 -1.277 . . . . 40.0 111.939 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -44.25 -58.89 2.63 Favored 'General case' 0 C--O 1.2 -1.531 0 O-C-N 119.446 -2.033 . . . . 40.0 105.659 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.733 ' N ' HD13 ' B' ' 76' ' ' ILE . 49.5 t80 -55.12 -27.93 48.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.829 ' HB3' ' O ' ' A' ' 143' ' ' LEU . 32.6 t60 -49.83 -42.34 47.02 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.532 -0.73 . . . . 40.0 111.638 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.453 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.5 OUTLIER -68.44 -46.15 70.61 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.353 -1.339 . . . . 40.0 108.295 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 149' ' ' HIS . 4.8 mp -56.0 -31.01 62.67 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 40.0 111.133 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.688 ' CD2' ' CE1' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -148.46 81.81 7.77 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 40.0 111.019 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 45.7 Cg_endo -76.93 173.23 14.81 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 N-CA-C 107.359 -1.823 . . . . 40.0 107.359 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.645 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 26.4 t0 70.55 -22.79 0.17 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.647 -1.283 . . . . 40.0 109.443 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.516 ' H ' ' C ' ' A' ' 150' ' ' PRO . 2.1 t80 -65.72 -52.64 49.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 105.794 -1.928 . . . . 40.0 105.794 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -59.9 -36.94 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.461 -1.696 . . . . 40.0 109.814 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.565 ' CE ' ' H ' ' B' ' 68' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 122.087 0.946 . . . . 40.0 110.942 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.685 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -107.43 68.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.312 -0.996 . . . . 40.0 108.312 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' B' ' 67' ' ' LYS . 9.4 mt -122.34 40.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 40.0 110.894 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.798 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 6.3 t70 -34.09 118.04 0.36 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.468 1.127 . . . . 40.0 111.52 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 3.0 p -91.91 -128.43 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.099 -1.074 . . . . 40.0 108.099 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.589 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -135.27 128.16 4.61 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.738 -1.345 . . . . 40.0 109.738 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.497 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 156.61 25.62 0.03 OUTLIER Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.396 -0.907 . . . . 40.0 112.132 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.52 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 55.91 55.85 26.99 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 120.203 -1.763 . . . . 40.0 109.861 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.686 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.7 OUTLIER -169.96 129.97 0.97 Allowed 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 117.917 -1.513 . . . . 40.0 109.749 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.733 HD13 ' N ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -68.78 144.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.326 0.584 . . . . 40.0 112.032 -176.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.798 ' HB3' ' HA ' ' B' ' 70' ' ' ASP . 11.4 tp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 117.34 -1.314 . . . . 40.0 111.75 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.3 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.753 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -104.13 141.14 21.89 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 119.38 -2.075 . . . . 40.0 110.209 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.02 -14.33 27.59 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.779 1.41 . . . . 40.0 108.866 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 2.8 ttm-85 -74.09 -2.19 23.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.036 -1.839 . . . . 40.0 106.036 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 104' ' ' SER . 7.8 tp60 -109.0 -5.01 16.23 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.148 0.499 . . . . 40.0 110.851 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 110' ' ' ASN . 35.7 ttm180 -55.06 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.524 -1.36 . . . . 40.0 109.055 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 67.78 -72.49 0.26 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 107.61 -2.196 . . . . 40.0 107.61 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.779 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 9.9 t-20 -27.31 111.31 0.23 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.593 -0.945 . . . . 40.0 111.282 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.456 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 37.7 Cg_endo -63.37 -13.52 36.56 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.131 1.888 . . . . 40.0 113.172 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.779 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.7 -35.4 39.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 O-C-N 119.891 -1.755 . . . . 40.0 109.503 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.456 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.58 33.27 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 t80 -103.13 139.13 39.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.609 -0.837 . . . . 40.0 110.364 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.704 HD12 ' HB2' ' A' ' 146' ' ' HIS 0.252 0.7 OUTLIER -143.16 102.58 4.01 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.671 -1.604 . . . . 40.0 106.671 179.23 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.687 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 28.6 t -70.93 15.38 0.11 Allowed 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 115.473 1.656 . . . . 40.0 115.473 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.801 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.7 OUTLIER 51.73 -69.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.389 -1.444 . . . . 40.0 112.633 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.641 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -43.75 -41.86 5.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.706 -1.872 . . . . 40.0 106.696 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.879 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 63.4 t80 -70.83 -32.51 69.59 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.736 -1.579 . . . . 40.0 106.736 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.801 ' N ' ' O ' ' A' ' 143' ' ' LEU . 61.7 t60 -49.52 -37.37 26.52 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.898 -0.502 . . . . 40.0 111.747 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -58.82 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.761 -1.57 . . . . 40.0 106.761 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.613 ' C ' ' ND1' ' A' ' 149' ' ' HIS . 5.1 mp -58.46 113.71 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.202 -1.407 . . . . 40.0 107.202 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.879 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 4.9 p-80 43.23 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 O-C-N 121.125 -0.984 . . . . 40.0 109.832 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 152' ' ' TYR . 51.0 Cg_endo -94.17 -61.01 0.01 OUTLIER 'Trans proline' 0 C--O 1.209 -0.963 0 C-N-CA 122.195 1.93 . . . . 40.0 112.898 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 25.2 t0 -29.35 -22.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.502 0 CA-C-N 119.293 0.951 . . . . 40.0 113.546 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.706 ' N ' ' O ' ' A' ' 150' ' ' PRO . 10.3 t80 -50.52 -49.56 55.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.892 -1.13 . . . . 40.0 111.158 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -63.77 -36.94 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.251 -1.78 . . . . 40.0 109.814 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.709 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.574 0.702 . . . . 40.0 110.801 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -119.91 28.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.225 -0.922 . . . . 40.0 110.414 -178.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.709 HG13 ' HD3' ' B' ' 67' ' ' LYS . 7.5 mt -90.81 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.145 -0.972 . . . . 40.0 111.583 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.481 ' OD1' ' CE1' ' A' ' 145' ' ' TYR . 3.8 t0 -42.09 103.16 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.901 -1.12 . . . . 40.0 110.721 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.3 p -78.15 -136.74 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.348 -1.353 . . . . 40.0 107.348 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -127.65 137.03 9.56 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.814 -1.314 . . . . 40.0 109.814 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.557 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 152.88 23.48 0.05 OUTLIER Glycine 0 N--CA 1.506 3.323 0 C-N-CA 120.573 -0.822 . . . . 40.0 111.753 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 56.33 57.47 19.13 Favored Glycine 0 N--CA 1.502 3.053 0 O-C-N 120.445 -1.621 . . . . 40.0 109.762 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.687 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -172.82 130.77 0.52 Allowed 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 118.468 -1.293 . . . . 40.0 110.036 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 145' ' ' TYR . 12.5 mm -71.45 128.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.2 0.815 . . . . 40.0 113.2 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.593 ' HG ' ' CE2' ' B' ' 75' ' ' PHE . 1.1 mt . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.587 -1.197 . . . . 40.0 110.91 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.93 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.747 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -101.67 137.86 19.69 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 119.607 -1.933 . . . . 40.0 110.438 175.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -59.93 -9.71 10.51 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.69 1.363 . . . . 40.0 108.745 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.441 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -78.74 -2.46 39.53 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 105.696 -1.965 . . . . 40.0 105.696 175.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.8 tp-100 -109.37 -0.01 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.107 0.48 . . . . 40.0 110.487 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -54.63 -163.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.583 -1.323 . . . . 40.0 109.507 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 53.57 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 107.092 -2.403 . . . . 40.0 107.092 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 108' ' ' ARG . 24.3 t-20 -7.74 109.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.621 0 O-C-N 121.651 -0.911 . . . . 40.0 112.879 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.496 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 39.8 Cg_endo -64.44 -13.81 40.63 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.043 1.828 . . . . 40.0 114.21 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.427 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.64 -35.4 38.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 119.48 -2.012 . . . . 40.0 109.503 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 130.73 30.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.0 OUTLIER -109.98 124.31 51.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.552 -1.259 . . . . 40.0 109.798 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.777 ' HA ' ' HA3' ' B' ' 74' ' ' GLY . 0.3 OUTLIER -130.85 104.81 7.37 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 106.262 -1.755 . . . . 40.0 106.262 178.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.474 ' H ' ' C ' ' B' ' 74' ' ' GLY . 7.4 t -62.78 176.99 0.6 Allowed 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 116.374 -2.131 . . . . 40.0 107.236 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.78 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.0 OUTLIER -98.75 -56.89 2.32 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 119.994 -1.691 . . . . 40.0 108.773 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.568 ' C ' ' O ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -39.68 -59.32 1.16 Allowed 'General case' 0 C--O 1.201 -1.45 0 N-CA-C 106.643 -1.614 . . . . 40.0 106.643 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.779 ' N ' HD11 ' B' ' 76' ' ' ILE . 68.8 t80 -54.68 -29.1 51.92 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.418 -0.913 . . . . 40.0 109.226 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.78 ' N ' ' O ' ' A' ' 143' ' ' LEU . 74.1 t60 -52.72 -37.19 58.74 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.801 -1.16 . . . . 40.0 111.659 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -68.23 -61.52 1.81 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.372 -1.455 . . . . 40.0 108.25 179.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.656 ' C ' ' CD2' ' A' ' 149' ' ' HIS . 3.1 mp -52.01 109.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 40.0 108.068 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.746 ' CE1' ' CE1' ' A' ' 145' ' ' TYR . 3.2 p80 43.05 98.72 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.672 0 O-C-N 121.331 -0.856 . . . . 40.0 110.245 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 152' ' ' TYR . 55.9 Cg_endo -96.33 -56.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.881 0 C-N-CA 122.418 2.078 . . . . 40.0 113.949 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -30.54 -22.34 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 113.775 1.028 . . . . 40.0 113.775 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 150' ' ' PRO . 2.5 t80 -52.12 -46.85 65.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.808 -1.182 . . . . 40.0 111.009 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -63.39 -36.94 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 116.455 -2.098 . . . . 40.0 109.814 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 152' ' ' TYR . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.762 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 121.513 0.673 . . . . 40.0 110.627 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.574 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -125.36 39.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.331 -0.855 . . . . 40.0 109.596 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.762 HG13 ' HD3' ' B' ' 67' ' ' LYS . 9.5 mt -93.08 33.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.456 -0.777 . . . . 40.0 111.47 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.645 ' C ' ' O ' ' B' ' 69' ' ' ILE . 5.6 t0 -28.79 107.26 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.576 1.179 . . . . 40.0 110.647 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.4 p -84.34 -128.55 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.814 -1.18 . . . . 40.0 107.814 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.611 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -136.72 133.76 6.72 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.397 -1.481 . . . . 40.0 109.397 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.493 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 153.28 31.72 0.03 OUTLIER Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.695 -0.764 . . . . 40.0 111.421 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 49.4 59.34 7.2 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.583 -1.539 . . . . 40.0 110.903 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 110' ' ' ASN . 1.8 p90 -174.89 130.48 0.31 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.828 -1.149 . . . . 40.0 109.443 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.779 HD11 ' N ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -69.27 135.75 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.408 0.623 . . . . 40.0 112.676 -176.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' B' ' 75' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 40.0 111.526 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.68 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.721 ' H ' HG11 ' A' ' 103' ' ' VAL . 5.0 t -102.57 142.82 25.36 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.338 -1.476 . . . . 40.0 110.708 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.1 Cg_endo -63.21 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 107.789 -1.658 . . . . 40.0 107.789 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 3.9 ttm-85 -72.64 -8.44 55.3 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 105.952 -1.87 . . . . 40.0 105.952 175.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.568 ' NE2' ' OH ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -105.47 1.89 28.06 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 115.867 -0.606 . . . . 40.0 109.51 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -54.91 -164.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.268 -0.895 . . . . 40.0 110.128 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 47.89 -126.92 14.55 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 104.136 -3.585 . . . . 40.0 104.136 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.578 ' HB2' ' CE2' ' B' ' 75' ' ' PHE . 38.4 t-20 39.37 105.54 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 118.872 1.336 . . . . 40.0 113.701 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.545 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 40.3 Cg_endo -63.35 -13.38 35.62 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.818 1.679 . . . . 40.0 114.551 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 140' ' ' PHE . 53.6 t -58.49 -35.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 119.516 -1.99 . . . . 40.0 109.503 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.545 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.67 33.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 t80 -107.07 129.66 54.79 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.326 -1.484 . . . . 40.0 111.819 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 7.5 tp -127.74 104.69 7.98 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.372 -1.344 . . . . 40.0 107.372 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.696 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 13.3 t -69.88 2.94 2.94 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 117.302 -1.759 . . . . 40.0 113.785 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.752 ' HA ' ' CB ' ' A' ' 146' ' ' HIS . 0.1 OUTLIER 62.5 -72.12 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.594 -1.316 . . . . 40.0 111.779 -178.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.663 ' C ' ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -37.03 -57.52 0.83 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 105.974 -1.862 . . . . 40.0 105.974 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.785 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 50.0 t80 -56.35 -42.35 77.61 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.921 -1.14 . . . . 40.0 107.921 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.752 ' CB ' ' HA ' ' A' ' 143' ' ' LEU . 33.8 t60 -38.12 -37.57 0.28 Allowed 'General case' 0 N--CA 1.519 3.015 0 O-C-N 121.21 -0.931 . . . . 40.0 112.134 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 149' ' ' HIS . 28.5 m-20 -66.6 -63.66 1.02 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.258 -0.901 . . . . 40.0 109.316 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.516 ' CB ' ' CD2' ' A' ' 149' ' ' HIS . 5.7 mp -40.52 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.1 -1.0 . . . . 40.0 111.643 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.785 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -158.62 99.76 1.69 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.266 -1.012 . . . . 40.0 108.266 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.0 -53.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.592 1.311 . . . . 40.0 112.404 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 66.5 t0 -49.77 -19.43 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.591 -1.318 . . . . 40.0 112.237 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -54.07 -56.96 13.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.77 -1.207 . . . . 40.0 111.915 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -63.23 -36.94 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.259 -1.376 . . . . 40.0 109.814 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.424 ' HZ2' HG13 ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.525 0.202 . . . . 40.0 110.941 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.41 72.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 CA-C-O 122.026 0.917 . . . . 40.0 111.02 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' B' ' 70' ' ' ASP . 0.5 OUTLIER -121.84 127.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 123.052 1.406 . . . . 40.0 111.144 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 9.1 t70 -25.37 167.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.48 2.4 . . . . 40.0 117.48 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -147.44 -115.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 112.181 -2.281 . . . . 40.0 107.719 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -153.03 118.98 0.91 Allowed Glycine 0 N--CA 1.508 3.486 0 C-N-CA 119.332 -1.413 . . . . 40.0 112.66 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.1 34.95 0.02 OUTLIER Glycine 0 N--CA 1.511 3.7 0 O-C-N 122.029 -0.689 . . . . 40.0 112.29 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.467 ' HA2' ' CD2' ' A' ' 145' ' ' TYR . . . 51.23 54.48 23.3 Favored Glycine 0 N--CA 1.514 3.897 0 O-C-N 120.195 -1.768 . . . . 40.0 109.571 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.696 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.2 OUTLIER -173.16 117.98 0.3 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.883 -1.127 . . . . 40.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -65.51 131.73 31.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.5 0.667 . . . . 40.0 111.927 -176.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.121 0 CA-C-O 118.23 -0.89 . . . . 40.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.98 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.755 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -97.75 138.98 21.07 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 119.869 -1.769 . . . . 40.0 111.236 176.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.47 -10.72 17.08 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.689 1.363 . . . . 40.0 109.272 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -88.01 6.67 34.9 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 105.931 -1.877 . . . . 40.0 105.931 176.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.661 ' HB2' ' O ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -110.7 -3.97 15.58 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.968 -0.753 . . . . 40.0 108.968 177.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -50.86 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.832 -1.167 . . . . 40.0 110.13 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.651 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 50.59 -97.38 0.02 OUTLIER Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.584 -2.206 . . . . 40.0 107.584 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.771 ' HB2' ' CD2' ' B' ' 75' ' ' PHE . 1.2 t30 -0.57 108.92 0.02 OUTLIER Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 121.791 -0.829 . . . . 40.0 112.459 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.54 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 39.0 Cg_endo -63.18 -11.49 25.46 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 122.334 2.022 . . . . 40.0 114.831 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.649 ' HB ' HD22 ' A' ' 110' ' ' ASN . 53.6 t -56.63 -35.4 45.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 O-C-N 119.352 -2.092 . . . . 40.0 109.503 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.54 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.44 33.07 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.3 t80 -106.25 132.24 52.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 40.0 111.34 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.562 ' HA ' ' HA3' ' B' ' 74' ' ' GLY . 0.2 OUTLIER -135.43 103.46 5.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.968 -1.493 . . . . 40.0 106.968 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.817 ' O ' ' N ' ' A' ' 144' ' ' ARG . 14.9 t -72.92 41.89 0.1 Allowed 'General case' 0 N--CA 1.525 3.302 0 O-C-N 120.228 -1.545 . . . . 40.0 114.765 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.747 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.5 OUTLIER 30.75 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 O-C-N 120.769 -1.207 . . . . 40.0 113.46 178.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.817 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -42.57 -65.19 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 119.766 -1.834 . . . . 40.0 106.983 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.918 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 49.0 t80 -52.59 -23.62 6.77 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.818 -0.808 . . . . 40.0 108.818 176.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.747 ' HB3' ' O ' ' A' ' 143' ' ' LEU . 56.9 t-80 -54.28 -39.64 67.1 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.904 -1.122 . . . . 40.0 111.135 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.4 OUTLIER -62.93 -65.25 0.71 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.179 -1.415 . . . . 40.0 107.179 178.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' A' ' 149' ' ' HIS . 3.8 mp -48.04 108.01 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.919 -1.141 . . . . 40.0 107.919 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.918 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 10.3 p-80 45.43 96.59 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 121.245 -0.91 . . . . 40.0 109.694 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 152' ' ' TYR . 56.2 Cg_endo -95.27 -48.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.156 1.904 . . . . 40.0 113.666 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -39.24 -18.93 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.265 0 O-C-N 120.562 -1.336 . . . . 40.0 112.901 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.551 ' OH ' ' HA2' ' B' ' 73' ' ' GLY . 8.9 t80 -53.3 -50.18 65.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.14 . . . . 40.0 111.634 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -62.92 -36.94 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.276 -1.77 . . . . 40.0 109.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.674 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.603 0.716 . . . . 40.0 110.715 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.513 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -124.99 33.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.403 -0.811 . . . . 40.0 110.521 -178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.674 HG13 ' HD3' ' B' ' 67' ' ' LYS . 7.4 mt -87.6 39.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.154 -0.966 . . . . 40.0 111.122 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' B' ' 69' ' ' ILE . 4.1 t0 -35.38 108.86 0.07 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.66 1.219 . . . . 40.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.7 p -85.19 -122.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.27 -1.011 . . . . 40.0 108.27 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.68 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -141.84 132.76 5.38 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.036 -1.226 . . . . 40.0 110.036 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 154.91 25.25 0.03 OUTLIER Glycine 0 N--CA 1.506 3.313 0 O-C-N 122.062 -0.669 . . . . 40.0 111.719 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 56.15 55.33 29.92 Favored Glycine 0 N--CA 1.502 3.071 0 O-C-N 120.256 -1.732 . . . . 40.0 110.012 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.771 ' CD2' ' HB2' ' A' ' 110' ' ' ASN . 1.4 p90 -170.09 130.71 0.97 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.868 -1.133 . . . . 40.0 109.455 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.689 HD12 ' N ' ' A' ' 145' ' ' TYR . 0.4 OUTLIER -73.41 132.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.601 0.715 . . . . 40.0 112.752 -175.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.493 ' HB3' ' HA ' ' B' ' 70' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.613 -1.184 . . . . 40.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 104' ' ' SER . 87.2 t -115.84 172.15 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.796 ' H ' HG11 ' A' ' 103' ' ' VAL . 1.3 t -98.28 142.8 25.17 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 120.36 -1.462 . . . . 40.0 111.206 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 -12.22 34.76 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 N-CA-C 107.771 -1.665 . . . . 40.0 107.771 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.67 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -82.73 -2.13 53.38 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 105.984 -1.858 . . . . 40.0 105.984 176.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.662 ' HB3' ' O ' ' A' ' 104' ' ' SER . 4.7 tp-100 -107.42 6.64 28.45 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.163 -1.051 . . . . 40.0 108.163 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.612 ' HG2' ' CZ ' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -52.65 -166.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 40.0 110.062 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 46.52 -110.59 0.54 Allowed Glycine 0 C--O 1.208 -1.521 0 N-CA-C 105.618 -2.993 . . . . 40.0 105.618 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.626 ' ND2' ' HB ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER 25.59 97.36 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 117.662 0.731 . . . . 40.0 112.768 176.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.477 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 36.2 Cg_endo -57.86 -13.39 14.72 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.84 1.693 . . . . 40.0 114.125 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.626 ' HB ' ' ND2' ' A' ' 110' ' ' ASN . 53.6 t -58.1 -35.4 52.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 O-C-N 119.783 -1.823 . . . . 40.0 109.503 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.612 ' CZ ' ' HG2' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.83 33.63 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 2.6 t80 -103.52 143.67 32.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.915 -1.116 . . . . 40.0 111.022 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.566 ' HA ' ' HA3' ' B' ' 74' ' ' GLY . 3.3 tp -146.24 101.04 3.46 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.594 -1.261 . . . . 40.0 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.642 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 10.5 t -67.12 5.56 0.68 Allowed 'General case' 0 N--CA 1.517 2.9 0 O-C-N 120.228 -1.545 . . . . 40.0 114.124 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.829 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.0 OUTLIER 61.3 -70.38 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.585 -1.322 . . . . 40.0 110.954 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.627 ' C ' ' O ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -40.81 -54.91 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.818 -1.919 . . . . 40.0 105.818 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.652 ' N ' ' CD1' ' B' ' 76' ' ' ILE . 4.5 t80 -52.84 -43.53 66.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.274 -1.38 . . . . 40.0 107.274 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.829 ' HB3' ' O ' ' A' ' 143' ' ' LEU . 80.4 t60 -39.82 -45.87 1.86 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 121.521 0.677 . . . . 40.0 112.553 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -67.16 -51.93 47.78 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.075 -1.016 . . . . 40.0 108.829 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 148' ' ' LEU . 4.3 mm? -44.55 -27.97 0.53 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.28 -0.887 . . . . 40.0 109.538 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.663 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -172.02 101.95 0.37 Allowed Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 40.0 110.812 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 152' ' ' TYR . 47.0 Cg_endo -87.88 -169.13 0.43 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 107.605 -1.729 . . . . 40.0 107.605 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.604 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 66.3 t0 67.98 -23.95 0.12 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.29 -1.506 . . . . 40.0 108.441 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.681 ' OH ' ' HA3' ' B' ' 73' ' ' GLY . 8.0 t80 -66.24 -54.38 25.7 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.936 -1.505 . . . . 40.0 106.936 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -60.15 -36.94 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.102 -1.439 . . . . 40.0 109.814 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.533 ' NH1' ' OH ' ' A' ' 152' ' ' TYR . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.499 ' HE3' ' CD1' ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 121.918 0.866 . . . . 40.0 110.826 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 15.7 tt -130.3 71.75 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 40.0 109.315 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.499 ' CD1' ' HE3' ' B' ' 67' ' ' LYS . 29.2 mt -137.06 54.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.1 -1.0 . . . . 40.0 110.888 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.543 ' OD1' ' HA ' ' B' ' 76' ' ' ILE . 0.2 OUTLIER -40.8 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.371 1.081 . . . . 40.0 110.009 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' THR . . . . . . . . . . . . 0.276 12.5 t -146.14 150.43 35.87 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.657 -0.817 . . . . 40.0 110.081 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.51 ' CA ' ' HG3' ' A' ' 106' ' ' ARG . . . 105.56 -110.24 3.4 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.759 -1.21 . . . . 40.0 110.332 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.681 ' HA3' ' OH ' ' A' ' 152' ' ' TYR . . . -153.88 109.95 0.43 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.835 -1.65 . . . . 40.0 113.709 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' B' ' 75' ' ' PHE . . . 41.68 82.38 0.02 OUTLIER Glycine 0 N--CA 1.5 2.921 0 O-C-N 122.23 -0.57 . . . . 40.0 111.801 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.642 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.1 OUTLIER 177.07 104.81 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.617 -1.253 . . . . 40.0 107.617 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.652 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 1.4 tp -53.16 122.78 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 113.179 0.807 . . . . 40.0 113.179 -175.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.591 ' HG ' ' CZ ' ' B' ' 75' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.296 -1.718 0 CA-C-O 117.354 -1.308 . . . . 40.0 110.525 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.747 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -103.43 143.09 25.92 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 119.29 -2.131 . . . . 40.0 109.982 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.9 -10.25 14.16 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.697 1.367 . . . . 40.0 108.556 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.489 ' NH2' ' HE1' ' A' ' 152' ' ' TYR . 1.4 ttp180 -76.85 -3.83 40.53 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.085 -1.821 . . . . 40.0 106.085 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 104' ' ' SER . 2.3 mm-40 -106.86 -7.47 17.1 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.064 0.459 . . . . 40.0 110.186 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -51.58 -177.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.992 -1.067 . . . . 40.0 109.439 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 64.27 -66.84 0.06 OUTLIER Glycine 0 C--N 1.288 -2.087 0 N-CA-C 108.576 -1.81 . . . . 40.0 108.576 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.621 ' N ' ' O ' ' A' ' 108' ' ' ARG . 33.8 t-20 -31.12 113.08 0.32 Allowed Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.265 -1.138 . . . . 40.0 112.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 38.1 Cg_endo -63.68 -15.49 49.06 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.825 1.683 . . . . 40.0 112.815 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.581 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.51 -35.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.732 -1.855 . . . . 40.0 109.503 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.444 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 132.23 32.75 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 7.4 t80 -103.12 143.43 32.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.037 -1.039 . . . . 40.0 110.976 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.255 1.7 tp -146.4 92.16 2.14 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.367 -0.975 . . . . 40.0 108.367 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 144' ' ' ARG . 6.7 t -57.65 17.43 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.622 0 O-C-N 120.357 -1.464 . . . . 40.0 114.873 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.895 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.9 OUTLIER 46.84 -71.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.149 -1.594 . . . . 40.0 112.761 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -38.98 -49.29 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 119.565 -1.96 . . . . 40.0 106.131 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.747 ' CE1' ' CE1' ' A' ' 149' ' ' HIS . 52.4 t80 -61.81 -35.67 78.87 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.646 -1.242 . . . . 40.0 107.646 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.895 ' N ' ' O ' ' A' ' 143' ' ' LEU . 49.3 t60 -43.51 -38.69 3.01 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.454 0.645 . . . . 40.0 111.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 2.8 m-20 -63.86 -61.83 2.04 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.284 -1.376 . . . . 40.0 107.284 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.777 ' C ' ' CD2' ' A' ' 149' ' ' HIS . 5.3 mp -55.72 107.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.084 -1.08 . . . . 40.0 108.084 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.777 ' CD2' ' C ' ' A' ' 148' ' ' LEU . 0.1 OUTLIER 48.83 96.1 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.503 0 O-C-N 121.415 -0.803 . . . . 40.0 109.973 -176.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 152' ' ' TYR . 52.0 Cg_endo -94.7 -46.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.439 2.093 . . . . 40.0 113.53 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.484 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -44.38 -16.47 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 120.417 -1.427 . . . . 40.0 111.961 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.514 ' OH ' ' HA2' ' B' ' 73' ' ' GLY . 4.1 t80 -55.93 -50.91 69.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 40.0 111.5 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -62.07 -36.94 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.648 -1.621 . . . . 40.0 109.814 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.626 ' HE3' HG13 ' B' ' 69' ' ' ILE . 1.3 ttpp . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 121.804 0.811 . . . . 40.0 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.49 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 13.1 tt -119.6 52.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.499 -0.926 . . . . 40.0 108.499 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.626 HG13 ' HE3' ' B' ' 67' ' ' LYS . 5.9 mt -100.45 41.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 40.0 110.645 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.623 ' C ' ' O ' ' B' ' 69' ' ' ILE . 11.3 t70 -32.47 122.12 0.33 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.501 -1.28 . . . . 40.0 110.328 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 2.8 p -95.52 -124.72 0.12 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.501 -1.296 . . . . 40.0 107.501 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.6 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -141.16 129.17 3.96 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.137 -1.585 . . . . 40.0 109.137 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.514 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 156.11 26.27 0.03 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 120.034 -1.079 . . . . 40.0 112.367 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 79.07 -42.68 2.36 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 119.902 -1.94 . . . . 40.0 110.718 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.559 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.6 OUTLIER -85.33 148.02 26.24 Favored 'General case' 0 C--N 1.263 -3.17 0 C-N-CA 117.692 -1.603 . . . . 40.0 112.455 -175.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.694 HD13 ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -90.76 131.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.465 0.65 . . . . 40.0 111.61 -176.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' B' ' 70' ' ' ASP . 6.8 tp . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.342 -0.849 . . . . 40.0 112.844 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.782 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 1.005 HG21 ' H ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 1.005 ' H ' HG21 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.762 HG13 ' CE1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.94 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.745 ' H ' HG11 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -101.96 139.76 20.6 Favored Pre-proline 0 C--N 1.289 -2.058 0 O-C-N 119.491 -2.005 . . . . 40.0 109.994 175.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.46 -15.57 36.77 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 108.195 -1.502 . . . . 40.0 108.195 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 2.5 ttm180 -72.6 -10.2 59.51 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 105.533 -2.025 . . . . 40.0 105.533 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.632 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.7 tp-100 -103.32 1.14 32.38 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.038 -0.528 . . . . 40.0 110.062 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.24 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.93 -1.106 . . . . 40.0 108.928 178.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 52.33 -89.92 0.01 OUTLIER Glycine 0 C--N 1.295 -1.736 0 N-CA-C 108.316 -1.914 . . . . 40.0 108.316 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.606 ' C ' ' O ' ' A' ' 109' ' ' GLY . 21.6 t-20 -6.18 115.18 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 121.604 -0.939 . . . . 40.0 112.954 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.419 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 42.1 Cg_endo -66.82 -14.66 44.64 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 122.29 1.994 . . . . 40.0 113.81 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.601 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.75 -35.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 119.834 -1.791 . . . . 40.0 109.503 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.419 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.677 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' A' ' 210' ' ' GLU . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.509 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG11 HG23 ' A' ' 102' ' ' ILE . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.826 HG23 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.762 ' CE1' HG13 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.834 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 160' ' ' LEU . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.9 tp -137.6 131.18 31.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.4 t80 -98.64 136.63 38.44 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.233 1.016 . . . . 40.0 109.217 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.307 0.5 OUTLIER -140.11 94.03 2.71 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 107.541 -1.281 . . . . 40.0 107.541 -178.817 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.535 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 20.7 t -66.26 172.69 3.69 Favored 'General case' 0 N--CA 1.513 2.699 0 C-N-CA 115.147 -2.621 . . . . 40.0 106.916 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.0 OUTLIER -97.72 -55.38 2.83 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 116.269 -2.173 . . . . 40.0 109.205 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.561 ' C ' ' O ' ' A' ' 143' ' ' LEU . 2.3 ttp180 -40.38 -58.21 1.59 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.288 -1.375 . . . . 40.0 107.288 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.806 ' N ' HD13 ' B' ' 76' ' ' ILE . 2.2 t80 -54.92 -35.82 64.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.314 -0.995 . . . . 40.0 108.314 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.667 ' N ' ' O ' ' A' ' 143' ' ' LEU . 85.7 t60 -45.04 -38.46 4.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.426 -0.91 . . . . 40.0 111.784 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 149' ' ' HIS . 1.3 m120 -72.12 -55.85 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.695 -1.253 . . . . 40.0 109.427 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 147' ' ' ASN . 4.9 mp -37.85 -31.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 40.0 111.46 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.661 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -162.28 94.81 1.24 Allowed Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 120.798 -1.189 . . . . 40.0 111.023 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.597 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 53.3 Cg_endo -80.12 -175.68 2.83 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 N-CA-C 106.68 -2.084 . . . . 40.0 106.68 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 37.6 t0 67.77 -25.44 0.12 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.752 -1.217 . . . . 40.0 109.383 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.575 ' H ' ' C ' ' A' ' 150' ' ' PRO . 3.5 t80 -63.32 -53.16 57.05 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.723 -1.954 . . . . 40.0 105.723 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.615 HG21 ' N ' ' A' ' 154' ' ' HIS . 9.6 tp -62.08 -36.94 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.368 -1.733 . . . . 40.0 109.814 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' HG21 ' A' ' 153' ' ' ILE . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.826 ' HA ' HG23 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.834 ' HB3' ' HB3' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 ' HB3' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.928 HG13 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.466 HD22 HG22 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.482 ' HA ' HD11 ' A' ' 170' ' ' LEU . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 HG22 HD22 ' A' ' 169' ' ' LEU . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 1.084 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 1.084 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 181' ' ' ALA . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.748 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.425 HG23 HG11 ' A' ' 168' ' ' VAL . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.625 ' C ' HD21 ' A' ' 196' ' ' LEU . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.694 HG23 ' CE1' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.677 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ARG . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 1.314 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.605 ' HA ' HG21 ' A' ' 119' ' ' VAL . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.314 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 210' ' ' GLU . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.748 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.293 0.568 . . . . 40.0 110.237 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.646 ' CG2' ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -122.94 73.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 122.042 0.925 . . . . 40.0 108.924 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.748 HG13 ' HD3' ' B' ' 67' ' ' LYS . 18.8 mt -122.47 25.69 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 40.0 109.562 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.798 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 13.1 t70 -17.13 103.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.251 1.024 . . . . 40.0 111.694 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.1 p -86.04 -139.43 0.08 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.312 -1.366 . . . . 40.0 107.312 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -118.24 137.28 12.9 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.415 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 153.23 23.62 0.04 OUTLIER Glycine 0 N--CA 1.5 2.931 0 C-N-CA 120.65 -0.785 . . . . 40.0 112.415 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.451 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 49.57 60.4 6.4 Favored Glycine 0 N--CA 1.51 3.604 0 CA-C-N 119.994 1.897 . . . . 40.0 109.074 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.54 ' CD2' ' HB2' ' A' ' 110' ' ' ASN . 1.0 OUTLIER -173.73 124.94 0.37 Allowed 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 118.848 -1.141 . . . . 40.0 108.877 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.806 HD13 ' N ' ' A' ' 145' ' ' TYR . 1.1 tp -64.48 157.63 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.331 -0.856 . . . . 40.0 111.89 -177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.798 ' HB3' ' HA ' ' B' ' 70' ' ' ASP 0.254 24.6 tp . . . . . 0 C--N 1.292 -1.904 0 C-N-CA 119.238 -0.985 . . . . 40.0 110.725 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.92 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 103' ' ' VAL . 1.9 t -98.07 137.58 20.86 Favored Pre-proline 0 C--N 1.292 -1.908 0 O-C-N 120.13 -1.606 . . . . 40.0 110.374 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.16 -9.34 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 124.013 1.533 . . . . 40.0 108.918 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.57 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.6 ttp180 -84.26 0.79 47.6 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 106.479 -1.674 . . . . 40.0 106.479 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 104' ' ' SER . 6.9 tp60 -108.55 -0.17 20.5 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.454 0.645 . . . . 40.0 109.584 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.707 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -53.0 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.982 -1.074 . . . . 40.0 108.81 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 56.28 -74.8 0.01 OUTLIER Glycine 0 C--N 1.288 -2.113 0 N-CA-C 108.773 -1.731 . . . . 40.0 108.773 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.737 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 12.6 t-20 -23.24 112.08 0.17 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.387 -1.066 . . . . 40.0 111.918 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.4 Cg_endo -64.76 -14.25 43.76 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.392 2.061 . . . . 40.0 113.0 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.737 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.05 -35.4 34.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 119.911 -1.743 . . . . 40.0 109.503 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.409 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.42 33.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.513 ' CD1' ' C ' ' A' ' 140' ' ' PHE . 1.1 t80 -104.34 137.01 42.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.746 -1.221 . . . . 40.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HB2' HD13 ' A' ' 153' ' ' ILE 0.25 1.2 tp -138.85 103.37 4.79 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.0 -1.481 . . . . 40.0 107.0 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 142' ' ' SER . 25.9 t . . . . . 0 N--CA 1.527 3.386 0 N-CA-C 115.269 1.581 . . . . 40.0 115.269 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.667 ' C ' ' H ' ' A' ' 152' ' ' TYR . 51.8 Cg_endo . . . . . 0 C--O 1.209 -0.967 0 N-CA-C 107.232 -1.872 . . . . 40.0 107.232 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 18.8 t0 61.71 -26.17 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 O-C-N 120.612 -1.305 . . . . 40.0 109.494 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.667 ' H ' ' C ' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -62.48 -45.47 92.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.072 -1.825 . . . . 40.0 106.072 177.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -61.67 -36.94 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 115.937 -2.305 . . . . 40.0 109.814 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.714 ' HE2' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.699 0.761 . . . . 40.0 110.723 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.781 HG23 ' O ' ' B' ' 68' ' ' ILE . 13.3 tt -126.35 59.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.515 -0.92 . . . . 40.0 108.515 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.6 HG13 ' HD3' ' B' ' 67' ' ' LYS . 8.3 mt . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 40.0 110.624 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.51 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.664 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -103.22 138.53 19.57 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 119.646 -1.909 . . . . 40.0 110.578 176.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -59.8 -13.61 23.12 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.656 1.345 . . . . 40.0 109.142 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.505 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -76.19 -7.46 54.87 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 105.797 -1.927 . . . . 40.0 105.797 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.664 ' HB3' ' O ' ' A' ' 104' ' ' SER . 9.0 tp60 -106.92 3.28 26.0 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.2 0.524 . . . . 40.0 110.05 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.9 -157.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.663 -1.273 . . . . 40.0 109.472 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.593 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 49.4 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 107.806 -2.118 . . . . 40.0 107.806 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 108' ' ' ARG . 5.6 t-20 -4.9 109.15 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.692 0 O-C-N 121.825 -0.809 . . . . 40.0 112.986 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.2 Cg_endo -63.05 -12.36 29.4 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 122.268 1.979 . . . . 40.0 114.794 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.592 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.32 -35.4 36.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 O-C-N 119.315 -2.116 . . . . 40.0 109.503 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.97 33.84 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.8 t80 -102.99 138.61 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 40.0 110.904 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 2.7 tp -140.86 102.82 4.36 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.774 -1.565 . . . . 40.0 106.774 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 142' ' ' SER . 28.0 t . . . . . 0 N--CA 1.527 3.416 0 C-N-CA 117.608 -1.637 . . . . 40.0 115.013 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 152' ' ' TYR . 54.0 Cg_endo . . . . . 0 C--O 1.209 -0.963 0 N-CA-C 113.051 0.366 . . . . 40.0 113.051 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 39.1 t0 -34.47 -19.08 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 119.387 0.994 . . . . 40.0 113.501 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 150' ' ' PRO . 9.1 t80 -54.45 -48.59 71.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.626 -1.296 . . . . 40.0 111.361 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.19 -36.94 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.321 -1.752 . . . . 40.0 109.814 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.546 ' HD2' HD11 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 121.683 0.754 . . . . 40.0 110.728 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' B' ' 68' ' ' ILE 0.252 0.1 OUTLIER -107.25 -40.75 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 122.015 0.912 . . . . 40.0 110.996 -178.277 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.653 ' O ' HG22 ' B' ' 69' ' ' ILE . 8.0 mt . . . . . 0 N--CA 1.517 2.9 0 CA-C-N 114.67 -1.15 . . . . 40.0 113.676 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.577 ' N ' HG12 ' A' ' 103' ' ' VAL . 2.4 t -99.32 138.53 20.54 Favored Pre-proline 0 C--N 1.289 -2.063 0 O-C-N 120.352 -1.468 . . . . 40.0 110.319 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.29 -9.14 9.86 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 124.115 1.587 . . . . 40.0 108.539 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.472 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 1.6 ttp180 -80.47 -2.78 47.32 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 106.204 -1.776 . . . . 40.0 106.204 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.589 ' HG2' ' OH ' ' A' ' 130' ' ' TYR . 8.5 tp60 -108.83 0.48 20.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.253 0.549 . . . . 40.0 110.249 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -52.23 -172.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.911 -1.118 . . . . 40.0 108.566 178.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.585 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 58.75 -80.03 0.01 OUTLIER Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.764 -1.734 . . . . 40.0 108.764 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 108' ' ' ARG . 3.1 t-20 -16.72 106.27 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.463 0 O-C-N 121.418 -1.048 . . . . 40.0 112.253 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 37.4 Cg_endo -61.22 -14.85 36.36 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.296 1.997 . . . . 40.0 113.247 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.542 HG21 ' HE2' ' A' ' 140' ' ' PHE . 53.6 t -54.79 -35.4 33.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 O-C-N 119.83 -1.794 . . . . 40.0 109.503 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.461 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 131.77 32.08 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.542 ' HE2' HG21 ' A' ' 112' ' ' VAL . 1.9 t80 -102.44 138.97 38.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 40.0 110.427 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.25 1.6 tp -141.49 103.82 4.46 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.147 -1.427 . . . . 40.0 107.147 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.525 3.299 0 O-C-N 120.231 -1.543 . . . . 40.0 114.655 -176.38 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.659 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 45.7 Cg_endo . . . . . 0 CA--C 1.542 0.898 0 N-CA-C 107.359 -1.823 . . . . 40.0 107.359 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.659 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 26.4 t0 70.55 -22.79 0.17 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.647 -1.283 . . . . 40.0 109.443 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 150' ' ' PRO . 2.1 t80 -65.72 -52.64 49.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 105.794 -1.928 . . . . 40.0 105.794 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -59.9 -36.94 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.461 -1.696 . . . . 40.0 109.814 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 151' ' ' ASP . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.765 ' HD3' HD11 ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 122.087 0.946 . . . . 40.0 110.942 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.849 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -107.43 68.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.312 -0.996 . . . . 40.0 108.312 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.765 HD11 ' HD3' ' B' ' 67' ' ' LYS . 9.4 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 40.0 110.894 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.3 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.61 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -104.13 141.14 21.89 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 119.38 -2.075 . . . . 40.0 110.209 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.02 -14.33 27.59 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.779 1.41 . . . . 40.0 108.866 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.09 -2.19 23.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.036 -1.839 . . . . 40.0 106.036 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 104' ' ' SER . 7.8 tp60 -109.0 -5.01 16.23 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.148 0.499 . . . . 40.0 110.851 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.554 ' HG2' ' H ' ' A' ' 109' ' ' GLY . 35.7 ttm180 -55.06 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.524 -1.36 . . . . 40.0 109.055 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 67.78 -72.49 0.26 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 107.61 -2.196 . . . . 40.0 107.61 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.79 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 9.9 t-20 -27.31 111.31 0.23 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.593 -0.945 . . . . 40.0 111.282 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.471 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 37.7 Cg_endo -63.37 -13.52 36.56 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.131 1.888 . . . . 40.0 113.172 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.79 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.7 -35.4 39.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 O-C-N 119.891 -1.755 . . . . 40.0 109.503 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.58 33.27 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 t80 -103.13 139.13 39.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.609 -0.837 . . . . 40.0 110.364 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.252 0.7 OUTLIER -143.16 102.58 4.01 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.671 -1.604 . . . . 40.0 106.671 179.23 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.527 3.386 0 N-CA-C 115.473 1.656 . . . . 40.0 115.473 -175.801 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 152' ' ' TYR . 51.0 Cg_endo . . . . . 0 C--O 1.209 -0.963 0 CA-C-O 119.186 -0.422 . . . . 40.0 112.898 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 25.2 t0 -29.35 -22.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.502 0 CA-C-N 119.293 0.951 . . . . 40.0 113.546 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.706 ' N ' ' O ' ' A' ' 150' ' ' PRO . 10.3 t80 -50.52 -49.56 55.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.892 -1.13 . . . . 40.0 111.158 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.77 -36.94 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.251 -1.78 . . . . 40.0 109.814 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.741 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.574 0.702 . . . . 40.0 110.801 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -119.91 28.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.225 -0.922 . . . . 40.0 110.414 -178.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.741 HG13 ' HD3' ' B' ' 67' ' ' LYS . 7.5 mt . . . . . 0 N--CA 1.503 2.209 0 O-C-N 121.145 -0.972 . . . . 40.0 111.583 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.93 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.615 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -101.67 137.86 19.69 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 119.607 -1.933 . . . . 40.0 110.438 175.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -59.93 -9.71 10.51 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.69 1.363 . . . . 40.0 108.745 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.466 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -78.74 -2.46 39.53 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 105.696 -1.965 . . . . 40.0 105.696 175.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.8 tp-100 -109.37 -0.01 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.107 0.48 . . . . 40.0 110.487 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -54.63 -163.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.583 -1.323 . . . . 40.0 109.507 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 53.57 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 107.092 -2.403 . . . . 40.0 107.092 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 108' ' ' ARG . 24.3 t-20 -7.74 109.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.621 0 O-C-N 121.651 -0.911 . . . . 40.0 112.879 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 39.8 Cg_endo -64.44 -13.81 40.63 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.043 1.828 . . . . 40.0 114.21 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.445 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.64 -35.4 38.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 119.48 -2.012 . . . . 40.0 109.503 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 130.73 30.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.54 ' HD1' ' N ' ' A' ' 141' ' ' LEU . 1.0 OUTLIER -109.98 124.31 51.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.552 -1.259 . . . . 40.0 109.798 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -130.85 104.81 7.37 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 106.262 -1.755 . . . . 40.0 106.262 178.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.827 ' O ' HD12 ' A' ' 141' ' ' LEU . 7.4 t . . . . . 0 N--CA 1.507 2.414 0 C-N-CA 116.374 -2.131 . . . . 40.0 107.236 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 152' ' ' TYR . 55.9 Cg_endo . . . . . 0 C--O 1.21 -0.881 0 N-CA-C 113.949 0.711 . . . . 40.0 113.949 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -30.54 -22.34 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 113.775 1.028 . . . . 40.0 113.775 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 150' ' ' PRO . 2.5 t80 -52.12 -46.85 65.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.808 -1.182 . . . . 40.0 111.009 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.826 HG12 HD22 ' A' ' 141' ' ' LEU . 9.6 tp -63.39 -36.94 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 116.455 -2.098 . . . . 40.0 109.814 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.798 HD21 HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.786 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 121.513 0.673 . . . . 40.0 110.627 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.736 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -125.36 39.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.331 -0.855 . . . . 40.0 109.596 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.786 HG13 ' HD3' ' B' ' 67' ' ' LYS . 9.5 mt . . . . . 0 N--CA 1.501 2.107 0 O-C-N 121.456 -0.777 . . . . 40.0 111.47 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.68 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 103' ' ' VAL . 5.0 t -102.57 142.82 25.36 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.338 -1.476 . . . . 40.0 110.708 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.1 Cg_endo -63.21 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 107.789 -1.658 . . . . 40.0 107.789 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm-85 -72.64 -8.44 55.3 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 105.952 -1.87 . . . . 40.0 105.952 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.568 ' NE2' ' OH ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -105.47 1.89 28.06 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 115.867 -0.606 . . . . 40.0 109.51 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -54.91 -164.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.268 -0.895 . . . . 40.0 110.128 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 47.89 -126.92 14.55 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 104.136 -3.585 . . . . 40.0 104.136 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 109' ' ' GLY . 38.4 t-20 39.37 105.54 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 118.872 1.336 . . . . 40.0 113.701 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.54 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 40.3 Cg_endo -63.35 -13.38 35.62 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.818 1.679 . . . . 40.0 114.551 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.49 -35.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 119.516 -1.99 . . . . 40.0 109.503 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.54 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.67 33.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.553 ' HD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 t80 -107.07 129.66 54.79 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.326 -1.484 . . . . 40.0 111.819 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.553 ' N ' ' HD1' ' A' ' 140' ' ' PHE . 7.5 tp -127.74 104.69 7.98 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.372 -1.344 . . . . 40.0 107.372 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.526 3.336 0 C-N-CA 117.302 -1.759 . . . . 40.0 113.785 -177.961 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 CA--C 1.544 1.022 0 N-CA-C 112.404 0.117 . . . . 40.0 112.404 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 66.5 t0 -49.77 -19.43 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.591 -1.318 . . . . 40.0 112.237 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 26.6 t80 -54.07 -56.96 13.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.77 -1.207 . . . . 40.0 111.915 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.23 -36.94 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.259 -1.376 . . . . 40.0 109.814 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.476 ' HE3' HD12 ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.525 0.202 . . . . 40.0 110.941 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.41 72.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 CA-C-O 122.026 0.917 . . . . 40.0 111.02 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.476 HD12 ' HE3' ' B' ' 67' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 123.052 1.406 . . . . 40.0 111.144 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.98 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.685 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -97.75 138.98 21.07 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 119.869 -1.769 . . . . 40.0 111.236 176.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.47 -10.72 17.08 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.689 1.363 . . . . 40.0 109.272 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -88.01 6.67 34.9 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 105.931 -1.877 . . . . 40.0 105.931 176.46 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.685 ' HB2' ' O ' ' A' ' 104' ' ' SER . 2.0 tm0? -110.7 -3.97 15.58 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.968 -0.753 . . . . 40.0 108.968 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -50.86 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.832 -1.167 . . . . 40.0 110.13 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.651 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 50.59 -97.38 0.02 OUTLIER Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.584 -2.206 . . . . 40.0 107.584 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.651 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.5 t-20 -0.57 108.92 0.02 OUTLIER Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 121.791 -0.829 . . . . 40.0 112.459 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.528 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 39.0 Cg_endo -63.18 -11.49 25.46 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 122.334 2.022 . . . . 40.0 114.831 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.63 -35.4 45.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 O-C-N 119.352 -2.092 . . . . 40.0 109.503 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.528 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.44 33.07 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.3 t80 -106.25 132.24 52.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 40.0 111.34 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -135.43 103.46 5.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.968 -1.493 . . . . 40.0 106.968 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 142' ' ' SER . 14.9 t . . . . . 0 N--CA 1.525 3.302 0 O-C-N 120.228 -1.545 . . . . 40.0 114.765 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 152' ' ' TYR . 56.2 Cg_endo . . . . . 0 CA--C 1.55 1.295 0 N-CA-C 113.666 0.602 . . . . 40.0 113.666 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -39.24 -18.93 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.265 0 O-C-N 120.562 -1.336 . . . . 40.0 112.901 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 150' ' ' PRO . 8.9 t80 -53.3 -50.18 65.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.14 . . . . 40.0 111.634 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -62.92 -36.94 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.276 -1.77 . . . . 40.0 109.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.748 ' NZ ' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.603 0.716 . . . . 40.0 110.715 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.748 HG22 ' NZ ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -124.99 33.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.403 -0.811 . . . . 40.0 110.521 -178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.741 ' O ' HG22 ' B' ' 69' ' ' ILE . 7.4 mt . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.154 -0.966 . . . . 40.0 111.122 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 172.15 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.679 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 1.3 t -98.28 142.8 25.17 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 120.36 -1.462 . . . . 40.0 111.206 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 -12.22 34.76 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 N-CA-C 107.771 -1.665 . . . . 40.0 107.771 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.679 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -82.73 -2.13 53.38 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 105.984 -1.858 . . . . 40.0 105.984 176.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.679 ' HB3' ' O ' ' A' ' 104' ' ' SER . 8.9 tp60 -107.42 6.64 28.45 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.163 -1.051 . . . . 40.0 108.163 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.622 ' HG2' ' CZ ' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -52.65 -166.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 40.0 110.062 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 46.52 -110.59 0.54 Allowed Glycine 0 C--O 1.208 -1.521 0 N-CA-C 105.618 -2.993 . . . . 40.0 105.618 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.645 ' ND2' ' HB ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER 25.59 97.36 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 117.662 0.731 . . . . 40.0 112.768 176.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.467 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 36.2 Cg_endo -57.86 -13.39 14.72 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.84 1.693 . . . . 40.0 114.125 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.645 ' HB ' ' ND2' ' A' ' 110' ' ' ASN . 53.6 t -58.1 -35.4 52.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 O-C-N 119.783 -1.823 . . . . 40.0 109.503 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.467 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.622 ' CZ ' ' HG2' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.83 33.63 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 2.6 t80 -103.52 143.67 32.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.915 -1.116 . . . . 40.0 111.022 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.547 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 3.3 tp -146.24 101.04 3.46 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.594 -1.261 . . . . 40.0 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.517 2.9 0 O-C-N 120.228 -1.545 . . . . 40.0 114.124 -176.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 152' ' ' TYR . 47.0 Cg_endo . . . . . 0 CA--C 1.54 0.801 0 N-CA-C 107.605 -1.729 . . . . 40.0 107.605 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.612 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 66.3 t0 67.98 -23.95 0.12 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.29 -1.506 . . . . 40.0 108.441 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.616 ' H ' ' C ' ' A' ' 150' ' ' PRO . 8.0 t80 -66.24 -54.38 25.7 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.936 -1.505 . . . . 40.0 106.936 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 153' ' ' ILE . 9.6 tp -60.15 -36.94 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.102 -1.439 . . . . 40.0 109.814 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.64 ' HE3' HD11 ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 121.918 0.866 . . . . 40.0 110.826 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.777 HG23 ' O ' ' B' ' 68' ' ' ILE . 15.7 tt -130.3 71.75 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 40.0 109.315 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.64 HD11 ' HE3' ' B' ' 67' ' ' LYS . 29.2 mt . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.1 -1.0 . . . . 40.0 110.888 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.677 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -103.43 143.09 25.92 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 119.29 -2.131 . . . . 40.0 109.982 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.9 -10.25 14.16 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.697 1.367 . . . . 40.0 108.556 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.496 ' NH2' ' HE1' ' A' ' 152' ' ' TYR . 1.4 ttp180 -76.85 -3.83 40.53 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.085 -1.821 . . . . 40.0 106.085 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.677 ' HB2' ' O ' ' A' ' 104' ' ' SER . 2.3 mm-40 -106.86 -7.47 17.1 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.064 0.459 . . . . 40.0 110.186 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -51.58 -177.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.992 -1.067 . . . . 40.0 109.439 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 64.27 -66.84 0.06 OUTLIER Glycine 0 C--N 1.288 -2.087 0 N-CA-C 108.576 -1.81 . . . . 40.0 108.576 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.621 ' N ' ' O ' ' A' ' 108' ' ' ARG . 33.8 t-20 -31.12 113.08 0.32 Allowed Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.265 -1.138 . . . . 40.0 112.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.1 Cg_endo -63.68 -15.49 49.06 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.825 1.683 . . . . 40.0 112.815 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.598 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.51 -35.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.732 -1.855 . . . . 40.0 109.503 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.23 32.75 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 7.4 t80 -103.12 143.43 32.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.037 -1.039 . . . . 40.0 110.976 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.255 1.7 tp -146.4 92.16 2.14 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.367 -0.975 . . . . 40.0 108.367 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 142' ' ' SER . 6.7 t . . . . . 0 N--CA 1.531 3.622 0 O-C-N 120.357 -1.464 . . . . 40.0 114.873 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 152' ' ' TYR . 52.0 Cg_endo . . . . . 0 CA--C 1.545 1.058 0 N-CA-C 113.53 0.55 . . . . 40.0 113.53 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.484 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -44.38 -16.47 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 120.417 -1.427 . . . . 40.0 111.961 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.496 ' HE1' ' NH2' ' A' ' 106' ' ' ARG . 4.1 t80 -55.93 -50.91 69.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 40.0 111.5 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.433 HG12 HD22 ' A' ' 141' ' ' LEU . 9.6 tp -62.07 -36.94 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.648 -1.621 . . . . 40.0 109.814 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.717 ' HD3' HD11 ' B' ' 69' ' ' ILE . 1.3 ttpp . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 121.804 0.811 . . . . 40.0 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.745 HG23 ' O ' ' B' ' 68' ' ' ILE . 13.1 tt -119.6 52.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.499 -0.926 . . . . 40.0 108.499 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.717 HD11 ' HD3' ' B' ' 67' ' ' LYS . 5.9 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 40.0 110.645 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.94 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.653 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -101.96 139.76 20.6 Favored Pre-proline 0 C--N 1.289 -2.058 0 O-C-N 119.491 -2.005 . . . . 40.0 109.994 175.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.46 -15.57 36.77 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 108.195 -1.502 . . . . 40.0 108.195 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.583 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.5 ttm180 -72.6 -10.2 59.51 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 105.533 -2.025 . . . . 40.0 105.533 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 104' ' ' SER . 15.0 tp60 -103.32 1.14 32.38 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.038 -0.528 . . . . 40.0 110.062 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.24 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.93 -1.106 . . . . 40.0 108.928 178.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 52.33 -89.92 0.01 OUTLIER Glycine 0 C--N 1.295 -1.736 0 N-CA-C 108.316 -1.914 . . . . 40.0 108.316 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 21.6 t-20 -6.18 115.18 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 121.604 -0.939 . . . . 40.0 112.954 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 42.1 Cg_endo -66.82 -14.66 44.64 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 122.29 1.994 . . . . 40.0 113.81 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 140' ' ' PHE . 53.6 t -55.75 -35.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 119.834 -1.791 . . . . 40.0 109.503 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.533 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 131.18 31.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 112' ' ' VAL . 1.4 t80 -98.64 136.63 38.44 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.233 1.016 . . . . 40.0 109.217 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 153' ' ' ILE 0.307 0.5 OUTLIER -140.11 94.03 2.71 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 107.541 -1.281 . . . . 40.0 107.541 -178.817 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.515 ' O ' ' CD2' ' A' ' 141' ' ' LEU . 20.7 t . . . . . 0 N--CA 1.513 2.699 0 C-N-CA 115.147 -2.621 . . . . 40.0 106.916 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 53.3 Cg_endo . . . . . 0 C--O 1.214 -0.679 0 N-CA-C 106.68 -2.084 . . . . 40.0 106.68 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 37.6 t0 67.77 -25.44 0.12 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.752 -1.217 . . . . 40.0 109.383 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.541 ' H ' ' C ' ' A' ' 150' ' ' PRO . 3.5 t80 -63.32 -53.16 57.05 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.723 -1.954 . . . . 40.0 105.723 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.709 HG12 HD12 ' A' ' 141' ' ' LEU . 9.6 tp -62.08 -36.94 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.368 -1.733 . . . . 40.0 109.814 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 151' ' ' ASP . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.791 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.293 0.568 . . . . 40.0 110.237 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.84 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -122.94 73.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 122.042 0.925 . . . . 40.0 108.924 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.791 HG13 ' HD3' ' B' ' 67' ' ' LYS . 18.8 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 40.0 109.562 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.92 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 103' ' ' VAL . 1.9 t -98.07 137.58 20.86 Favored Pre-proline 0 C--N 1.292 -1.908 0 O-C-N 120.13 -1.606 . . . . 40.0 110.374 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.16 -9.34 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 124.013 1.533 . . . . 40.0 108.918 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.57 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.6 ttp180 -84.26 0.79 47.6 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 106.479 -1.674 . . . . 40.0 106.479 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 104' ' ' SER . 6.9 tp60 -108.55 -0.17 20.5 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.454 0.645 . . . . 40.0 109.584 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.707 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -53.0 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.982 -1.074 . . . . 40.0 108.81 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 56.28 -74.8 0.01 OUTLIER Glycine 0 C--N 1.288 -2.113 0 N-CA-C 108.773 -1.731 . . . . 40.0 108.773 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.737 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 12.6 t-20 -23.24 112.08 0.17 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.387 -1.066 . . . . 40.0 111.918 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.4 Cg_endo -64.76 -14.25 43.76 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.392 2.061 . . . . 40.0 113.0 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.737 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.05 -35.4 34.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 119.911 -1.743 . . . . 40.0 109.503 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.409 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.42 33.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.513 ' CD1' ' C ' ' A' ' 140' ' ' PHE . 1.1 t80 -104.34 137.01 42.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.746 -1.221 . . . . 40.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 146' ' ' HIS 0.25 1.2 tp -138.85 103.37 4.79 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.0 -1.481 . . . . 40.0 107.0 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.705 ' O ' ' N ' ' A' ' 144' ' ' ARG . 25.9 t -70.13 17.04 0.06 Allowed 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 115.269 1.581 . . . . 40.0 115.269 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.814 ' HA ' ' HB2' ' A' ' 146' ' ' HIS . 1.1 tt 49.33 -67.85 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.561 0 O-C-N 120.478 -1.389 . . . . 40.0 112.138 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.705 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -43.28 -47.69 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 119.769 -1.832 . . . . 40.0 106.678 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.778 ' N ' HD11 ' B' ' 76' ' ' ILE . 51.9 t80 -67.46 -29.4 68.84 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.82 -1.548 . . . . 40.0 106.82 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.814 ' HB2' ' HA ' ' A' ' 143' ' ' LEU . 63.6 t60 -50.59 -37.0 37.61 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.803 -0.759 . . . . 40.0 110.676 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -62.15 1.55 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.335 -1.728 . . . . 40.0 106.335 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -52.75 104.93 0.1 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.622 -1.251 . . . . 40.0 107.622 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' A' ' 145' ' ' TYR . 27.7 p-80 43.09 96.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.593 -0.73 . . . . 40.0 112.455 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.667 ' C ' ' H ' ' A' ' 152' ' ' TYR . 51.8 Cg_endo -96.88 -148.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.209 -0.967 0 C-N-CA 123.296 2.664 . . . . 40.0 107.232 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 18.8 t0 61.71 -26.17 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 O-C-N 120.612 -1.305 . . . . 40.0 109.494 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.667 ' H ' ' C ' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -62.48 -45.47 92.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.072 -1.825 . . . . 40.0 106.072 177.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -61.67 -36.94 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 115.937 -2.305 . . . . 40.0 109.814 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.714 ' HE2' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.699 0.761 . . . . 40.0 110.723 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.781 HG23 ' O ' ' B' ' 68' ' ' ILE . 13.3 tt -126.35 59.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.515 -0.92 . . . . 40.0 108.515 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.6 HG13 ' HD3' ' B' ' 67' ' ' LYS . 8.3 mt -109.85 38.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 40.0 110.624 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.597 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 2.6 t0 -29.46 106.03 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.686 1.232 . . . . 40.0 111.409 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.789 HG23 HD23 ' B' ' 77' ' ' LEU . 5.6 p -82.52 -132.6 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.254 -1.387 . . . . 40.0 107.254 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.512 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -129.47 134.53 7.97 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.036 -1.626 . . . . 40.0 109.036 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 152.52 25.66 0.05 OUTLIER Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.202 -0.999 . . . . 40.0 111.709 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' A' ' 145' ' ' TYR . . . 52.91 58.18 12.32 Favored Glycine 0 N--CA 1.504 3.182 0 O-C-N 120.477 -1.602 . . . . 40.0 109.622 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.823 ' CE2' HD13 ' B' ' 77' ' ' LEU . 0.8 OUTLIER -172.09 131.25 0.64 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.103 -1.439 . . . . 40.0 110.424 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.778 HD11 ' N ' ' A' ' 145' ' ' TYR . 13.3 mm -71.4 130.5 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 113.279 0.844 . . . . 40.0 113.279 -176.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.823 HD13 ' CE2' ' B' ' 75' ' ' PHE . 10.7 tp . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.432 -0.794 . . . . 40.0 111.527 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.51 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.664 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -103.22 138.53 19.57 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 119.646 -1.909 . . . . 40.0 110.578 176.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -59.8 -13.61 23.12 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.656 1.345 . . . . 40.0 109.142 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.723 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 3.0 ttm-85 -76.19 -7.46 54.87 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 105.797 -1.927 . . . . 40.0 105.797 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.664 ' HB3' ' O ' ' A' ' 104' ' ' SER . 9.0 tp60 -106.92 3.28 26.0 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.2 0.524 . . . . 40.0 110.05 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.9 -157.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.663 -1.273 . . . . 40.0 109.472 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.593 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 49.4 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 107.806 -2.118 . . . . 40.0 107.806 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.703 ' HB2' ' CD2' ' B' ' 75' ' ' PHE . 5.6 t-20 -4.9 109.15 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.692 0 O-C-N 121.825 -0.809 . . . . 40.0 112.986 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.2 Cg_endo -63.05 -12.36 29.4 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 122.268 1.979 . . . . 40.0 114.794 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.592 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.32 -35.4 36.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 O-C-N 119.315 -2.116 . . . . 40.0 109.503 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.97 33.84 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.8 t80 -102.99 138.61 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 40.0 110.904 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 146' ' ' HIS . 2.7 tp -140.86 102.82 4.36 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.774 -1.565 . . . . 40.0 106.774 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 144' ' ' ARG . 28.0 t -71.02 17.15 0.08 Allowed 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 117.608 -1.637 . . . . 40.0 115.013 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.793 ' HA ' ' CB ' ' A' ' 146' ' ' HIS . 1.0 OUTLIER 49.75 -67.58 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.718 -1.239 . . . . 40.0 112.244 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.792 ' HB3' HG13 ' B' ' 76' ' ' ILE . 0.0 OUTLIER -43.19 -42.54 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 119.986 -1.696 . . . . 40.0 106.714 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.826 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 86.9 t80 -71.66 -32.67 68.14 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.701 -1.592 . . . . 40.0 106.701 175.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.793 ' CB ' ' HA ' ' A' ' 143' ' ' LEU . 72.7 t60 -48.69 -33.81 10.77 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.011 -0.676 . . . . 40.0 111.202 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -64.52 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.811 ' H ' HD12 ' A' ' 148' ' ' LEU . 4.2 mp -54.42 113.66 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.826 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 8.0 p-80 42.24 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.647 0 O-C-N 121.179 -0.95 . . . . 40.0 109.829 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 152' ' ' TYR . 54.0 Cg_endo -94.72 -53.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.068 1.845 . . . . 40.0 113.051 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 39.1 t0 -34.47 -19.08 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 119.387 0.994 . . . . 40.0 113.501 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 150' ' ' PRO . 9.1 t80 -54.45 -48.59 71.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.626 -1.296 . . . . 40.0 111.361 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.19 -36.94 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.321 -1.752 . . . . 40.0 109.814 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.546 ' HD2' HD11 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 121.683 0.754 . . . . 40.0 110.728 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.724 ' O ' ' N ' ' B' ' 70' ' ' ASP 0.252 0.1 OUTLIER -107.25 -40.75 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 122.015 0.912 . . . . 40.0 110.996 -178.277 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.653 ' O ' HG22 ' B' ' 69' ' ' ILE . 8.0 mt -26.59 65.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 CA-C-N 114.67 -1.15 . . . . 40.0 113.676 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.724 ' N ' ' O ' ' B' ' 68' ' ' ILE . 1.0 OUTLIER -68.16 111.7 4.66 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 117.363 -1.735 . . . . 40.0 108.781 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.799 HG23 HD12 ' B' ' 77' ' ' LEU . 3.3 p -83.66 -138.65 0.05 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.389 -1.337 . . . . 40.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.723 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -123.71 141.59 13.69 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.284 -1.527 . . . . 40.0 109.284 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.586 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 147.92 16.43 0.12 Allowed Glycine 0 N--CA 1.508 3.44 0 C-N-CA 120.29 -0.957 . . . . 40.0 111.965 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.507 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 57.78 61.16 7.77 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.014 -1.635 . . . . 40.0 109.014 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -171.86 129.3 0.63 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.446 -1.302 . . . . 40.0 110.115 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.822 HD11 ' CA ' ' A' ' 145' ' ' TYR . 18.8 mm -72.16 123.22 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.651 -0.656 . . . . 40.0 112.231 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.799 HD12 HG23 ' B' ' 71' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 CA-C-O 117.884 -1.055 . . . . 40.0 111.308 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.577 ' N ' HG12 ' A' ' 103' ' ' VAL . 2.4 t -99.32 138.53 20.54 Favored Pre-proline 0 C--N 1.289 -2.063 0 O-C-N 120.352 -1.468 . . . . 40.0 110.319 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.29 -9.14 9.86 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 124.115 1.587 . . . . 40.0 108.539 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' B' ' 72' ' ' GLY . 1.6 ttp180 -80.47 -2.78 47.32 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 106.204 -1.776 . . . . 40.0 106.204 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.589 ' HG2' ' OH ' ' A' ' 130' ' ' TYR . 8.5 tp60 -108.83 0.48 20.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.253 0.549 . . . . 40.0 110.249 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -52.23 -172.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.911 -1.118 . . . . 40.0 108.566 178.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.585 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 58.75 -80.03 0.01 OUTLIER Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.764 -1.734 . . . . 40.0 108.764 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 108' ' ' ARG . 3.1 t-20 -16.72 106.27 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.463 0 O-C-N 121.418 -1.048 . . . . 40.0 112.253 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 37.4 Cg_endo -61.22 -14.85 36.36 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.296 1.997 . . . . 40.0 113.247 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.542 HG21 ' HE2' ' A' ' 140' ' ' PHE . 53.6 t -54.79 -35.4 33.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 O-C-N 119.83 -1.794 . . . . 40.0 109.503 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.461 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 131.77 32.08 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.542 ' HE2' HG21 ' A' ' 112' ' ' VAL . 1.9 t80 -102.44 138.97 38.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 40.0 110.427 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 146' ' ' HIS 0.25 1.6 tp -141.49 103.82 4.46 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.147 -1.427 . . . . 40.0 107.147 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.694 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 24.8 t -70.45 10.53 0.46 Allowed 'General case' 0 N--CA 1.525 3.299 0 O-C-N 120.231 -1.543 . . . . 40.0 114.655 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.855 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.3 OUTLIER 56.35 -66.35 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.658 -1.277 . . . . 40.0 111.939 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.844 ' HB3' HD13 ' B' ' 76' ' ' ILE . 0.1 OUTLIER -44.25 -58.89 2.63 Favored 'General case' 0 C--O 1.2 -1.531 0 O-C-N 119.446 -2.033 . . . . 40.0 105.659 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.924 ' HB2' HD12 ' B' ' 76' ' ' ILE . 49.5 t80 -55.12 -27.93 48.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.855 ' HB3' ' O ' ' A' ' 143' ' ' LEU . 34.2 t-80 -49.83 -42.34 47.02 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.532 -0.73 . . . . 40.0 111.638 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -68.44 -46.15 70.61 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.353 -1.339 . . . . 40.0 108.295 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.613 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 4.8 mp -56.0 -31.01 62.67 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 40.0 111.133 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.762 ' CE1' ' CE1' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -148.46 81.81 7.77 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 40.0 111.019 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.659 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 45.7 Cg_endo -76.93 173.23 14.81 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 N-CA-C 107.359 -1.823 . . . . 40.0 107.359 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.659 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 26.4 t0 70.55 -22.79 0.17 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.647 -1.283 . . . . 40.0 109.443 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.491 ' OH ' ' HA2' ' B' ' 73' ' ' GLY . 2.1 t80 -65.72 -52.64 49.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 105.794 -1.928 . . . . 40.0 105.794 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -59.9 -36.94 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.461 -1.696 . . . . 40.0 109.814 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 151' ' ' ASP . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.765 ' HD3' HD11 ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 122.087 0.946 . . . . 40.0 110.942 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.849 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -107.43 68.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.312 -0.996 . . . . 40.0 108.312 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.765 HD11 ' HD3' ' B' ' 67' ' ' LYS . 9.4 mt -122.34 40.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 40.0 110.894 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.826 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 6.3 t70 -34.09 118.04 0.36 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.468 1.127 . . . . 40.0 111.52 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.939 HG23 HD23 ' B' ' 77' ' ' LEU . 3.0 p -91.91 -128.43 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.099 -1.074 . . . . 40.0 108.099 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.589 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -135.27 128.16 4.61 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.738 -1.345 . . . . 40.0 109.738 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.491 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 156.61 25.62 0.03 OUTLIER Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.396 -0.907 . . . . 40.0 112.132 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.523 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 55.91 55.85 26.99 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 120.203 -1.763 . . . . 40.0 109.861 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.779 ' CZ ' HD22 ' B' ' 77' ' ' LEU . 0.7 OUTLIER -169.96 129.97 0.97 Allowed 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 117.917 -1.513 . . . . 40.0 109.749 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.924 HD12 ' HB2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -68.78 144.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.326 0.584 . . . . 40.0 112.032 -176.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.939 HD23 HG23 ' B' ' 71' ' ' THR . 11.4 tp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 117.34 -1.314 . . . . 40.0 111.75 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.3 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.61 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -104.13 141.14 21.89 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 119.38 -2.075 . . . . 40.0 110.209 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.02 -14.33 27.59 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.779 1.41 . . . . 40.0 108.866 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 2.8 ttm-85 -74.09 -2.19 23.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.036 -1.839 . . . . 40.0 106.036 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 104' ' ' SER . 7.8 tp60 -109.0 -5.01 16.23 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.148 0.499 . . . . 40.0 110.851 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.554 ' HG2' ' H ' ' A' ' 109' ' ' GLY . 35.7 ttm180 -55.06 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.524 -1.36 . . . . 40.0 109.055 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 67.78 -72.49 0.26 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 107.61 -2.196 . . . . 40.0 107.61 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.79 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 9.9 t-20 -27.31 111.31 0.23 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.593 -0.945 . . . . 40.0 111.282 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.471 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 37.7 Cg_endo -63.37 -13.52 36.56 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.131 1.888 . . . . 40.0 113.172 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.79 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.7 -35.4 39.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 O-C-N 119.891 -1.755 . . . . 40.0 109.503 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.58 33.27 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 t80 -103.13 139.13 39.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.609 -0.837 . . . . 40.0 110.364 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.712 HD11 ' HB2' ' A' ' 146' ' ' HIS 0.252 0.7 OUTLIER -143.16 102.58 4.01 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.671 -1.604 . . . . 40.0 106.671 179.23 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.689 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 28.6 t -70.93 15.38 0.11 Allowed 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 115.473 1.656 . . . . 40.0 115.473 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.803 ' HA ' ' CB ' ' A' ' 146' ' ' HIS . 0.7 OUTLIER 51.73 -69.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.389 -1.444 . . . . 40.0 112.633 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.641 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -43.75 -41.86 5.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.706 -1.872 . . . . 40.0 106.696 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.879 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 63.4 t80 -70.83 -32.51 69.59 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.736 -1.579 . . . . 40.0 106.736 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.803 ' CB ' ' HA ' ' A' ' 143' ' ' LEU . 61.7 t60 -49.52 -37.37 26.52 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.898 -0.502 . . . . 40.0 111.747 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.447 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.3 OUTLIER -66.19 -58.82 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.761 -1.57 . . . . 40.0 106.761 178.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -58.46 113.71 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.202 -1.407 . . . . 40.0 107.202 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.879 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 4.9 p-80 43.23 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 O-C-N 121.125 -0.984 . . . . 40.0 109.832 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 152' ' ' TYR . 51.0 Cg_endo -94.17 -61.01 0.01 OUTLIER 'Trans proline' 0 C--O 1.209 -0.963 0 C-N-CA 122.195 1.93 . . . . 40.0 112.898 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 25.2 t0 -29.35 -22.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.502 0 CA-C-N 119.293 0.951 . . . . 40.0 113.546 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.706 ' N ' ' O ' ' A' ' 150' ' ' PRO . 10.3 t80 -50.52 -49.56 55.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.892 -1.13 . . . . 40.0 111.158 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.77 -36.94 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.251 -1.78 . . . . 40.0 109.814 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' A' ' 144' ' ' ARG . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.741 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.574 0.702 . . . . 40.0 110.801 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -119.91 28.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.225 -0.922 . . . . 40.0 110.414 -178.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.741 HG13 ' HD3' ' B' ' 67' ' ' LYS . 7.5 mt -90.81 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.145 -0.972 . . . . 40.0 111.583 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.481 ' OD1' ' CE1' ' A' ' 145' ' ' TYR . 3.8 t0 -42.09 103.16 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.901 -1.12 . . . . 40.0 110.721 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.3 p -78.15 -136.74 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.348 -1.353 . . . . 40.0 107.348 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -127.65 137.03 9.56 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.814 -1.314 . . . . 40.0 109.814 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.555 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 152.88 23.48 0.05 OUTLIER Glycine 0 N--CA 1.506 3.323 0 C-N-CA 120.573 -0.822 . . . . 40.0 111.753 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.513 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 56.33 57.47 19.13 Favored Glycine 0 N--CA 1.502 3.053 0 O-C-N 120.445 -1.621 . . . . 40.0 109.762 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.689 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -172.82 130.77 0.52 Allowed 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 118.468 -1.293 . . . . 40.0 110.036 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.795 HD11 ' CA ' ' A' ' 145' ' ' TYR . 12.5 mm -71.45 128.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.2 0.815 . . . . 40.0 113.2 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.596 ' HG ' ' CE2' ' B' ' 75' ' ' PHE . 1.1 mt . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.587 -1.197 . . . . 40.0 110.91 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.93 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.615 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -101.67 137.86 19.69 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 119.607 -1.933 . . . . 40.0 110.438 175.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -59.93 -9.71 10.51 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.69 1.363 . . . . 40.0 108.745 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.466 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -78.74 -2.46 39.53 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 105.696 -1.965 . . . . 40.0 105.696 175.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.8 tp-100 -109.37 -0.01 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.107 0.48 . . . . 40.0 110.487 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -54.63 -163.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.583 -1.323 . . . . 40.0 109.507 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 53.57 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 107.092 -2.403 . . . . 40.0 107.092 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 108' ' ' ARG . 24.3 t-20 -7.74 109.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.621 0 O-C-N 121.651 -0.911 . . . . 40.0 112.879 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 39.8 Cg_endo -64.44 -13.81 40.63 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.043 1.828 . . . . 40.0 114.21 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.445 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.64 -35.4 38.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 119.48 -2.012 . . . . 40.0 109.503 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 130.73 30.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.54 ' HD1' ' N ' ' A' ' 141' ' ' LEU . 1.0 OUTLIER -109.98 124.31 51.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.552 -1.259 . . . . 40.0 109.798 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -130.85 104.81 7.37 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 106.262 -1.755 . . . . 40.0 106.262 178.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.827 ' O ' HD12 ' A' ' 141' ' ' LEU . 7.4 t -62.78 176.99 0.6 Allowed 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 116.374 -2.131 . . . . 40.0 107.236 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.777 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.0 OUTLIER -98.75 -56.89 2.32 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 119.994 -1.691 . . . . 40.0 108.773 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.616 ' HB3' HD13 ' B' ' 76' ' ' ILE . 0.1 OUTLIER -39.68 -59.32 1.16 Allowed 'General case' 0 C--O 1.201 -1.45 0 N-CA-C 106.643 -1.614 . . . . 40.0 106.643 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.777 ' HB2' HD12 ' B' ' 76' ' ' ILE . 68.8 t80 -54.68 -29.1 51.92 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.418 -0.913 . . . . 40.0 109.226 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.777 ' N ' ' O ' ' A' ' 143' ' ' LEU . 74.1 t60 -52.72 -37.19 58.74 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.801 -1.16 . . . . 40.0 111.659 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -68.23 -61.52 1.81 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.372 -1.455 . . . . 40.0 108.25 179.076 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 148' ' ' LEU . 3.1 mp -52.01 109.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 40.0 108.068 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.555 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 15.4 p-80 43.05 98.72 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.672 0 O-C-N 121.331 -0.856 . . . . 40.0 110.245 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 152' ' ' TYR . 55.9 Cg_endo -96.33 -56.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.881 0 C-N-CA 122.418 2.078 . . . . 40.0 113.949 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -30.54 -22.34 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 113.775 1.028 . . . . 40.0 113.775 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 150' ' ' PRO . 2.5 t80 -52.12 -46.85 65.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.808 -1.182 . . . . 40.0 111.009 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.826 HG12 HD22 ' A' ' 141' ' ' LEU . 9.6 tp -63.39 -36.94 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 116.455 -2.098 . . . . 40.0 109.814 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.798 HD21 HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.786 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 121.513 0.673 . . . . 40.0 110.627 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.736 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -125.36 39.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.331 -0.855 . . . . 40.0 109.596 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.786 HG13 ' HD3' ' B' ' 67' ' ' LYS . 9.5 mt -93.08 33.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.456 -0.777 . . . . 40.0 111.47 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.645 ' C ' ' O ' ' B' ' 69' ' ' ILE . 5.6 t0 -28.79 107.26 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.576 1.179 . . . . 40.0 110.647 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.4 p -84.34 -128.55 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.814 -1.18 . . . . 40.0 107.814 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.611 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -136.72 133.76 6.72 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.397 -1.481 . . . . 40.0 109.397 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.49 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 153.28 31.72 0.03 OUTLIER Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.695 -0.764 . . . . 40.0 111.421 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.754 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 49.4 59.34 7.2 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.583 -1.539 . . . . 40.0 110.903 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 110' ' ' ASN . 1.8 p90 -174.89 130.48 0.31 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.828 -1.149 . . . . 40.0 109.443 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -69.27 135.75 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.408 0.623 . . . . 40.0 112.676 -176.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.507 ' HG ' ' CZ ' ' B' ' 75' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 40.0 111.526 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.68 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 103' ' ' VAL . 5.0 t -102.57 142.82 25.36 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.338 -1.476 . . . . 40.0 110.708 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.1 Cg_endo -63.21 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 107.789 -1.658 . . . . 40.0 107.789 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 3.9 ttm-85 -72.64 -8.44 55.3 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 105.952 -1.87 . . . . 40.0 105.952 175.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.568 ' NE2' ' OH ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -105.47 1.89 28.06 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 115.867 -0.606 . . . . 40.0 109.51 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -54.91 -164.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.268 -0.895 . . . . 40.0 110.128 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 47.89 -126.92 14.55 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 104.136 -3.585 . . . . 40.0 104.136 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.571 ' HB2' ' CE2' ' B' ' 75' ' ' PHE . 38.4 t-20 39.37 105.54 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 118.872 1.336 . . . . 40.0 113.701 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.54 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 40.3 Cg_endo -63.35 -13.38 35.62 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.818 1.679 . . . . 40.0 114.551 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.49 -35.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 119.516 -1.99 . . . . 40.0 109.503 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.54 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.67 33.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.553 ' HD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 t80 -107.07 129.66 54.79 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.326 -1.484 . . . . 40.0 111.819 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.85 HD11 ' HB2' ' A' ' 146' ' ' HIS . 7.5 tp -127.74 104.69 7.98 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.372 -1.344 . . . . 40.0 107.372 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.706 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 13.3 t -69.88 2.94 2.94 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 117.302 -1.759 . . . . 40.0 113.785 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.89 HD23 ' HB3' ' A' ' 146' ' ' HIS . 0.1 OUTLIER 62.5 -72.12 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.594 -1.316 . . . . 40.0 111.779 -178.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.663 ' C ' ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -37.03 -57.52 0.83 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 105.974 -1.862 . . . . 40.0 105.974 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.785 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 50.0 t80 -56.35 -42.35 77.61 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.921 -1.14 . . . . 40.0 107.921 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.89 ' HB3' HD23 ' A' ' 143' ' ' LEU . 33.8 t60 -38.12 -37.57 0.28 Allowed 'General case' 0 N--CA 1.519 3.015 0 O-C-N 121.21 -0.931 . . . . 40.0 112.134 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 149' ' ' HIS . 7.8 m120 -66.6 -63.66 1.02 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.258 -0.901 . . . . 40.0 109.316 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 148' ' ' LEU . 5.7 mp -40.52 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.1 -1.0 . . . . 40.0 111.643 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.785 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -158.62 99.76 1.69 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.266 -1.012 . . . . 40.0 108.266 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.0 -53.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.592 1.311 . . . . 40.0 112.404 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 66.5 t0 -49.77 -19.43 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.591 -1.318 . . . . 40.0 112.237 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 26.6 t80 -54.07 -56.96 13.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.77 -1.207 . . . . 40.0 111.915 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.23 -36.94 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.259 -1.376 . . . . 40.0 109.814 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.476 ' HE3' HD12 ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.525 0.202 . . . . 40.0 110.941 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.7 HG22 ' O ' ' B' ' 77' ' ' LEU . 8.6 mt -83.41 72.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 CA-C-O 122.026 0.917 . . . . 40.0 111.02 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' B' ' 70' ' ' ASP . 0.5 OUTLIER -121.84 127.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 123.052 1.406 . . . . 40.0 111.144 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.699 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 9.1 t70 -25.37 167.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.48 2.4 . . . . 40.0 117.48 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.444 HG23 ' N ' ' B' ' 72' ' ' GLY . 1.2 t -147.44 -115.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 112.181 -2.281 . . . . 40.0 107.719 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -153.03 118.98 0.91 Allowed Glycine 0 N--CA 1.508 3.486 0 C-N-CA 119.332 -1.413 . . . . 40.0 112.66 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.1 34.95 0.02 OUTLIER Glycine 0 N--CA 1.511 3.7 0 O-C-N 122.029 -0.689 . . . . 40.0 112.29 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.457 ' HA2' ' CD2' ' A' ' 145' ' ' TYR . . . 51.23 54.48 23.3 Favored Glycine 0 N--CA 1.514 3.897 0 O-C-N 120.195 -1.768 . . . . 40.0 109.571 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.706 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.2 OUTLIER -173.16 117.98 0.3 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.883 -1.127 . . . . 40.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.654 HD12 ' CA ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -65.51 131.73 31.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.5 0.667 . . . . 40.0 111.927 -176.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.7 ' O ' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.121 0 CA-C-O 118.23 -0.89 . . . . 40.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.98 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.685 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -97.75 138.98 21.07 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 119.869 -1.769 . . . . 40.0 111.236 176.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.47 -10.72 17.08 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.689 1.363 . . . . 40.0 109.272 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -88.01 6.67 34.9 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 105.931 -1.877 . . . . 40.0 105.931 176.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.685 ' HB2' ' O ' ' A' ' 104' ' ' SER . 2.0 tm0? -110.7 -3.97 15.58 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.968 -0.753 . . . . 40.0 108.968 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -50.86 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.832 -1.167 . . . . 40.0 110.13 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.651 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 50.59 -97.38 0.02 OUTLIER Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.584 -2.206 . . . . 40.0 107.584 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.785 ' HB2' ' CD2' ' B' ' 75' ' ' PHE . 1.5 t-20 -0.57 108.92 0.02 OUTLIER Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 121.791 -0.829 . . . . 40.0 112.459 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.528 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 39.0 Cg_endo -63.18 -11.49 25.46 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 122.334 2.022 . . . . 40.0 114.831 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.63 -35.4 45.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 O-C-N 119.352 -2.092 . . . . 40.0 109.503 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.528 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.44 33.07 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.3 t80 -106.25 132.24 52.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 40.0 111.34 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 146' ' ' HIS . 0.2 OUTLIER -135.43 103.46 5.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.968 -1.493 . . . . 40.0 106.968 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.817 ' O ' ' N ' ' A' ' 144' ' ' ARG . 14.9 t -72.92 41.89 0.1 Allowed 'General case' 0 N--CA 1.525 3.302 0 O-C-N 120.228 -1.545 . . . . 40.0 114.765 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.771 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.5 OUTLIER 30.75 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 O-C-N 120.769 -1.207 . . . . 40.0 113.46 178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.817 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -42.57 -65.19 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 119.766 -1.834 . . . . 40.0 106.983 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.916 ' HE1' ' HE2' ' A' ' 149' ' ' HIS . 49.0 t80 -52.59 -23.62 6.77 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.818 -0.808 . . . . 40.0 108.818 176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.803 ' HB2' HD11 ' A' ' 141' ' ' LEU . 56.9 t-80 -54.28 -39.64 67.1 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.904 -1.122 . . . . 40.0 111.135 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -65.25 0.71 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.179 -1.415 . . . . 40.0 107.179 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.725 ' H ' HD12 ' A' ' 148' ' ' LEU . 3.8 mp -48.04 108.01 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.919 -1.141 . . . . 40.0 107.919 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.916 ' HE2' ' HE1' ' A' ' 145' ' ' TYR . 10.3 p-80 45.43 96.59 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 121.245 -0.91 . . . . 40.0 109.694 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 152' ' ' TYR . 56.2 Cg_endo -95.27 -48.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.156 1.904 . . . . 40.0 113.666 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -39.24 -18.93 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.265 0 O-C-N 120.562 -1.336 . . . . 40.0 112.901 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.547 ' OH ' ' HA2' ' B' ' 73' ' ' GLY . 8.9 t80 -53.3 -50.18 65.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.14 . . . . 40.0 111.634 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -62.92 -36.94 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.276 -1.77 . . . . 40.0 109.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.748 ' NZ ' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.603 0.716 . . . . 40.0 110.715 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.748 HG22 ' NZ ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -124.99 33.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.403 -0.811 . . . . 40.0 110.521 -178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.741 ' O ' HG22 ' B' ' 69' ' ' ILE . 7.4 mt -87.6 39.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.154 -0.966 . . . . 40.0 111.122 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' B' ' 69' ' ' ILE . 4.1 t0 -35.38 108.86 0.07 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.66 1.219 . . . . 40.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.7 p -85.19 -122.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.27 -1.011 . . . . 40.0 108.27 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.68 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -141.84 132.76 5.38 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.036 -1.226 . . . . 40.0 110.036 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.547 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 154.91 25.25 0.03 OUTLIER Glycine 0 N--CA 1.506 3.313 0 O-C-N 122.062 -0.669 . . . . 40.0 111.719 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 56.15 55.33 29.92 Favored Glycine 0 N--CA 1.502 3.071 0 O-C-N 120.256 -1.732 . . . . 40.0 110.012 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 110' ' ' ASN . 1.4 p90 -170.09 130.71 0.97 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.868 -1.133 . . . . 40.0 109.455 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.737 HD12 ' CA ' ' A' ' 145' ' ' TYR . 0.4 OUTLIER -73.41 132.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.601 0.715 . . . . 40.0 112.752 -175.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' B' ' 70' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.613 -1.184 . . . . 40.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 172.15 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.679 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 1.3 t -98.28 142.8 25.17 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 120.36 -1.462 . . . . 40.0 111.206 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 -12.22 34.76 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 N-CA-C 107.771 -1.665 . . . . 40.0 107.771 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.679 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -82.73 -2.13 53.38 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 105.984 -1.858 . . . . 40.0 105.984 176.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.679 ' HB3' ' O ' ' A' ' 104' ' ' SER . 8.9 tp60 -107.42 6.64 28.45 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.163 -1.051 . . . . 40.0 108.163 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.622 ' HG2' ' CZ ' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -52.65 -166.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 40.0 110.062 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 46.52 -110.59 0.54 Allowed Glycine 0 C--O 1.208 -1.521 0 N-CA-C 105.618 -2.993 . . . . 40.0 105.618 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.645 ' ND2' ' HB ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER 25.59 97.36 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 117.662 0.731 . . . . 40.0 112.768 176.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.467 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 36.2 Cg_endo -57.86 -13.39 14.72 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.84 1.693 . . . . 40.0 114.125 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.645 ' HB ' ' ND2' ' A' ' 110' ' ' ASN . 53.6 t -58.1 -35.4 52.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 O-C-N 119.783 -1.823 . . . . 40.0 109.503 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.467 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.622 ' CZ ' ' HG2' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.83 33.63 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 2.6 t80 -103.52 143.67 32.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.915 -1.116 . . . . 40.0 111.022 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 146' ' ' HIS . 3.3 tp -146.24 101.04 3.46 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.594 -1.261 . . . . 40.0 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.613 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 10.5 t -67.12 5.56 0.68 Allowed 'General case' 0 N--CA 1.517 2.9 0 O-C-N 120.228 -1.545 . . . . 40.0 114.124 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.848 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.0 OUTLIER 61.3 -70.38 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.585 -1.322 . . . . 40.0 110.954 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.627 ' C ' ' O ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -40.81 -54.91 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.818 -1.919 . . . . 40.0 105.818 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.946 ' N ' HD13 ' B' ' 76' ' ' ILE . 4.5 t80 -52.84 -43.53 66.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.274 -1.38 . . . . 40.0 107.274 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.848 ' HB3' ' O ' ' A' ' 143' ' ' LEU . 80.4 t60 -39.82 -45.87 1.86 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 121.521 0.677 . . . . 40.0 112.553 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -67.16 -51.93 47.78 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.075 -1.016 . . . . 40.0 108.829 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 148' ' ' LEU . 4.3 mm? -44.55 -27.97 0.53 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.28 -0.887 . . . . 40.0 109.538 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.663 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -172.02 101.95 0.37 Allowed Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 40.0 110.812 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 152' ' ' TYR . 47.0 Cg_endo -87.88 -169.13 0.43 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 107.605 -1.729 . . . . 40.0 107.605 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.612 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 66.3 t0 67.98 -23.95 0.12 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.29 -1.506 . . . . 40.0 108.441 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.706 ' OH ' ' HA3' ' B' ' 73' ' ' GLY . 8.0 t80 -66.24 -54.38 25.7 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.936 -1.505 . . . . 40.0 106.936 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 153' ' ' ILE . 9.6 tp -60.15 -36.94 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.102 -1.439 . . . . 40.0 109.814 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.64 ' HE3' HD11 ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 121.918 0.866 . . . . 40.0 110.826 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.777 HG23 ' O ' ' B' ' 68' ' ' ILE . 15.7 tt -130.3 71.75 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 40.0 109.315 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.64 HD11 ' HE3' ' B' ' 67' ' ' LYS . 29.2 mt -137.06 54.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.1 -1.0 . . . . 40.0 110.888 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' B' ' 76' ' ' ILE . 0.2 OUTLIER -40.8 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.371 1.081 . . . . 40.0 110.009 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.653 HG22 HD12 ' B' ' 77' ' ' LEU 0.276 12.5 t -146.14 150.43 35.87 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.657 -0.817 . . . . 40.0 110.081 -177.108 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.512 ' CA ' ' HG3' ' A' ' 106' ' ' ARG . . . 105.56 -110.24 3.4 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.759 -1.21 . . . . 40.0 110.332 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.706 ' HA3' ' OH ' ' A' ' 152' ' ' TYR . . . -153.88 109.95 0.43 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.835 -1.65 . . . . 40.0 113.709 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' B' ' 75' ' ' PHE . . . 41.68 82.38 0.02 OUTLIER Glycine 0 N--CA 1.5 2.921 0 O-C-N 122.23 -0.57 . . . . 40.0 111.801 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.613 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.1 OUTLIER 177.07 104.81 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.617 -1.253 . . . . 40.0 107.617 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.946 HD13 ' N ' ' A' ' 145' ' ' TYR . 1.4 tp -53.16 122.78 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 113.179 0.807 . . . . 40.0 113.179 -175.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.653 HD12 HG22 ' B' ' 71' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.296 -1.718 0 CA-C-O 117.354 -1.308 . . . . 40.0 110.525 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.677 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -103.43 143.09 25.92 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 119.29 -2.131 . . . . 40.0 109.982 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.9 -10.25 14.16 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.697 1.367 . . . . 40.0 108.556 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.496 ' NH2' ' HE1' ' A' ' 152' ' ' TYR . 1.4 ttp180 -76.85 -3.83 40.53 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.085 -1.821 . . . . 40.0 106.085 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.677 ' HB2' ' O ' ' A' ' 104' ' ' SER . 2.3 mm-40 -106.86 -7.47 17.1 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.064 0.459 . . . . 40.0 110.186 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -51.58 -177.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.992 -1.067 . . . . 40.0 109.439 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 64.27 -66.84 0.06 OUTLIER Glycine 0 C--N 1.288 -2.087 0 N-CA-C 108.576 -1.81 . . . . 40.0 108.576 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.621 ' N ' ' O ' ' A' ' 108' ' ' ARG . 33.8 t-20 -31.12 113.08 0.32 Allowed Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.265 -1.138 . . . . 40.0 112.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.1 Cg_endo -63.68 -15.49 49.06 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.825 1.683 . . . . 40.0 112.815 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.598 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.51 -35.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.732 -1.855 . . . . 40.0 109.503 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.23 32.75 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 7.4 t80 -103.12 143.43 32.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.037 -1.039 . . . . 40.0 110.976 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 146' ' ' HIS 0.255 1.7 tp -146.4 92.16 2.14 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.367 -0.975 . . . . 40.0 108.367 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 144' ' ' ARG . 6.7 t -57.65 17.43 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.622 0 O-C-N 120.357 -1.464 . . . . 40.0 114.873 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.895 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.9 OUTLIER 46.84 -71.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.149 -1.594 . . . . 40.0 112.761 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -38.98 -49.29 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 119.565 -1.96 . . . . 40.0 106.131 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 1.022 ' N ' HD12 ' B' ' 76' ' ' ILE . 52.4 t80 -61.81 -35.67 78.87 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.646 -1.242 . . . . 40.0 107.646 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.895 ' N ' ' O ' ' A' ' 143' ' ' LEU . 42.5 t-80 -43.51 -38.69 3.01 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.454 0.645 . . . . 40.0 111.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 2.8 m-20 -63.86 -61.83 2.04 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.284 -1.376 . . . . 40.0 107.284 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.802 ' H ' HD12 ' A' ' 148' ' ' LEU . 5.3 mp -55.72 107.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.084 -1.08 . . . . 40.0 108.084 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.578 ' ND1' ' C ' ' A' ' 148' ' ' LEU . 0.1 OUTLIER 48.83 96.1 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.503 0 O-C-N 121.415 -0.803 . . . . 40.0 109.973 -176.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 152' ' ' TYR . 52.0 Cg_endo -94.7 -46.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.439 2.093 . . . . 40.0 113.53 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.484 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -44.38 -16.47 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 120.417 -1.427 . . . . 40.0 111.961 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.512 ' OH ' ' HA2' ' B' ' 73' ' ' GLY . 4.1 t80 -55.93 -50.91 69.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 40.0 111.5 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.433 HG12 HD22 ' A' ' 141' ' ' LEU . 9.6 tp -62.07 -36.94 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.648 -1.621 . . . . 40.0 109.814 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.717 ' HD3' HD11 ' B' ' 69' ' ' ILE . 1.3 ttpp . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 121.804 0.811 . . . . 40.0 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.745 HG23 ' O ' ' B' ' 68' ' ' ILE . 13.1 tt -119.6 52.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.499 -0.926 . . . . 40.0 108.499 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.717 HD11 ' HD3' ' B' ' 67' ' ' LYS . 5.9 mt -100.45 41.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 40.0 110.645 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.623 ' C ' ' O ' ' B' ' 69' ' ' ILE . 11.3 t70 -32.47 122.12 0.33 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.501 -1.28 . . . . 40.0 110.328 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 2.8 p -95.52 -124.72 0.12 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.501 -1.296 . . . . 40.0 107.501 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.6 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -141.16 129.17 3.96 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.137 -1.585 . . . . 40.0 109.137 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.512 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 156.11 26.27 0.03 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 120.034 -1.079 . . . . 40.0 112.367 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 141' ' ' LEU . . . 79.07 -42.68 2.36 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 119.902 -1.94 . . . . 40.0 110.718 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.8 ' CZ ' HD22 ' B' ' 77' ' ' LEU . 0.6 OUTLIER -85.33 148.02 26.24 Favored 'General case' 0 C--N 1.263 -3.17 0 C-N-CA 117.692 -1.603 . . . . 40.0 112.455 -175.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.022 HD12 ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -90.76 131.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.465 0.65 . . . . 40.0 111.61 -176.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.8 HD22 ' CZ ' ' B' ' 75' ' ' PHE . 6.8 tp . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.342 -0.849 . . . . 40.0 112.844 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.94 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.653 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -101.96 139.76 20.6 Favored Pre-proline 0 C--N 1.289 -2.058 0 O-C-N 119.491 -2.005 . . . . 40.0 109.994 175.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.46 -15.57 36.77 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 108.195 -1.502 . . . . 40.0 108.195 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 2.5 ttm180 -72.6 -10.2 59.51 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 105.533 -2.025 . . . . 40.0 105.533 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 104' ' ' SER . 15.0 tp60 -103.32 1.14 32.38 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.038 -0.528 . . . . 40.0 110.062 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.24 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.93 -1.106 . . . . 40.0 108.928 178.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 52.33 -89.92 0.01 OUTLIER Glycine 0 C--N 1.295 -1.736 0 N-CA-C 108.316 -1.914 . . . . 40.0 108.316 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 21.6 t-20 -6.18 115.18 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 121.604 -0.939 . . . . 40.0 112.954 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 42.1 Cg_endo -66.82 -14.66 44.64 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 122.29 1.994 . . . . 40.0 113.81 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 140' ' ' PHE . 53.6 t -55.75 -35.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 119.834 -1.791 . . . . 40.0 109.503 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.533 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 131.18 31.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 112' ' ' VAL . 1.4 t80 -98.64 136.63 38.44 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.233 1.016 . . . . 40.0 109.217 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 153' ' ' ILE 0.307 0.5 OUTLIER -140.11 94.03 2.71 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 107.541 -1.281 . . . . 40.0 107.541 -178.817 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 20.7 t -66.26 172.69 3.69 Favored 'General case' 0 N--CA 1.513 2.699 0 C-N-CA 115.147 -2.621 . . . . 40.0 106.916 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.0 OUTLIER -97.72 -55.38 2.83 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 116.269 -2.173 . . . . 40.0 109.205 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.679 ' HB3' HD13 ' B' ' 76' ' ' ILE . 2.3 ttp180 -40.38 -58.21 1.59 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.288 -1.375 . . . . 40.0 107.288 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.682 ' N ' HD13 ' B' ' 76' ' ' ILE . 2.2 t80 -54.92 -35.82 64.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.314 -0.995 . . . . 40.0 108.314 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.667 ' N ' ' O ' ' A' ' 143' ' ' LEU . 85.7 t60 -45.04 -38.46 4.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.426 -0.91 . . . . 40.0 111.784 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 149' ' ' HIS . 2.5 m-20 -72.12 -55.85 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.695 -1.253 . . . . 40.0 109.427 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 147' ' ' ASN . 4.9 mp -37.85 -31.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 40.0 111.46 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.661 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -162.28 94.81 1.24 Allowed Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 120.798 -1.189 . . . . 40.0 111.023 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 53.3 Cg_endo -80.12 -175.68 2.83 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 N-CA-C 106.68 -2.084 . . . . 40.0 106.68 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 37.6 t0 67.77 -25.44 0.12 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.752 -1.217 . . . . 40.0 109.383 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.541 ' H ' ' C ' ' A' ' 150' ' ' PRO . 3.5 t80 -63.32 -53.16 57.05 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.723 -1.954 . . . . 40.0 105.723 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.709 HG12 HD12 ' A' ' 141' ' ' LEU . 9.6 tp -62.08 -36.94 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.368 -1.733 . . . . 40.0 109.814 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 151' ' ' ASP . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 2.0 mm-40 -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.791 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.293 0.568 . . . . 40.0 110.237 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.84 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -122.94 73.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 122.042 0.925 . . . . 40.0 108.924 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.791 HG13 ' HD3' ' B' ' 67' ' ' LYS . 18.8 mt -122.47 25.69 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 40.0 109.562 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.833 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 13.1 t70 -17.13 103.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.251 1.024 . . . . 40.0 111.694 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' THR . . . . . 1.082 HG23 HD23 ' B' ' 77' ' ' LEU . 1.1 p -86.04 -139.43 0.08 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.312 -1.366 . . . . 40.0 107.312 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.594 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -118.24 137.28 12.9 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 153.23 23.62 0.04 OUTLIER Glycine 0 N--CA 1.5 2.931 0 C-N-CA 120.65 -0.785 . . . . 40.0 112.415 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 49.57 60.4 6.4 Favored Glycine 0 N--CA 1.51 3.604 0 CA-C-N 119.994 1.897 . . . . 40.0 109.074 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.562 ' CZ ' HD22 ' B' ' 77' ' ' LEU . 1.0 OUTLIER -173.73 124.94 0.37 Allowed 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 118.848 -1.141 . . . . 40.0 108.877 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.682 HD13 ' N ' ' A' ' 145' ' ' TYR . 1.1 tp -64.48 157.63 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.331 -0.856 . . . . 40.0 111.89 -177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 1.082 HD23 HG23 ' B' ' 71' ' ' THR 0.254 24.6 tp . . . . . 0 C--N 1.292 -1.904 0 C-N-CA 119.238 -0.985 . . . . 40.0 110.725 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.92 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 103' ' ' VAL . 1.9 t -98.07 137.58 20.86 Favored Pre-proline 0 C--N 1.292 -1.908 0 O-C-N 120.13 -1.606 . . . . 40.0 110.374 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.16 -9.34 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 124.013 1.533 . . . . 40.0 108.918 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.57 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.6 ttp180 -84.26 0.79 47.6 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 106.479 -1.674 . . . . 40.0 106.479 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 104' ' ' SER . 6.9 tp60 -108.55 -0.17 20.5 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.454 0.645 . . . . 40.0 109.584 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.707 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -53.0 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.982 -1.074 . . . . 40.0 108.81 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 56.28 -74.8 0.01 OUTLIER Glycine 0 C--N 1.288 -2.113 0 N-CA-C 108.773 -1.731 . . . . 40.0 108.773 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.737 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 12.6 t-20 -23.24 112.08 0.17 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.387 -1.066 . . . . 40.0 111.918 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.4 Cg_endo -64.76 -14.25 43.76 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.392 2.061 . . . . 40.0 113.0 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.737 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.05 -35.4 34.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 119.911 -1.743 . . . . 40.0 109.503 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.409 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.42 33.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.513 ' CD1' ' C ' ' A' ' 140' ' ' PHE . 1.1 t80 -104.34 137.01 42.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.746 -1.221 . . . . 40.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HB2' HD13 ' A' ' 153' ' ' ILE 0.25 1.2 tp -138.85 103.37 4.79 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.0 -1.481 . . . . 40.0 107.0 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 142' ' ' SER . 25.9 t . . . . . 0 N--CA 1.527 3.386 0 N-CA-C 115.269 1.581 . . . . 40.0 115.269 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.667 ' C ' ' H ' ' A' ' 152' ' ' TYR . 51.8 Cg_endo . . . . . 0 C--O 1.209 -0.967 0 N-CA-C 107.232 -1.872 . . . . 40.0 107.232 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 18.8 t0 61.71 -26.17 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 O-C-N 120.612 -1.305 . . . . 40.0 109.494 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.667 ' H ' ' C ' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -62.48 -45.47 92.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.072 -1.825 . . . . 40.0 106.072 177.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -61.67 -36.94 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 115.937 -2.305 . . . . 40.0 109.814 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.714 ' HE2' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.699 0.761 . . . . 40.0 110.723 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.781 HG23 ' O ' ' B' ' 68' ' ' ILE . 13.3 tt -126.35 59.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.515 -0.92 . . . . 40.0 108.515 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.6 HG13 ' HD3' ' B' ' 67' ' ' LYS . 8.3 mt . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 40.0 110.624 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.51 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.664 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -103.22 138.53 19.57 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 119.646 -1.909 . . . . 40.0 110.578 176.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -59.8 -13.61 23.12 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.656 1.345 . . . . 40.0 109.142 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.505 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -76.19 -7.46 54.87 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 105.797 -1.927 . . . . 40.0 105.797 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.664 ' HB3' ' O ' ' A' ' 104' ' ' SER . 9.0 tp60 -106.92 3.28 26.0 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.2 0.524 . . . . 40.0 110.05 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.9 -157.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.663 -1.273 . . . . 40.0 109.472 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.593 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 49.4 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 107.806 -2.118 . . . . 40.0 107.806 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 108' ' ' ARG . 5.6 t-20 -4.9 109.15 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.692 0 O-C-N 121.825 -0.809 . . . . 40.0 112.986 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.2 Cg_endo -63.05 -12.36 29.4 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 122.268 1.979 . . . . 40.0 114.794 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.592 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.32 -35.4 36.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 O-C-N 119.315 -2.116 . . . . 40.0 109.503 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.97 33.84 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.8 t80 -102.99 138.61 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 40.0 110.904 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 2.7 tp -140.86 102.82 4.36 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.774 -1.565 . . . . 40.0 106.774 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 142' ' ' SER . 28.0 t . . . . . 0 N--CA 1.527 3.416 0 C-N-CA 117.608 -1.637 . . . . 40.0 115.013 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 152' ' ' TYR . 54.0 Cg_endo . . . . . 0 C--O 1.209 -0.963 0 N-CA-C 113.051 0.366 . . . . 40.0 113.051 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 39.1 t0 -34.47 -19.08 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 119.387 0.994 . . . . 40.0 113.501 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 150' ' ' PRO . 9.1 t80 -54.45 -48.59 71.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.626 -1.296 . . . . 40.0 111.361 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.19 -36.94 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.321 -1.752 . . . . 40.0 109.814 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.546 ' HD2' HD11 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 121.683 0.754 . . . . 40.0 110.728 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' B' ' 68' ' ' ILE 0.252 0.1 OUTLIER -107.25 -40.75 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 122.015 0.912 . . . . 40.0 110.996 -178.277 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.653 ' O ' HG22 ' B' ' 69' ' ' ILE . 8.0 mt . . . . . 0 N--CA 1.517 2.9 0 CA-C-N 114.67 -1.15 . . . . 40.0 113.676 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.577 ' N ' HG12 ' A' ' 103' ' ' VAL . 2.4 t -99.32 138.53 20.54 Favored Pre-proline 0 C--N 1.289 -2.063 0 O-C-N 120.352 -1.468 . . . . 40.0 110.319 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.29 -9.14 9.86 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 124.115 1.587 . . . . 40.0 108.539 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.472 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 1.6 ttp180 -80.47 -2.78 47.32 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 106.204 -1.776 . . . . 40.0 106.204 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.589 ' HG2' ' OH ' ' A' ' 130' ' ' TYR . 8.5 tp60 -108.83 0.48 20.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.253 0.549 . . . . 40.0 110.249 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -52.23 -172.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.911 -1.118 . . . . 40.0 108.566 178.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.585 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 58.75 -80.03 0.01 OUTLIER Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.764 -1.734 . . . . 40.0 108.764 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 108' ' ' ARG . 34.6 t30 -16.72 106.27 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.463 0 O-C-N 121.418 -1.048 . . . . 40.0 112.253 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 37.4 Cg_endo -61.22 -14.85 36.36 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.296 1.997 . . . . 40.0 113.247 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.542 HG21 ' HE2' ' A' ' 140' ' ' PHE . 53.6 t -54.79 -35.4 33.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 O-C-N 119.83 -1.794 . . . . 40.0 109.503 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.461 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 131.77 32.08 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.542 ' HE2' HG21 ' A' ' 112' ' ' VAL . 1.9 t80 -102.44 138.97 38.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 40.0 110.427 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.25 1.6 tp -141.49 103.82 4.46 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.147 -1.427 . . . . 40.0 107.147 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.525 3.299 0 O-C-N 120.231 -1.543 . . . . 40.0 114.655 -176.38 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.659 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 45.7 Cg_endo . . . . . 0 CA--C 1.542 0.898 0 N-CA-C 107.359 -1.823 . . . . 40.0 107.359 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.659 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 26.4 t0 70.55 -22.79 0.17 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.647 -1.283 . . . . 40.0 109.443 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 150' ' ' PRO . 2.1 t80 -65.72 -52.64 49.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 105.794 -1.928 . . . . 40.0 105.794 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -59.9 -36.94 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.461 -1.696 . . . . 40.0 109.814 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 151' ' ' ASP . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.765 ' HD3' HD11 ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 122.087 0.946 . . . . 40.0 110.942 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.849 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -107.43 68.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.312 -0.996 . . . . 40.0 108.312 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.765 HD11 ' HD3' ' B' ' 67' ' ' LYS . 9.4 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 40.0 110.894 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.3 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.61 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -104.13 141.14 21.89 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 119.38 -2.075 . . . . 40.0 110.209 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.02 -14.33 27.59 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.779 1.41 . . . . 40.0 108.866 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.09 -2.19 23.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.036 -1.839 . . . . 40.0 106.036 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 104' ' ' SER . 7.8 tp60 -109.0 -5.01 16.23 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.148 0.499 . . . . 40.0 110.851 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.554 ' HG2' ' H ' ' A' ' 109' ' ' GLY . 35.7 ttm180 -55.06 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.524 -1.36 . . . . 40.0 109.055 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 67.78 -72.49 0.26 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 107.61 -2.196 . . . . 40.0 107.61 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.79 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 9.9 t-20 -27.31 111.31 0.23 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.593 -0.945 . . . . 40.0 111.282 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.471 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 37.7 Cg_endo -63.37 -13.52 36.56 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.131 1.888 . . . . 40.0 113.172 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.79 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.7 -35.4 39.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 O-C-N 119.891 -1.755 . . . . 40.0 109.503 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.58 33.27 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 t80 -103.13 139.13 39.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.609 -0.837 . . . . 40.0 110.364 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.252 0.7 OUTLIER -143.16 102.58 4.01 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.671 -1.604 . . . . 40.0 106.671 179.23 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.527 3.386 0 N-CA-C 115.473 1.656 . . . . 40.0 115.473 -175.801 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 152' ' ' TYR . 51.0 Cg_endo . . . . . 0 C--O 1.209 -0.963 0 CA-C-O 119.186 -0.422 . . . . 40.0 112.898 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 25.2 t0 -29.35 -22.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.502 0 CA-C-N 119.293 0.951 . . . . 40.0 113.546 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.706 ' N ' ' O ' ' A' ' 150' ' ' PRO . 10.3 t80 -50.52 -49.56 55.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.892 -1.13 . . . . 40.0 111.158 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.77 -36.94 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.251 -1.78 . . . . 40.0 109.814 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.741 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.574 0.702 . . . . 40.0 110.801 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -119.91 28.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.225 -0.922 . . . . 40.0 110.414 -178.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.741 HG13 ' HD3' ' B' ' 67' ' ' LYS . 7.5 mt . . . . . 0 N--CA 1.503 2.209 0 O-C-N 121.145 -0.972 . . . . 40.0 111.583 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.93 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.615 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -101.67 137.86 19.69 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 119.607 -1.933 . . . . 40.0 110.438 175.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -59.93 -9.71 10.51 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.69 1.363 . . . . 40.0 108.745 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.466 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -78.74 -2.46 39.53 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 105.696 -1.965 . . . . 40.0 105.696 175.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.8 tp-100 -109.37 -0.01 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.107 0.48 . . . . 40.0 110.487 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -54.63 -163.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.583 -1.323 . . . . 40.0 109.507 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 53.57 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 107.092 -2.403 . . . . 40.0 107.092 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 108' ' ' ARG . 24.3 t-20 -7.74 109.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.621 0 O-C-N 121.651 -0.911 . . . . 40.0 112.879 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 39.8 Cg_endo -64.44 -13.81 40.63 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.043 1.828 . . . . 40.0 114.21 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.445 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.64 -35.4 38.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 119.48 -2.012 . . . . 40.0 109.503 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 130.73 30.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.54 ' HD1' ' N ' ' A' ' 141' ' ' LEU . 1.0 OUTLIER -109.98 124.31 51.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.552 -1.259 . . . . 40.0 109.798 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -130.85 104.81 7.37 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 106.262 -1.755 . . . . 40.0 106.262 178.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.827 ' O ' HD12 ' A' ' 141' ' ' LEU . 7.4 t . . . . . 0 N--CA 1.507 2.414 0 C-N-CA 116.374 -2.131 . . . . 40.0 107.236 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 152' ' ' TYR . 55.9 Cg_endo . . . . . 0 C--O 1.21 -0.881 0 N-CA-C 113.949 0.711 . . . . 40.0 113.949 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -30.54 -22.34 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 113.775 1.028 . . . . 40.0 113.775 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 150' ' ' PRO . 2.5 t80 -52.12 -46.85 65.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.808 -1.182 . . . . 40.0 111.009 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.826 HG12 HD22 ' A' ' 141' ' ' LEU . 9.6 tp -63.39 -36.94 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 116.455 -2.098 . . . . 40.0 109.814 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.798 HD21 HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.786 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 121.513 0.673 . . . . 40.0 110.627 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.736 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -125.36 39.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.331 -0.855 . . . . 40.0 109.596 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.786 HG13 ' HD3' ' B' ' 67' ' ' LYS . 9.5 mt . . . . . 0 N--CA 1.501 2.107 0 O-C-N 121.456 -0.777 . . . . 40.0 111.47 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.68 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 103' ' ' VAL . 5.0 t -102.57 142.82 25.36 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.338 -1.476 . . . . 40.0 110.708 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.1 Cg_endo -63.21 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 107.789 -1.658 . . . . 40.0 107.789 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm-85 -72.64 -8.44 55.3 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 105.952 -1.87 . . . . 40.0 105.952 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.568 ' NE2' ' OH ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -105.47 1.89 28.06 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 115.867 -0.606 . . . . 40.0 109.51 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -54.91 -164.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.268 -0.895 . . . . 40.0 110.128 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 47.89 -126.92 14.55 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 104.136 -3.585 . . . . 40.0 104.136 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 109' ' ' GLY . 38.4 t-20 39.37 105.54 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 118.872 1.336 . . . . 40.0 113.701 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.54 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 40.3 Cg_endo -63.35 -13.38 35.62 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.818 1.679 . . . . 40.0 114.551 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.49 -35.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 119.516 -1.99 . . . . 40.0 109.503 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.54 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.67 33.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.553 ' HD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 t80 -107.07 129.66 54.79 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.326 -1.484 . . . . 40.0 111.819 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.553 ' N ' ' HD1' ' A' ' 140' ' ' PHE . 7.5 tp -127.74 104.69 7.98 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.372 -1.344 . . . . 40.0 107.372 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.526 3.336 0 C-N-CA 117.302 -1.759 . . . . 40.0 113.785 -177.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 CA--C 1.544 1.022 0 N-CA-C 112.404 0.117 . . . . 40.0 112.404 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 66.5 t0 -49.77 -19.43 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.591 -1.318 . . . . 40.0 112.237 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 26.6 t80 -54.07 -56.96 13.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.77 -1.207 . . . . 40.0 111.915 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.23 -36.94 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.259 -1.376 . . . . 40.0 109.814 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.476 ' HE3' HD12 ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.525 0.202 . . . . 40.0 110.941 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.41 72.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 CA-C-O 122.026 0.917 . . . . 40.0 111.02 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.476 HD12 ' HE3' ' B' ' 67' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 123.052 1.406 . . . . 40.0 111.144 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.98 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.685 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -97.75 138.98 21.07 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 119.869 -1.769 . . . . 40.0 111.236 176.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.47 -10.72 17.08 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.689 1.363 . . . . 40.0 109.272 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -88.01 6.67 34.9 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 105.931 -1.877 . . . . 40.0 105.931 176.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.685 ' HB2' ' O ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -110.7 -3.97 15.58 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.968 -0.753 . . . . 40.0 108.968 177.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -50.86 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.832 -1.167 . . . . 40.0 110.13 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.651 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 50.59 -97.38 0.02 OUTLIER Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.584 -2.206 . . . . 40.0 107.584 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.685 HD21 ' HB ' ' A' ' 112' ' ' VAL . 1.2 t30 -0.57 108.92 0.02 OUTLIER Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 121.791 -0.829 . . . . 40.0 112.459 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.528 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 39.0 Cg_endo -63.18 -11.49 25.46 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 122.334 2.022 . . . . 40.0 114.831 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.685 ' HB ' HD21 ' A' ' 110' ' ' ASN . 53.6 t -56.63 -35.4 45.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 O-C-N 119.352 -2.092 . . . . 40.0 109.503 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.528 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.44 33.07 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.3 t80 -106.25 132.24 52.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 40.0 111.34 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -135.43 103.46 5.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.968 -1.493 . . . . 40.0 106.968 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 142' ' ' SER . 14.9 t . . . . . 0 N--CA 1.525 3.302 0 O-C-N 120.228 -1.545 . . . . 40.0 114.765 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 152' ' ' TYR . 56.2 Cg_endo . . . . . 0 CA--C 1.55 1.295 0 N-CA-C 113.666 0.602 . . . . 40.0 113.666 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -39.24 -18.93 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.265 0 O-C-N 120.562 -1.336 . . . . 40.0 112.901 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 150' ' ' PRO . 8.9 t80 -53.3 -50.18 65.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.14 . . . . 40.0 111.634 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -62.92 -36.94 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.276 -1.77 . . . . 40.0 109.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.748 ' NZ ' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.603 0.716 . . . . 40.0 110.715 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.748 HG22 ' NZ ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -124.99 33.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.403 -0.811 . . . . 40.0 110.521 -178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.741 ' O ' HG22 ' B' ' 69' ' ' ILE . 7.4 mt . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.154 -0.966 . . . . 40.0 111.122 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 172.15 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.679 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 1.3 t -98.28 142.8 25.17 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 120.36 -1.462 . . . . 40.0 111.206 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 -12.22 34.76 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 N-CA-C 107.771 -1.665 . . . . 40.0 107.771 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.679 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -82.73 -2.13 53.38 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 105.984 -1.858 . . . . 40.0 105.984 176.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.679 ' HB3' ' O ' ' A' ' 104' ' ' SER . 4.7 tp-100 -107.42 6.64 28.45 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.163 -1.051 . . . . 40.0 108.163 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.622 ' HG2' ' CZ ' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -52.65 -166.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 40.0 110.062 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 46.52 -110.59 0.54 Allowed Glycine 0 C--O 1.208 -1.521 0 N-CA-C 105.618 -2.993 . . . . 40.0 105.618 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.645 ' ND2' ' HB ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER 25.59 97.36 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 117.662 0.731 . . . . 40.0 112.768 176.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.467 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 36.2 Cg_endo -57.86 -13.39 14.72 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.84 1.693 . . . . 40.0 114.125 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.645 ' HB ' ' ND2' ' A' ' 110' ' ' ASN . 53.6 t -58.1 -35.4 52.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 O-C-N 119.783 -1.823 . . . . 40.0 109.503 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.467 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.622 ' CZ ' ' HG2' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.83 33.63 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 2.6 t80 -103.52 143.67 32.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.915 -1.116 . . . . 40.0 111.022 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.547 ' N ' ' CD1' ' A' ' 140' ' ' PHE . 3.3 tp -146.24 101.04 3.46 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.594 -1.261 . . . . 40.0 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.517 2.9 0 O-C-N 120.228 -1.545 . . . . 40.0 114.124 -176.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 152' ' ' TYR . 47.0 Cg_endo . . . . . 0 CA--C 1.54 0.801 0 N-CA-C 107.605 -1.729 . . . . 40.0 107.605 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.612 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 66.3 t0 67.98 -23.95 0.12 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.29 -1.506 . . . . 40.0 108.441 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.616 ' H ' ' C ' ' A' ' 150' ' ' PRO . 8.0 t80 -66.24 -54.38 25.7 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.936 -1.505 . . . . 40.0 106.936 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 153' ' ' ILE . 9.6 tp -60.15 -36.94 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.102 -1.439 . . . . 40.0 109.814 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.64 ' HE3' HD11 ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 121.918 0.866 . . . . 40.0 110.826 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.777 HG23 ' O ' ' B' ' 68' ' ' ILE . 15.7 tt -130.3 71.75 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 40.0 109.315 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.64 HD11 ' HE3' ' B' ' 67' ' ' LYS . 29.2 mt . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.1 -1.0 . . . . 40.0 110.888 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.677 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -103.43 143.09 25.92 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 119.29 -2.131 . . . . 40.0 109.982 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.9 -10.25 14.16 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.697 1.367 . . . . 40.0 108.556 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.496 ' NH2' ' HE1' ' A' ' 152' ' ' TYR . 1.4 ttp180 -76.85 -3.83 40.53 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.085 -1.821 . . . . 40.0 106.085 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.677 ' HB2' ' O ' ' A' ' 104' ' ' SER . 2.3 mm-40 -106.86 -7.47 17.1 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.064 0.459 . . . . 40.0 110.186 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -51.58 -177.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.992 -1.067 . . . . 40.0 109.439 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 64.27 -66.84 0.06 OUTLIER Glycine 0 C--N 1.288 -2.087 0 N-CA-C 108.576 -1.81 . . . . 40.0 108.576 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.621 ' N ' ' O ' ' A' ' 108' ' ' ARG . 33.8 t-20 -31.12 113.08 0.32 Allowed Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.265 -1.138 . . . . 40.0 112.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.1 Cg_endo -63.68 -15.49 49.06 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.825 1.683 . . . . 40.0 112.815 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.598 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.51 -35.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.732 -1.855 . . . . 40.0 109.503 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.23 32.75 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 7.4 t80 -103.12 143.43 32.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.037 -1.039 . . . . 40.0 110.976 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 140' ' ' PHE 0.255 1.7 tp -146.4 92.16 2.14 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.367 -0.975 . . . . 40.0 108.367 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 142' ' ' SER . 6.7 t . . . . . 0 N--CA 1.531 3.622 0 O-C-N 120.357 -1.464 . . . . 40.0 114.873 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 152' ' ' TYR . 52.0 Cg_endo . . . . . 0 CA--C 1.545 1.058 0 N-CA-C 113.53 0.55 . . . . 40.0 113.53 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.484 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -44.38 -16.47 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 120.417 -1.427 . . . . 40.0 111.961 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.496 ' HE1' ' NH2' ' A' ' 106' ' ' ARG . 4.1 t80 -55.93 -50.91 69.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 40.0 111.5 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.433 HG12 HD22 ' A' ' 141' ' ' LEU . 9.6 tp -62.07 -36.94 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.648 -1.621 . . . . 40.0 109.814 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.717 ' HD3' HD11 ' B' ' 69' ' ' ILE . 1.3 ttpp . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 121.804 0.811 . . . . 40.0 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.745 HG23 ' O ' ' B' ' 68' ' ' ILE . 13.1 tt -119.6 52.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.499 -0.926 . . . . 40.0 108.499 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.717 HD11 ' HD3' ' B' ' 67' ' ' LYS . 5.9 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 40.0 110.645 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.94 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.653 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -101.96 139.76 20.6 Favored Pre-proline 0 C--N 1.289 -2.058 0 O-C-N 119.491 -2.005 . . . . 40.0 109.994 175.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.46 -15.57 36.77 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 108.195 -1.502 . . . . 40.0 108.195 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.583 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.5 ttm180 -72.6 -10.2 59.51 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 105.533 -2.025 . . . . 40.0 105.533 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.7 tp-100 -103.32 1.14 32.38 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.038 -0.528 . . . . 40.0 110.062 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.24 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.93 -1.106 . . . . 40.0 108.928 178.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 52.33 -89.92 0.01 OUTLIER Glycine 0 C--N 1.295 -1.736 0 N-CA-C 108.316 -1.914 . . . . 40.0 108.316 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 21.6 t-20 -6.18 115.18 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 121.604 -0.939 . . . . 40.0 112.954 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 42.1 Cg_endo -66.82 -14.66 44.64 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 122.29 1.994 . . . . 40.0 113.81 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 140' ' ' PHE . 53.6 t -55.75 -35.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 119.834 -1.791 . . . . 40.0 109.503 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.533 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 131.18 31.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 112' ' ' VAL . 1.4 t80 -98.64 136.63 38.44 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.233 1.016 . . . . 40.0 109.217 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 153' ' ' ILE 0.307 0.5 OUTLIER -140.11 94.03 2.71 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 107.541 -1.281 . . . . 40.0 107.541 -178.817 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.515 ' O ' ' CD2' ' A' ' 141' ' ' LEU . 20.7 t . . . . . 0 N--CA 1.513 2.699 0 C-N-CA 115.147 -2.621 . . . . 40.0 106.916 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 53.3 Cg_endo . . . . . 0 C--O 1.214 -0.679 0 N-CA-C 106.68 -2.084 . . . . 40.0 106.68 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 37.6 t0 67.77 -25.44 0.12 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.752 -1.217 . . . . 40.0 109.383 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.541 ' H ' ' C ' ' A' ' 150' ' ' PRO . 3.5 t80 -63.32 -53.16 57.05 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.723 -1.954 . . . . 40.0 105.723 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.709 HG12 HD12 ' A' ' 141' ' ' LEU . 9.6 tp -62.08 -36.94 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.368 -1.733 . . . . 40.0 109.814 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 151' ' ' ASP . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.791 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.293 0.568 . . . . 40.0 110.237 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.84 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -122.94 73.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 122.042 0.925 . . . . 40.0 108.924 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.791 HG13 ' HD3' ' B' ' 67' ' ' LYS . 18.8 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 40.0 109.562 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.92 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 103' ' ' VAL . 1.9 t -98.07 137.58 20.86 Favored Pre-proline 0 C--N 1.292 -1.908 0 O-C-N 120.13 -1.606 . . . . 40.0 110.374 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.16 -9.34 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 124.013 1.533 . . . . 40.0 108.918 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.57 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 2.6 ttp180 -84.26 0.79 47.6 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 106.479 -1.674 . . . . 40.0 106.479 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 104' ' ' SER . 6.9 tp60 -108.55 -0.17 20.5 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.454 0.645 . . . . 40.0 109.584 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.707 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -53.0 -166.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.982 -1.074 . . . . 40.0 108.81 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 56.28 -74.8 0.01 OUTLIER Glycine 0 C--N 1.288 -2.113 0 N-CA-C 108.773 -1.731 . . . . 40.0 108.773 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.737 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 12.6 t-20 -23.24 112.08 0.17 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.387 -1.066 . . . . 40.0 111.918 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.488 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.4 Cg_endo -64.76 -14.25 43.76 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.392 2.061 . . . . 40.0 113.0 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.737 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.05 -35.4 34.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 119.911 -1.743 . . . . 40.0 109.503 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.409 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.42 33.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.513 ' CD1' ' C ' ' A' ' 140' ' ' PHE . 1.1 t80 -104.34 137.01 42.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.746 -1.221 . . . . 40.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 146' ' ' HIS 0.25 1.2 tp -138.85 103.37 4.79 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.0 -1.481 . . . . 40.0 107.0 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.705 ' O ' ' N ' ' A' ' 144' ' ' ARG . 25.9 t -70.13 17.04 0.06 Allowed 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 115.269 1.581 . . . . 40.0 115.269 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.814 ' HA ' ' HB2' ' A' ' 146' ' ' HIS . 1.1 tt 49.33 -67.85 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.561 0 O-C-N 120.478 -1.389 . . . . 40.0 112.138 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.705 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -43.28 -47.69 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 119.769 -1.832 . . . . 40.0 106.678 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.784 ' CE1' ' CE1' ' A' ' 149' ' ' HIS . 51.9 t80 -67.46 -29.4 68.84 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.82 -1.548 . . . . 40.0 106.82 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.814 ' HB2' ' HA ' ' A' ' 143' ' ' LEU . 63.6 t60 -50.59 -37.0 37.61 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.803 -0.759 . . . . 40.0 110.676 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 144' ' ' ARG . 0.7 OUTLIER -67.71 -62.15 1.55 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.335 -1.728 . . . . 40.0 106.335 177.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -52.75 104.93 0.1 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.622 -1.251 . . . . 40.0 107.622 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.784 ' CE1' ' CE1' ' A' ' 145' ' ' TYR . 4.9 p80 43.09 96.98 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.593 -0.73 . . . . 40.0 112.455 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.667 ' C ' ' H ' ' A' ' 152' ' ' TYR . 51.8 Cg_endo -96.88 -148.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.209 -0.967 0 C-N-CA 123.296 2.664 . . . . 40.0 107.232 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 18.8 t0 61.71 -26.17 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 O-C-N 120.612 -1.305 . . . . 40.0 109.494 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.667 ' H ' ' C ' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -62.48 -45.47 92.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.072 -1.825 . . . . 40.0 106.072 177.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -61.67 -36.94 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 115.937 -2.305 . . . . 40.0 109.814 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.714 ' HE2' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.699 0.761 . . . . 40.0 110.723 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.781 HG23 ' O ' ' B' ' 68' ' ' ILE . 13.3 tt -126.35 59.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.515 -0.92 . . . . 40.0 108.515 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.6 HG13 ' HD3' ' B' ' 67' ' ' LYS . 8.3 mt -109.85 38.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 40.0 110.624 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.597 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 2.6 t0 -29.46 106.03 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.686 1.232 . . . . 40.0 111.409 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.789 HG23 HD23 ' B' ' 77' ' ' LEU . 5.6 p -82.52 -132.6 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.254 -1.387 . . . . 40.0 107.254 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.512 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -129.47 134.53 7.97 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.036 -1.626 . . . . 40.0 109.036 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 152.52 25.66 0.05 OUTLIER Glycine 0 N--CA 1.5 2.915 0 C-N-CA 120.202 -0.999 . . . . 40.0 111.709 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' A' ' 145' ' ' TYR . . . 52.91 58.18 12.32 Favored Glycine 0 N--CA 1.504 3.182 0 O-C-N 120.477 -1.602 . . . . 40.0 109.622 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.823 ' CE2' HD13 ' B' ' 77' ' ' LEU . 0.8 OUTLIER -172.09 131.25 0.64 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.103 -1.439 . . . . 40.0 110.424 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.778 HD11 ' N ' ' A' ' 145' ' ' TYR . 13.3 mm -71.4 130.5 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 113.279 0.844 . . . . 40.0 113.279 -176.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.823 HD13 ' CE2' ' B' ' 75' ' ' PHE . 10.7 tp . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.432 -0.794 . . . . 40.0 111.527 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.51 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.664 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -103.22 138.53 19.57 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 119.646 -1.909 . . . . 40.0 110.578 176.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -59.8 -13.61 23.12 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.656 1.345 . . . . 40.0 109.142 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.723 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 3.0 ttm-85 -76.19 -7.46 54.87 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 105.797 -1.927 . . . . 40.0 105.797 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.664 ' HB3' ' O ' ' A' ' 104' ' ' SER . 9.0 tp60 -106.92 3.28 26.0 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.2 0.524 . . . . 40.0 110.05 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.9 -157.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.663 -1.273 . . . . 40.0 109.472 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.593 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 49.4 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 107.806 -2.118 . . . . 40.0 107.806 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.703 ' HB2' ' CD2' ' B' ' 75' ' ' PHE . 5.6 t-20 -4.9 109.15 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.692 0 O-C-N 121.825 -0.809 . . . . 40.0 112.986 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.2 Cg_endo -63.05 -12.36 29.4 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 122.268 1.979 . . . . 40.0 114.794 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.592 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.32 -35.4 36.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 O-C-N 119.315 -2.116 . . . . 40.0 109.503 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.97 33.84 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.8 t80 -102.99 138.61 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 40.0 110.904 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 146' ' ' HIS . 2.7 tp -140.86 102.82 4.36 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.774 -1.565 . . . . 40.0 106.774 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 144' ' ' ARG . 28.0 t -71.02 17.15 0.08 Allowed 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 117.608 -1.637 . . . . 40.0 115.013 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.793 ' HA ' ' CB ' ' A' ' 146' ' ' HIS . 1.0 OUTLIER 49.75 -67.58 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.718 -1.239 . . . . 40.0 112.244 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.792 ' HB3' HG13 ' B' ' 76' ' ' ILE . 0.0 OUTLIER -43.19 -42.54 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 119.986 -1.696 . . . . 40.0 106.714 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.826 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 86.9 t80 -71.66 -32.67 68.14 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.701 -1.592 . . . . 40.0 106.701 175.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.793 ' CB ' ' HA ' ' A' ' 143' ' ' LEU . 72.7 t60 -48.69 -33.81 10.77 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 120.011 -0.676 . . . . 40.0 111.202 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -64.52 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.811 ' H ' HD12 ' A' ' 148' ' ' LEU . 4.2 mp -54.42 113.66 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.826 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 8.0 p-80 42.24 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.647 0 O-C-N 121.179 -0.95 . . . . 40.0 109.829 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 152' ' ' TYR . 54.0 Cg_endo -94.72 -53.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.068 1.845 . . . . 40.0 113.051 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 39.1 t0 -34.47 -19.08 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 119.387 0.994 . . . . 40.0 113.501 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 150' ' ' PRO . 9.1 t80 -54.45 -48.59 71.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.626 -1.296 . . . . 40.0 111.361 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.19 -36.94 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.321 -1.752 . . . . 40.0 109.814 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.546 ' HD2' HD11 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 121.683 0.754 . . . . 40.0 110.728 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.724 ' O ' ' N ' ' B' ' 70' ' ' ASP 0.252 0.1 OUTLIER -107.25 -40.75 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 122.015 0.912 . . . . 40.0 110.996 -178.277 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.653 ' O ' HG22 ' B' ' 69' ' ' ILE . 8.0 mt -26.59 65.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 CA-C-N 114.67 -1.15 . . . . 40.0 113.676 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.724 ' N ' ' O ' ' B' ' 68' ' ' ILE . 1.0 OUTLIER -68.16 111.7 4.66 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 117.363 -1.735 . . . . 40.0 108.781 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.799 HG23 HD12 ' B' ' 77' ' ' LEU . 3.3 p -83.66 -138.65 0.05 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.389 -1.337 . . . . 40.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.723 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -123.71 141.59 13.69 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.284 -1.527 . . . . 40.0 109.284 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.586 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 147.92 16.43 0.12 Allowed Glycine 0 N--CA 1.508 3.44 0 C-N-CA 120.29 -0.957 . . . . 40.0 111.965 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.507 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 57.78 61.16 7.77 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.014 -1.635 . . . . 40.0 109.014 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -171.86 129.3 0.63 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.446 -1.302 . . . . 40.0 110.115 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.822 HD11 ' CA ' ' A' ' 145' ' ' TYR . 18.8 mm -72.16 123.22 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.651 -0.656 . . . . 40.0 112.231 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.799 HD12 HG23 ' B' ' 71' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 CA-C-O 117.884 -1.055 . . . . 40.0 111.308 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.577 ' N ' HG12 ' A' ' 103' ' ' VAL . 2.4 t -99.32 138.53 20.54 Favored Pre-proline 0 C--N 1.289 -2.063 0 O-C-N 120.352 -1.468 . . . . 40.0 110.319 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.29 -9.14 9.86 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 124.115 1.587 . . . . 40.0 108.539 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' B' ' 72' ' ' GLY . 1.6 ttp180 -80.47 -2.78 47.32 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 106.204 -1.776 . . . . 40.0 106.204 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.589 ' HG2' ' OH ' ' A' ' 130' ' ' TYR . 8.5 tp60 -108.83 0.48 20.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.253 0.549 . . . . 40.0 110.249 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -52.23 -172.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.911 -1.118 . . . . 40.0 108.566 178.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.585 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 58.75 -80.03 0.01 OUTLIER Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.764 -1.734 . . . . 40.0 108.764 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 108' ' ' ARG . 34.6 t30 -16.72 106.27 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.463 0 O-C-N 121.418 -1.048 . . . . 40.0 112.253 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 37.4 Cg_endo -61.22 -14.85 36.36 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.296 1.997 . . . . 40.0 113.247 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.542 HG21 ' HE2' ' A' ' 140' ' ' PHE . 53.6 t -54.79 -35.4 33.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 O-C-N 119.83 -1.794 . . . . 40.0 109.503 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.461 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 131.77 32.08 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.542 ' HE2' HG21 ' A' ' 112' ' ' VAL . 1.9 t80 -102.44 138.97 38.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 40.0 110.427 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 146' ' ' HIS 0.25 1.6 tp -141.49 103.82 4.46 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.147 -1.427 . . . . 40.0 107.147 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.694 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 24.8 t -70.45 10.53 0.46 Allowed 'General case' 0 N--CA 1.525 3.299 0 O-C-N 120.231 -1.543 . . . . 40.0 114.655 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.855 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.3 OUTLIER 56.35 -66.35 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.658 -1.277 . . . . 40.0 111.939 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.844 ' HB3' HD13 ' B' ' 76' ' ' ILE . 0.1 OUTLIER -44.25 -58.89 2.63 Favored 'General case' 0 C--O 1.2 -1.531 0 O-C-N 119.446 -2.033 . . . . 40.0 105.659 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.924 ' HB2' HD12 ' B' ' 76' ' ' ILE . 49.5 t80 -55.12 -27.93 48.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.855 ' HB3' ' O ' ' A' ' 143' ' ' LEU . 32.6 t60 -49.83 -42.34 47.02 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.532 -0.73 . . . . 40.0 111.638 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -68.44 -46.15 70.61 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.353 -1.339 . . . . 40.0 108.295 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 149' ' ' HIS . 4.8 mp -56.0 -31.01 62.67 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 40.0 111.133 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.688 ' CD2' ' CE1' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -148.46 81.81 7.77 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 40.0 111.019 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.659 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 45.7 Cg_endo -76.93 173.23 14.81 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 N-CA-C 107.359 -1.823 . . . . 40.0 107.359 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.659 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 26.4 t0 70.55 -22.79 0.17 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.647 -1.283 . . . . 40.0 109.443 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.491 ' OH ' ' HA2' ' B' ' 73' ' ' GLY . 2.1 t80 -65.72 -52.64 49.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 105.794 -1.928 . . . . 40.0 105.794 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -59.9 -36.94 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.461 -1.696 . . . . 40.0 109.814 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 151' ' ' ASP . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.765 ' HD3' HD11 ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 122.087 0.946 . . . . 40.0 110.942 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.849 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -107.43 68.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.312 -0.996 . . . . 40.0 108.312 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.765 HD11 ' HD3' ' B' ' 67' ' ' LYS . 9.4 mt -122.34 40.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 40.0 110.894 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.826 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 6.3 t70 -34.09 118.04 0.36 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.468 1.127 . . . . 40.0 111.52 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.939 HG23 HD23 ' B' ' 77' ' ' LEU . 3.0 p -91.91 -128.43 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.099 -1.074 . . . . 40.0 108.099 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.589 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -135.27 128.16 4.61 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.738 -1.345 . . . . 40.0 109.738 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.491 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 156.61 25.62 0.03 OUTLIER Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.396 -0.907 . . . . 40.0 112.132 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.523 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 55.91 55.85 26.99 Favored Glycine 0 N--CA 1.504 3.17 0 O-C-N 120.203 -1.763 . . . . 40.0 109.861 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.779 ' CZ ' HD22 ' B' ' 77' ' ' LEU . 0.7 OUTLIER -169.96 129.97 0.97 Allowed 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 117.917 -1.513 . . . . 40.0 109.749 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.924 HD12 ' HB2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -68.78 144.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.326 0.584 . . . . 40.0 112.032 -176.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.939 HD23 HG23 ' B' ' 71' ' ' THR . 11.4 tp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 117.34 -1.314 . . . . 40.0 111.75 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.3 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.61 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -104.13 141.14 21.89 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 119.38 -2.075 . . . . 40.0 110.209 175.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.02 -14.33 27.59 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.779 1.41 . . . . 40.0 108.866 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 2.8 ttm-85 -74.09 -2.19 23.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.036 -1.839 . . . . 40.0 106.036 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 104' ' ' SER . 7.8 tp60 -109.0 -5.01 16.23 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.148 0.499 . . . . 40.0 110.851 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.554 ' HG2' ' H ' ' A' ' 109' ' ' GLY . 35.7 ttm180 -55.06 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.524 -1.36 . . . . 40.0 109.055 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 67.78 -72.49 0.26 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 107.61 -2.196 . . . . 40.0 107.61 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.79 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 9.9 t-20 -27.31 111.31 0.23 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.593 -0.945 . . . . 40.0 111.282 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.471 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 37.7 Cg_endo -63.37 -13.52 36.56 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.131 1.888 . . . . 40.0 113.172 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.79 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.7 -35.4 39.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 O-C-N 119.891 -1.755 . . . . 40.0 109.503 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.58 33.27 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 t80 -103.13 139.13 39.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.609 -0.837 . . . . 40.0 110.364 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.712 HD11 ' HB2' ' A' ' 146' ' ' HIS 0.252 0.7 OUTLIER -143.16 102.58 4.01 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.671 -1.604 . . . . 40.0 106.671 179.23 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.689 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 28.6 t -70.93 15.38 0.11 Allowed 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 115.473 1.656 . . . . 40.0 115.473 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.803 ' HA ' ' CB ' ' A' ' 146' ' ' HIS . 0.7 OUTLIER 51.73 -69.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.389 -1.444 . . . . 40.0 112.633 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.641 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -43.75 -41.86 5.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.706 -1.872 . . . . 40.0 106.696 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.879 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 63.4 t80 -70.83 -32.51 69.59 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.736 -1.579 . . . . 40.0 106.736 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.803 ' CB ' ' HA ' ' A' ' 143' ' ' LEU . 61.7 t60 -49.52 -37.37 26.52 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.898 -0.502 . . . . 40.0 111.747 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -58.82 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.761 -1.57 . . . . 40.0 106.761 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -58.46 113.71 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.202 -1.407 . . . . 40.0 107.202 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.879 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 4.9 p-80 43.23 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 O-C-N 121.125 -0.984 . . . . 40.0 109.832 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 152' ' ' TYR . 51.0 Cg_endo -94.17 -61.01 0.01 OUTLIER 'Trans proline' 0 C--O 1.209 -0.963 0 C-N-CA 122.195 1.93 . . . . 40.0 112.898 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 25.2 t0 -29.35 -22.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.502 0 CA-C-N 119.293 0.951 . . . . 40.0 113.546 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.706 ' N ' ' O ' ' A' ' 150' ' ' PRO . 10.3 t80 -50.52 -49.56 55.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.892 -1.13 . . . . 40.0 111.158 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.77 -36.94 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.251 -1.78 . . . . 40.0 109.814 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' A' ' 144' ' ' ARG . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.741 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.574 0.702 . . . . 40.0 110.801 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -119.91 28.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.225 -0.922 . . . . 40.0 110.414 -178.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.741 HG13 ' HD3' ' B' ' 67' ' ' LYS . 7.5 mt -90.81 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.145 -0.972 . . . . 40.0 111.583 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.481 ' OD1' ' CE1' ' A' ' 145' ' ' TYR . 3.8 t0 -42.09 103.16 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.901 -1.12 . . . . 40.0 110.721 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.3 p -78.15 -136.74 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.348 -1.353 . . . . 40.0 107.348 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.558 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -127.65 137.03 9.56 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.814 -1.314 . . . . 40.0 109.814 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.555 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 152.88 23.48 0.05 OUTLIER Glycine 0 N--CA 1.506 3.323 0 C-N-CA 120.573 -0.822 . . . . 40.0 111.753 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.513 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 56.33 57.47 19.13 Favored Glycine 0 N--CA 1.502 3.053 0 O-C-N 120.445 -1.621 . . . . 40.0 109.762 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.689 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -172.82 130.77 0.52 Allowed 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 118.468 -1.293 . . . . 40.0 110.036 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.795 HD11 ' CA ' ' A' ' 145' ' ' TYR . 12.5 mm -71.45 128.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.2 0.815 . . . . 40.0 113.2 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.596 ' HG ' ' CE2' ' B' ' 75' ' ' PHE . 1.1 mt . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.587 -1.197 . . . . 40.0 110.91 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.93 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.615 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -101.67 137.86 19.69 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 119.607 -1.933 . . . . 40.0 110.438 175.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -59.93 -9.71 10.51 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.69 1.363 . . . . 40.0 108.745 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.466 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 3.0 ttm-85 -78.74 -2.46 39.53 Favored 'General case' 0 C--O 1.2 -1.531 0 N-CA-C 105.696 -1.965 . . . . 40.0 105.696 175.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.8 tp-100 -109.37 -0.01 19.23 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.107 0.48 . . . . 40.0 110.487 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -54.63 -163.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.583 -1.323 . . . . 40.0 109.507 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 53.57 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 107.092 -2.403 . . . . 40.0 107.092 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 108' ' ' ARG . 24.3 t-20 -7.74 109.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.621 0 O-C-N 121.651 -0.911 . . . . 40.0 112.879 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 39.8 Cg_endo -64.44 -13.81 40.63 Favored 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 122.043 1.828 . . . . 40.0 114.21 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.445 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.64 -35.4 38.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 119.48 -2.012 . . . . 40.0 109.503 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 130.73 30.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.54 ' HD1' ' N ' ' A' ' 141' ' ' LEU . 1.0 OUTLIER -109.98 124.31 51.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.552 -1.259 . . . . 40.0 109.798 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -130.85 104.81 7.37 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 106.262 -1.755 . . . . 40.0 106.262 178.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.827 ' O ' HD12 ' A' ' 141' ' ' LEU . 7.4 t -62.78 176.99 0.6 Allowed 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 116.374 -2.131 . . . . 40.0 107.236 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.777 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.0 OUTLIER -98.75 -56.89 2.32 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 119.994 -1.691 . . . . 40.0 108.773 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.616 ' HB3' HD13 ' B' ' 76' ' ' ILE . 0.1 OUTLIER -39.68 -59.32 1.16 Allowed 'General case' 0 C--O 1.201 -1.45 0 N-CA-C 106.643 -1.614 . . . . 40.0 106.643 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.777 ' HB2' HD12 ' B' ' 76' ' ' ILE . 68.8 t80 -54.68 -29.1 51.92 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.418 -0.913 . . . . 40.0 109.226 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.777 ' N ' ' O ' ' A' ' 143' ' ' LEU . 74.1 t60 -52.72 -37.19 58.74 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.801 -1.16 . . . . 40.0 111.659 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -68.23 -61.52 1.81 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.372 -1.455 . . . . 40.0 108.25 179.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 148' ' ' LEU . 3.1 mp -52.01 109.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 40.0 108.068 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.746 ' CE1' ' CE1' ' A' ' 145' ' ' TYR . 3.2 p80 43.05 98.72 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.672 0 O-C-N 121.331 -0.856 . . . . 40.0 110.245 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 152' ' ' TYR . 55.9 Cg_endo -96.33 -56.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.881 0 C-N-CA 122.418 2.078 . . . . 40.0 113.949 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -30.54 -22.34 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 113.775 1.028 . . . . 40.0 113.775 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 150' ' ' PRO . 2.5 t80 -52.12 -46.85 65.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.808 -1.182 . . . . 40.0 111.009 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.826 HG12 HD22 ' A' ' 141' ' ' LEU . 9.6 tp -63.39 -36.94 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 116.455 -2.098 . . . . 40.0 109.814 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.798 HD21 HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.786 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 121.513 0.673 . . . . 40.0 110.627 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.736 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -125.36 39.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.331 -0.855 . . . . 40.0 109.596 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.786 HG13 ' HD3' ' B' ' 67' ' ' LYS . 9.5 mt -93.08 33.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.456 -0.777 . . . . 40.0 111.47 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.645 ' C ' ' O ' ' B' ' 69' ' ' ILE . 5.6 t0 -28.79 107.26 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.576 1.179 . . . . 40.0 110.647 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.4 p -84.34 -128.55 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.814 -1.18 . . . . 40.0 107.814 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.611 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -136.72 133.76 6.72 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.397 -1.481 . . . . 40.0 109.397 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.49 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 153.28 31.72 0.03 OUTLIER Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.695 -0.764 . . . . 40.0 111.421 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.754 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 49.4 59.34 7.2 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.583 -1.539 . . . . 40.0 110.903 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 110' ' ' ASN . 1.8 p90 -174.89 130.48 0.31 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.828 -1.149 . . . . 40.0 109.443 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -69.27 135.75 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.408 0.623 . . . . 40.0 112.676 -176.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.507 ' HG ' ' CZ ' ' B' ' 75' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 40.0 111.526 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 169.68 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 103' ' ' VAL . 5.0 t -102.57 142.82 25.36 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.338 -1.476 . . . . 40.0 110.708 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.1 Cg_endo -63.21 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 107.789 -1.658 . . . . 40.0 107.789 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 3.9 ttm-85 -72.64 -8.44 55.3 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 105.952 -1.87 . . . . 40.0 105.952 175.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.568 ' NE2' ' OH ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -105.47 1.89 28.06 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 115.867 -0.606 . . . . 40.0 109.51 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -54.91 -164.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.268 -0.895 . . . . 40.0 110.128 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 47.89 -126.92 14.55 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 104.136 -3.585 . . . . 40.0 104.136 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.571 ' HB2' ' CE2' ' B' ' 75' ' ' PHE . 38.4 t-20 39.37 105.54 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 118.872 1.336 . . . . 40.0 113.701 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.54 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 40.3 Cg_endo -63.35 -13.38 35.62 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.818 1.679 . . . . 40.0 114.551 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.49 -35.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 119.516 -1.99 . . . . 40.0 109.503 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.54 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.67 33.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.553 ' HD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 t80 -107.07 129.66 54.79 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.326 -1.484 . . . . 40.0 111.819 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.85 HD11 ' HB2' ' A' ' 146' ' ' HIS . 7.5 tp -127.74 104.69 7.98 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.372 -1.344 . . . . 40.0 107.372 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.706 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 13.3 t -69.88 2.94 2.94 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 117.302 -1.759 . . . . 40.0 113.785 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.89 HD23 ' HB3' ' A' ' 146' ' ' HIS . 0.1 OUTLIER 62.5 -72.12 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.956 0 O-C-N 120.594 -1.316 . . . . 40.0 111.779 -178.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.663 ' C ' ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -37.03 -57.52 0.83 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 105.974 -1.862 . . . . 40.0 105.974 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.785 ' CE1' ' NE2' ' A' ' 149' ' ' HIS . 50.0 t80 -56.35 -42.35 77.61 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.921 -1.14 . . . . 40.0 107.921 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.89 ' HB3' HD23 ' A' ' 143' ' ' LEU . 33.8 t60 -38.12 -37.57 0.28 Allowed 'General case' 0 N--CA 1.519 3.015 0 O-C-N 121.21 -0.931 . . . . 40.0 112.134 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 149' ' ' HIS . 28.5 m-20 -66.6 -63.66 1.02 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.258 -0.901 . . . . 40.0 109.316 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 148' ' ' LEU . 5.7 mp -40.52 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.1 -1.0 . . . . 40.0 111.643 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.785 ' NE2' ' CE1' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -158.62 99.76 1.69 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.266 -1.012 . . . . 40.0 108.266 178.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.0 -53.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.592 1.311 . . . . 40.0 112.404 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 66.5 t0 -49.77 -19.43 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.591 -1.318 . . . . 40.0 112.237 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 26.6 t80 -54.07 -56.96 13.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.77 -1.207 . . . . 40.0 111.915 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -63.23 -36.94 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.259 -1.376 . . . . 40.0 109.814 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.476 ' HE3' HD12 ' B' ' 69' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.525 0.202 . . . . 40.0 110.941 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.7 HG22 ' O ' ' B' ' 77' ' ' LEU . 8.6 mt -83.41 72.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 CA-C-O 122.026 0.917 . . . . 40.0 111.02 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' B' ' 70' ' ' ASP . 0.5 OUTLIER -121.84 127.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 123.052 1.406 . . . . 40.0 111.144 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.699 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 9.1 t70 -25.37 167.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.48 2.4 . . . . 40.0 117.48 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.444 HG23 ' N ' ' B' ' 72' ' ' GLY . 1.2 t -147.44 -115.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 112.181 -2.281 . . . . 40.0 107.719 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -153.03 118.98 0.91 Allowed Glycine 0 N--CA 1.508 3.486 0 C-N-CA 119.332 -1.413 . . . . 40.0 112.66 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.1 34.95 0.02 OUTLIER Glycine 0 N--CA 1.511 3.7 0 O-C-N 122.029 -0.689 . . . . 40.0 112.29 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.457 ' HA2' ' CD2' ' A' ' 145' ' ' TYR . . . 51.23 54.48 23.3 Favored Glycine 0 N--CA 1.514 3.897 0 O-C-N 120.195 -1.768 . . . . 40.0 109.571 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.706 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.2 OUTLIER -173.16 117.98 0.3 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.883 -1.127 . . . . 40.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.654 HD12 ' CA ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -65.51 131.73 31.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.5 0.667 . . . . 40.0 111.927 -176.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.7 ' O ' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.121 0 CA-C-O 118.23 -0.89 . . . . 40.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.98 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.685 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -97.75 138.98 21.07 Favored Pre-proline 0 N--CA 1.5 2.028 0 O-C-N 119.869 -1.769 . . . . 40.0 111.236 176.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.47 -10.72 17.08 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.689 1.363 . . . . 40.0 109.272 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -88.01 6.67 34.9 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 105.931 -1.877 . . . . 40.0 105.931 176.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.685 ' HB2' ' O ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -110.7 -3.97 15.58 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.968 -0.753 . . . . 40.0 108.968 177.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -50.86 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.832 -1.167 . . . . 40.0 110.13 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.651 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 50.59 -97.38 0.02 OUTLIER Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.584 -2.206 . . . . 40.0 107.584 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.785 ' HB2' ' CD2' ' B' ' 75' ' ' PHE . 1.2 t30 -0.57 108.92 0.02 OUTLIER Pre-proline 0 N--CA 1.51 2.556 0 O-C-N 121.791 -0.829 . . . . 40.0 112.459 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.528 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 39.0 Cg_endo -63.18 -11.49 25.46 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 122.334 2.022 . . . . 40.0 114.831 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.685 ' HB ' HD21 ' A' ' 110' ' ' ASN . 53.6 t -56.63 -35.4 45.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 O-C-N 119.352 -2.092 . . . . 40.0 109.503 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.528 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.44 33.07 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.3 t80 -106.25 132.24 52.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 40.0 111.34 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 146' ' ' HIS . 0.2 OUTLIER -135.43 103.46 5.49 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.968 -1.493 . . . . 40.0 106.968 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.817 ' O ' ' N ' ' A' ' 144' ' ' ARG . 14.9 t -72.92 41.89 0.1 Allowed 'General case' 0 N--CA 1.525 3.302 0 O-C-N 120.228 -1.545 . . . . 40.0 114.765 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.771 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.5 OUTLIER 30.75 -66.96 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 O-C-N 120.769 -1.207 . . . . 40.0 113.46 178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.817 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -42.57 -65.19 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 119.766 -1.834 . . . . 40.0 106.983 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.916 ' HE1' ' HE2' ' A' ' 149' ' ' HIS . 49.0 t80 -52.59 -23.62 6.77 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.818 -0.808 . . . . 40.0 108.818 176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.803 ' HB2' HD11 ' A' ' 141' ' ' LEU . 56.9 t-80 -54.28 -39.64 67.1 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.904 -1.122 . . . . 40.0 111.135 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.4 OUTLIER -62.93 -65.25 0.71 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.179 -1.415 . . . . 40.0 107.179 178.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.725 ' H ' HD12 ' A' ' 148' ' ' LEU . 3.8 mp -48.04 108.01 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.919 -1.141 . . . . 40.0 107.919 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.916 ' HE2' ' HE1' ' A' ' 145' ' ' TYR . 10.3 p-80 45.43 96.59 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 121.245 -0.91 . . . . 40.0 109.694 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 152' ' ' TYR . 56.2 Cg_endo -95.27 -48.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 122.156 1.904 . . . . 40.0 113.666 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -39.24 -18.93 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.265 0 O-C-N 120.562 -1.336 . . . . 40.0 112.901 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.547 ' OH ' ' HA2' ' B' ' 73' ' ' GLY . 8.9 t80 -53.3 -50.18 65.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.14 . . . . 40.0 111.634 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 141' ' ' LEU . 9.6 tp -62.92 -36.94 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.276 -1.77 . . . . 40.0 109.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.748 ' NZ ' HG22 ' B' ' 68' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.603 0.716 . . . . 40.0 110.715 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.748 HG22 ' NZ ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -124.99 33.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 121.403 -0.811 . . . . 40.0 110.521 -178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.741 ' O ' HG22 ' B' ' 69' ' ' ILE . 7.4 mt -87.6 39.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.154 -0.966 . . . . 40.0 111.122 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' B' ' 69' ' ' ILE . 4.1 t0 -35.38 108.86 0.07 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.66 1.219 . . . . 40.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 1.7 p -85.19 -122.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.27 -1.011 . . . . 40.0 108.27 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.68 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -141.84 132.76 5.38 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.036 -1.226 . . . . 40.0 110.036 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.547 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 154.91 25.25 0.03 OUTLIER Glycine 0 N--CA 1.506 3.313 0 O-C-N 122.062 -0.669 . . . . 40.0 111.719 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 141' ' ' LEU . . . 56.15 55.33 29.92 Favored Glycine 0 N--CA 1.502 3.071 0 O-C-N 120.256 -1.732 . . . . 40.0 110.012 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 110' ' ' ASN . 1.4 p90 -170.09 130.71 0.97 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.868 -1.133 . . . . 40.0 109.455 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.737 HD12 ' CA ' ' A' ' 145' ' ' TYR . 0.4 OUTLIER -73.41 132.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.601 0.715 . . . . 40.0 112.752 -175.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' B' ' 70' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.613 -1.184 . . . . 40.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 172.15 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.679 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 1.3 t -98.28 142.8 25.17 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 120.36 -1.462 . . . . 40.0 111.206 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 -12.22 34.76 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 N-CA-C 107.771 -1.665 . . . . 40.0 107.771 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.679 ' HB3' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -82.73 -2.13 53.38 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 105.984 -1.858 . . . . 40.0 105.984 176.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.679 ' HB3' ' O ' ' A' ' 104' ' ' SER . 4.7 tp-100 -107.42 6.64 28.45 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.163 -1.051 . . . . 40.0 108.163 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.622 ' HG2' ' CZ ' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -52.65 -166.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 40.0 110.062 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 46.52 -110.59 0.54 Allowed Glycine 0 C--O 1.208 -1.521 0 N-CA-C 105.618 -2.993 . . . . 40.0 105.618 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.645 ' ND2' ' HB ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER 25.59 97.36 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 117.662 0.731 . . . . 40.0 112.768 176.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.467 ' CB ' ' HE2' ' A' ' 114' ' ' LYS . 36.2 Cg_endo -57.86 -13.39 14.72 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.84 1.693 . . . . 40.0 114.125 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.645 ' HB ' ' ND2' ' A' ' 110' ' ' ASN . 53.6 t -58.1 -35.4 52.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 O-C-N 119.783 -1.823 . . . . 40.0 109.503 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.467 ' HE2' ' CB ' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.622 ' CZ ' ' HG2' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.83 33.63 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 2.6 t80 -103.52 143.67 32.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.915 -1.116 . . . . 40.0 111.022 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 146' ' ' HIS . 3.3 tp -146.24 101.04 3.46 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.594 -1.261 . . . . 40.0 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.613 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 10.5 t -67.12 5.56 0.68 Allowed 'General case' 0 N--CA 1.517 2.9 0 O-C-N 120.228 -1.545 . . . . 40.0 114.124 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.848 ' O ' ' HB3' ' A' ' 146' ' ' HIS . 0.0 OUTLIER 61.3 -70.38 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.585 -1.322 . . . . 40.0 110.954 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.627 ' C ' ' O ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -40.81 -54.91 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.818 -1.919 . . . . 40.0 105.818 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.946 ' N ' HD13 ' B' ' 76' ' ' ILE . 4.5 t80 -52.84 -43.53 66.1 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.274 -1.38 . . . . 40.0 107.274 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.848 ' HB3' ' O ' ' A' ' 143' ' ' LEU . 80.4 t60 -39.82 -45.87 1.86 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 121.521 0.677 . . . . 40.0 112.553 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -67.16 -51.93 47.78 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.075 -1.016 . . . . 40.0 108.829 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 148' ' ' LEU . 4.3 mm? -44.55 -27.97 0.53 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.28 -0.887 . . . . 40.0 109.538 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.663 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -172.02 101.95 0.37 Allowed Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 40.0 110.812 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 152' ' ' TYR . 47.0 Cg_endo -87.88 -169.13 0.43 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 107.605 -1.729 . . . . 40.0 107.605 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.612 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 66.3 t0 67.98 -23.95 0.12 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.29 -1.506 . . . . 40.0 108.441 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.706 ' OH ' ' HA3' ' B' ' 73' ' ' GLY . 8.0 t80 -66.24 -54.38 25.7 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.936 -1.505 . . . . 40.0 106.936 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 153' ' ' ILE . 9.6 tp -60.15 -36.94 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.102 -1.439 . . . . 40.0 109.814 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.64 ' HE3' HD11 ' B' ' 69' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 121.918 0.866 . . . . 40.0 110.826 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.777 HG23 ' O ' ' B' ' 68' ' ' ILE . 15.7 tt -130.3 71.75 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 40.0 109.315 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.64 HD11 ' HE3' ' B' ' 67' ' ' LYS . 29.2 mt -137.06 54.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.1 -1.0 . . . . 40.0 110.888 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' B' ' 76' ' ' ILE . 0.2 OUTLIER -40.8 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.371 1.081 . . . . 40.0 110.009 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.653 HG22 HD12 ' B' ' 77' ' ' LEU 0.276 12.5 t -146.14 150.43 35.87 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.657 -0.817 . . . . 40.0 110.081 -177.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.512 ' CA ' ' HG3' ' A' ' 106' ' ' ARG . . . 105.56 -110.24 3.4 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.759 -1.21 . . . . 40.0 110.332 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.706 ' HA3' ' OH ' ' A' ' 152' ' ' TYR . . . -153.88 109.95 0.43 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.835 -1.65 . . . . 40.0 113.709 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' B' ' 75' ' ' PHE . . . 41.68 82.38 0.02 OUTLIER Glycine 0 N--CA 1.5 2.921 0 O-C-N 122.23 -0.57 . . . . 40.0 111.801 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.613 ' HA ' ' CB ' ' A' ' 142' ' ' SER . 0.1 OUTLIER 177.07 104.81 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.617 -1.253 . . . . 40.0 107.617 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.946 HD13 ' N ' ' A' ' 145' ' ' TYR . 1.4 tp -53.16 122.78 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 113.179 0.807 . . . . 40.0 113.179 -175.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.653 HD12 HG22 ' B' ' 71' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.296 -1.718 0 CA-C-O 117.354 -1.308 . . . . 40.0 110.525 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 171.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.677 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -103.43 143.09 25.92 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 119.29 -2.131 . . . . 40.0 109.982 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.9 -10.25 14.16 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.697 1.367 . . . . 40.0 108.556 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.496 ' NH2' ' HE1' ' A' ' 152' ' ' TYR . 1.4 ttp180 -76.85 -3.83 40.53 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.085 -1.821 . . . . 40.0 106.085 175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.677 ' HB2' ' O ' ' A' ' 104' ' ' SER . 2.3 mm-40 -106.86 -7.47 17.1 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.064 0.459 . . . . 40.0 110.186 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -51.58 -177.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.992 -1.067 . . . . 40.0 109.439 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 64.27 -66.84 0.06 OUTLIER Glycine 0 C--N 1.288 -2.087 0 N-CA-C 108.576 -1.81 . . . . 40.0 108.576 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.621 ' N ' ' O ' ' A' ' 108' ' ' ARG . 33.8 t-20 -31.12 113.08 0.32 Allowed Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.265 -1.138 . . . . 40.0 112.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 38.1 Cg_endo -63.68 -15.49 49.06 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.825 1.683 . . . . 40.0 112.815 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.598 ' HB ' ' OD1' ' A' ' 110' ' ' ASN . 53.6 t -55.51 -35.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.732 -1.855 . . . . 40.0 109.503 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 132.23 32.75 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 7.4 t80 -103.12 143.43 32.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.037 -1.039 . . . . 40.0 110.976 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 146' ' ' HIS 0.255 1.7 tp -146.4 92.16 2.14 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.367 -0.975 . . . . 40.0 108.367 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 144' ' ' ARG . 6.7 t -57.65 17.43 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.622 0 O-C-N 120.357 -1.464 . . . . 40.0 114.873 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.895 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.9 OUTLIER 46.84 -71.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 O-C-N 120.149 -1.594 . . . . 40.0 112.761 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -38.98 -49.29 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 119.565 -1.96 . . . . 40.0 106.131 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 1.022 ' N ' HD12 ' B' ' 76' ' ' ILE . 52.4 t80 -61.81 -35.67 78.87 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.646 -1.242 . . . . 40.0 107.646 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.895 ' N ' ' O ' ' A' ' 143' ' ' LEU . 49.3 t60 -43.51 -38.69 3.01 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.454 0.645 . . . . 40.0 111.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 2.8 m-20 -63.86 -61.83 2.04 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.284 -1.376 . . . . 40.0 107.284 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.802 ' H ' HD12 ' A' ' 148' ' ' LEU . 5.3 mp -55.72 107.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.084 -1.08 . . . . 40.0 108.084 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.777 ' CD2' ' C ' ' A' ' 148' ' ' LEU . 0.1 OUTLIER 48.83 96.1 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.503 0 O-C-N 121.415 -0.803 . . . . 40.0 109.973 -176.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 152' ' ' TYR . 52.0 Cg_endo -94.7 -46.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.439 2.093 . . . . 40.0 113.53 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.484 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -44.38 -16.47 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 120.417 -1.427 . . . . 40.0 111.961 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.512 ' OH ' ' HA2' ' B' ' 73' ' ' GLY . 4.1 t80 -55.93 -50.91 69.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.903 -1.123 . . . . 40.0 111.5 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.433 HG12 HD22 ' A' ' 141' ' ' LEU . 9.6 tp -62.07 -36.94 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.648 -1.621 . . . . 40.0 109.814 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.717 ' HD3' HD11 ' B' ' 69' ' ' ILE . 1.3 ttpp . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 121.804 0.811 . . . . 40.0 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.745 HG23 ' O ' ' B' ' 68' ' ' ILE . 13.1 tt -119.6 52.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.499 -0.926 . . . . 40.0 108.499 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.717 HD11 ' HD3' ' B' ' 67' ' ' LYS . 5.9 mt -100.45 41.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.477 -0.765 . . . . 40.0 110.645 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.623 ' C ' ' O ' ' B' ' 69' ' ' ILE . 11.3 t70 -32.47 122.12 0.33 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.501 -1.28 . . . . 40.0 110.328 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' B' ' 72' ' ' GLY . 2.8 p -95.52 -124.72 0.12 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.501 -1.296 . . . . 40.0 107.501 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.6 ' N ' ' OG1' ' B' ' 71' ' ' THR . . . -141.16 129.17 3.96 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.137 -1.585 . . . . 40.0 109.137 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.512 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 156.11 26.27 0.03 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 120.034 -1.079 . . . . 40.0 112.367 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 141' ' ' LEU . . . 79.07 -42.68 2.36 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 119.902 -1.94 . . . . 40.0 110.718 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.8 ' CZ ' HD22 ' B' ' 77' ' ' LEU . 0.6 OUTLIER -85.33 148.02 26.24 Favored 'General case' 0 C--N 1.263 -3.17 0 C-N-CA 117.692 -1.603 . . . . 40.0 112.455 -175.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.022 HD12 ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -90.76 131.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.465 0.65 . . . . 40.0 111.61 -176.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.8 HD22 ' CZ ' ' B' ' 75' ' ' PHE . 6.8 tp . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.342 -0.849 . . . . 40.0 112.844 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 100' ' ' SER 0.308 26.5 t-20 . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 103.493 -2.78 . . . . 40.0 103.493 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.79 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 59.6 p -79.56 117.68 20.72 Favored 'General case' 0 C--N 1.301 -1.502 1 N-CA-C 93.176 -6.601 . . . . 40.0 93.176 165.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 102' ' ' ILE . 3.3 mm -17.84 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 N-CA-C 120.228 3.418 . . . . 40.0 120.228 -167.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 ' N ' HG22 ' A' ' 101' ' ' ILE . 29.0 mm -135.64 119.75 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 111.73 -2.487 . . . . 40.0 104.913 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG22 ' HD1' ' A' ' 130' ' ' TYR . 87.2 t -115.84 170.94 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.01 -1.108 . . . . 40.0 108.01 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.653 ' O ' ' HB3' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -101.96 139.76 20.6 Favored Pre-proline 0 C--N 1.289 -2.058 0 O-C-N 119.491 -2.005 . . . . 40.0 109.994 175.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.46 -15.57 36.77 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 108.195 -1.502 . . . . 40.0 108.195 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' B' ' 72' ' ' GLY . 2.5 ttm180 -72.6 -10.2 59.51 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 105.533 -2.025 . . . . 40.0 105.533 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 104' ' ' SER . 5.7 tp-100 -103.32 1.14 32.38 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.038 -0.528 . . . . 40.0 110.062 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.595 ' O ' ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -55.24 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.93 -1.106 . . . . 40.0 108.928 178.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 110' ' ' ASN . . . 52.33 -89.92 0.01 OUTLIER Glycine 0 C--N 1.295 -1.736 0 N-CA-C 108.316 -1.914 . . . . 40.0 108.316 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 112' ' ' VAL . 21.6 t-20 -6.18 115.18 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 121.604 -0.939 . . . . 40.0 112.954 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . 42.1 Cg_endo -66.82 -14.66 44.64 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 122.29 1.994 . . . . 40.0 113.81 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 140' ' ' PHE . 53.6 t -55.75 -35.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 119.834 -1.791 . . . . 40.0 109.503 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.65 -24.87 36.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 40.0 109.336 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 111' ' ' PRO . 39.5 mtmt -69.34 -21.37 63.83 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.518 -0.873 . . . . 40.0 109.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.665 ' CG ' ' HA ' ' A' ' 203' ' ' GLU . 98.6 m-85 -97.72 2.54 49.74 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 119.002 -2.311 . . . . 40.0 109.657 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.58 77.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.628 -2.36 . . . . 40.0 104.628 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -108.83 -35.6 6.34 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.559 0.948 . . . . 40.0 113.559 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -75.57 -13.93 60.37 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 119.934 -1.729 . . . . 40.0 111.805 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.04 147.05 64.03 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 117.547 -1.661 . . . . 40.0 110.803 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 100' ' ' SER . 37.0 Cg_endo -68.58 134.93 31.93 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 125.092 2.101 . . . . 40.0 111.868 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -145.58 153.95 41.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 40.0 109.667 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.62 154.77 38.12 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.867 -0.733 . . . . 40.0 110.575 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.533 ' CE2' ' HG3' ' A' ' 108' ' ' ARG . 11.2 m-85 -74.56 130.84 40.31 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.12 0.962 . . . . 40.0 111.627 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.27 162.56 25.71 Favored Glycine 0 C--N 1.291 -1.93 0 N-CA-C 107.742 -2.143 . . . . 40.0 107.742 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.87 83.03 7.93 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 120.911 -1.347 . . . . 40.0 109.547 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 128' ' ' PRO . 5.6 m -124.31 154.35 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 CA-C-O 122.939 1.352 . . . . 40.0 112.14 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.573 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.2 mt -58.91 -47.94 97.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.297 1.221 . . . . 40.0 114.297 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 127' ' ' ILE . 59.7 Cg_endo -79.02 -173.59 1.94 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 N-CA-C 109.497 -1.001 . . . . 40.0 109.497 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 139' ' ' LEU . 10.1 m-20 -83.63 -48.2 10.44 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.11 -1.07 . . . . 40.0 108.11 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' A' ' 103' ' ' VAL . 77.4 m-85 -132.41 129.7 39.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.547 -1.261 . . . . 40.0 111.675 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 102' ' ' ILE . 34.0 t -95.3 118.48 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 106.051 -1.833 . . . . 40.0 106.051 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 212' ' ' TYR . 5.3 mp -105.8 -15.34 14.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.303 -0.873 . . . . 40.0 110.824 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.29 170.06 40.74 Favored Glycine 1 N--CA 1.52 4.259 0 N-CA-C 109.047 -1.621 . . . . 40.0 109.047 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -49.02 -30.72 6.49 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-N 118.373 1.086 . . . . 40.0 112.524 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.619 ' O ' ' N ' ' A' ' 165' ' ' ALA . 0.2 OUTLIER -138.34 21.18 2.76 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.317 -2.115 . . . . 40.0 110.75 178.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 166' ' ' LEU . 85.9 m -109.9 134.49 52.02 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.556 -1.276 . . . . 40.0 107.556 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.7 p -151.94 151.98 31.92 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 120.794 -1.191 . . . . 40.0 110.7 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' VAL . . . -122.05 167.8 12.69 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.09 -1.044 . . . . 40.0 110.374 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 156' ' ' ARG . 6.9 tp -137.6 131.18 31.23 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.339 -1.356 . . . . 40.0 107.339 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 112' ' ' VAL . 1.4 t80 -98.64 136.63 38.44 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.233 1.016 . . . . 40.0 109.217 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 153' ' ' ILE 0.307 0.5 OUTLIER -140.11 94.03 2.71 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 107.541 -1.281 . . . . 40.0 107.541 -178.817 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' B' ' 75' ' ' PHE . 20.7 t -66.26 172.69 3.69 Favored 'General case' 0 N--CA 1.513 2.699 0 C-N-CA 115.147 -2.621 . . . . 40.0 106.916 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 146' ' ' HIS . 0.0 OUTLIER -97.72 -55.38 2.83 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 116.269 -2.173 . . . . 40.0 109.205 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.679 ' HB3' HD13 ' B' ' 76' ' ' ILE . 2.3 ttp180 -40.38 -58.21 1.59 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.288 -1.375 . . . . 40.0 107.288 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.682 ' N ' HD13 ' B' ' 76' ' ' ILE . 2.2 t80 -54.92 -35.82 64.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.314 -0.995 . . . . 40.0 108.314 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.667 ' N ' ' O ' ' A' ' 143' ' ' LEU . 85.7 t60 -45.04 -38.46 4.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.426 -0.91 . . . . 40.0 111.784 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 149' ' ' HIS . 1.3 m120 -72.12 -55.85 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.695 -1.253 . . . . 40.0 109.427 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 147' ' ' ASN . 4.9 mp -37.85 -31.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 40.0 111.46 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.661 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -162.28 94.81 1.24 Allowed Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 120.798 -1.189 . . . . 40.0 111.023 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 151' ' ' ASP . 53.3 Cg_endo -80.12 -175.68 2.83 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 N-CA-C 106.68 -2.084 . . . . 40.0 106.68 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 150' ' ' PRO . 37.6 t0 67.77 -25.44 0.12 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 120.752 -1.217 . . . . 40.0 109.383 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.541 ' H ' ' C ' ' A' ' 150' ' ' PRO . 3.5 t80 -63.32 -53.16 57.05 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.723 -1.954 . . . . 40.0 105.723 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.709 HG12 HD12 ' A' ' 141' ' ' LEU . 9.6 tp -62.08 -36.94 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 117.368 -1.733 . . . . 40.0 109.814 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 151' ' ' ASP . 82.2 t60 -65.04 -51.76 59.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.725 -1.213 . . . . 40.0 107.725 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.01 -12.44 54.8 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.68 -0.968 . . . . 40.0 110.68 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.705 ' HG3' HD21 ' A' ' 139' ' ' LEU . 7.5 tpt180 -85.46 -36.09 20.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.35 -1.088 . . . . 40.0 109.5 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.46 -39.14 68.0 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.166 -1.583 . . . . 40.0 109.812 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.51 -33.76 75.54 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 120.885 -1.134 . . . . 40.0 108.719 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 160' ' ' LEU . 47.6 p -65.39 -46.61 79.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.918 -1.114 . . . . 40.0 109.323 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 127' ' ' ILE . 57.4 tp -58.73 -35.1 72.14 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.328 -0.949 . . . . 40.0 109.079 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.43 -91.58 0.13 Allowed Glycine 0 N--CA 1.507 3.387 0 O-C-N 121.789 -0.57 . . . . 40.0 113.275 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -158.77 17.86 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.475 -1.015 . . . . 40.0 111.852 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -61.44 -23.55 65.92 Favored 'General case' 0 N--CA 1.533 3.692 0 N-CA-C 114.48 1.289 . . . . 40.0 114.48 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.73 134.47 54.94 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.447 -1.408 . . . . 40.0 112.398 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 135' ' ' SER . . . -62.64 -66.86 0.48 Allowed 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.134 -1.026 . . . . 40.0 112.282 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.03 104.74 9.88 Favored 'General case' 0 C--N 1.275 -2.648 0 C-N-CA 117.157 -1.817 . . . . 40.0 111.246 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.647 ' NH1' ' O ' ' A' ' 192' ' ' ALA . 13.9 mtm105 -100.98 134.4 44.04 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.019 -1.474 . . . . 40.0 107.019 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.981 HG11 ' OH ' ' A' ' 208' ' ' TYR . 56.8 t -136.02 143.17 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.689 -0.632 . . . . 40.0 111.292 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' SG ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -113.4 99.35 7.71 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 121.064 -1.023 . . . . 40.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.619 HD21 ' HB1' ' A' ' 205' ' ' ALA . 27.4 tp -74.7 120.31 20.07 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 119.473 -2.017 . . . . 40.0 109.144 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 83.9 t -114.56 127.33 72.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 C-N-CA 118.346 -1.342 . . . . 40.0 111.519 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.4 109.5 21.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.918 -1.739 . . . . 40.0 108.649 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 200' ' ' TRP . 10.6 t -74.58 82.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.925 -1.109 . . . . 40.0 109.99 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.566 ' OD1' HG23 ' A' ' 175' ' ' VAL . 55.8 p-10 -108.12 34.98 3.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.501 -0.555 . . . . 40.0 109.501 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG23 ' OD1' ' A' ' 174' ' ' ASP . 71.5 t -147.68 140.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.934 -0.706 . . . . 40.0 110.427 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 177' ' ' ASP . 41.3 tttm -78.51 143.82 36.24 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.176 -0.952 . . . . 40.0 110.38 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 176' ' ' LYS . 74.8 m-20 66.63 41.89 0.28 Allowed Pre-proline 0 N--CA 1.511 2.591 0 O-C-N 119.965 -1.709 . . . . 40.0 111.622 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 177' ' ' ASP . 51.6 Cg_endo -69.35 -29.53 25.67 Favored 'Trans proline' 0 C--N 1.295 -2.257 0 C-N-CA 121.512 1.475 . . . . 40.0 112.948 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 1.011 ' HG2' ' H ' ' A' ' 180' ' ' GLN . 13.7 pm0 -26.38 -64.4 0.07 Allowed 'General case' 0 C--N 1.274 -2.68 0 O-C-N 120.829 -1.169 . . . . 40.0 113.738 -176.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 1.011 ' H ' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -40.97 -59.53 1.43 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.402 -0.919 . . . . 40.0 112.044 -176.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 182' ' ' LEU . . . -58.81 -52.67 64.71 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 120.577 -1.327 . . . . 40.0 111.632 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 182' ' ' LEU . 4.5 mt -44.22 -47.38 9.26 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.656 -1.218 . . . . 40.0 109.248 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -49.8 -61.23 2.25 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.374 -0.829 . . . . 40.0 110.096 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.47 -19.68 64.57 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.654 -1.279 . . . . 40.0 112.844 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 185' ' ' LEU . 16.6 mt -76.87 -45.84 26.77 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 117.658 -1.617 . . . . 40.0 106.802 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 190' ' ' ILE . . . -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.081 -0.648 . . . . 40.0 109.917 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.741 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 92.4 mttt -52.79 -44.01 66.29 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 107.861 -1.163 . . . . 40.0 107.861 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 33.0 ttm -59.32 -44.9 92.54 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.028 -0.669 . . . . 40.0 110.338 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 193' ' ' ASP . 96.1 m -66.07 -33.29 75.46 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.466 -0.771 . . . . 40.0 112.759 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 186' ' ' ALA . 3.4 mt -67.08 -48.51 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 117.547 -1.661 . . . . 40.0 106.835 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 187' ' ' LYS . 4.2 mt -57.89 -47.27 83.28 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.631 -1.248 . . . . 40.0 107.631 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.647 ' O ' ' NH1' ' A' ' 167' ' ' ARG . . . -73.85 -8.63 56.77 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 122.74 1.257 . . . . 40.0 110.76 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' CYS . 12.8 t70 48.39 47.82 19.65 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.329 -0.857 . . . . 40.0 112.335 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 15.0 p -120.84 152.19 38.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.082 -1.451 . . . . 40.0 107.082 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 197' ' ' ILE . 1.2 m -73.65 147.75 43.45 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.622 -0.674 . . . . 40.0 112.695 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 tt -107.17 117.48 34.19 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.852 -1.166 . . . . 40.0 107.852 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.638 HG13 ' CZ ' ' A' ' 208' ' ' TYR . 7.0 mm -115.87 143.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 O-C-N 121.163 -0.961 . . . . 40.0 110.583 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.74 121.31 40.49 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 117.781 -1.568 . . . . 40.0 115.064 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 200' ' ' TRP . . . -115.99 169.84 8.94 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.317 -1.364 . . . . 40.0 107.317 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TRP . . . . . 0.591 ' N ' ' OE1' ' A' ' 204' ' ' GLU . 37.4 m95 -132.21 -8.56 3.38 Favored 'General case' 0 C--N 1.275 -2.661 0 O-C-N 120.092 -1.63 . . . . 40.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 204' ' ' GLU . 54.0 p -137.19 164.15 44.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 40.0 109.643 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.71 -22.32 32.47 Favored 'Trans proline' 0 C--N 1.281 -2.996 0 O-C-N 123.41 1.216 . . . . 40.0 109.749 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.665 ' HA ' ' CG ' ' A' ' 115' ' ' PHE . 23.5 tt0 -77.28 -46.61 22.51 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.524 -1.271 . . . . 40.0 109.984 175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB2' ' OG ' ' A' ' 201' ' ' SER . 1.9 tt0 -52.93 -52.2 58.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 120.705 -1.247 . . . . 40.0 111.024 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.619 ' HB1' HD21 ' A' ' 170' ' ' LEU . . . -59.57 -45.67 91.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.993 -1.484 . . . . 40.0 106.993 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 115' ' ' PHE . . . -49.63 -40.86 33.33 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 106.831 -2.508 . . . . 40.0 106.831 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 204' ' ' GLU . 10.1 mmt85 -62.33 -49.2 76.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.599 -1.53 . . . . 40.0 108.473 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 1.317 ' CZ ' ' HE2' ' A' ' 212' ' ' TYR . 86.7 t80 -50.48 -25.91 4.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.064 0.765 . . . . 40.0 113.064 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -49.94 11.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.206 -0.934 . . . . 40.0 109.151 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 207' ' ' ARG . 11.7 mt-10 -56.01 -35.22 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.439 -1.413 . . . . 40.0 108.767 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -35.57 71.26 Favored 'General case' 0 N--CA 1.524 3.247 0 N-CA-C 113.128 0.788 . . . . 40.0 113.128 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 1.317 ' HE2' ' CZ ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -78.33 -28.21 47.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.843 -1.786 . . . . 40.0 111.1 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 101' ' ' ILE . 7.8 tptt -82.19 -20.97 36.76 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.075 -1.454 . . . . 40.0 107.075 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.336 0 CA-C-O 118.757 -0.639 . . . . 40.0 109.676 177.156 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.791 ' HD3' HG13 ' B' ' 69' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.293 0.568 . . . . 40.0 110.237 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.84 HG23 ' O ' ' B' ' 68' ' ' ILE . 0.0 OUTLIER -122.94 73.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 122.042 0.925 . . . . 40.0 108.924 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.791 HG13 ' HD3' ' B' ' 67' ' ' LYS . 18.8 mt -122.47 25.69 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 40.0 109.562 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.833 ' HA ' ' HB3' ' B' ' 77' ' ' LEU . 13.1 t70 -17.13 103.08 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.251 1.024 . . . . 40.0 111.694 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 1.082 HG23 HD23 ' B' ' 77' ' ' LEU . 1.1 p -86.04 -139.43 0.08 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.312 -1.366 . . . . 40.0 107.312 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.594 ' O ' ' HG2' ' A' ' 106' ' ' ARG . . . -118.24 137.28 12.9 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' OH ' ' A' ' 152' ' ' TYR . . . 153.23 23.62 0.04 OUTLIER Glycine 0 N--CA 1.5 2.931 0 C-N-CA 120.65 -0.785 . . . . 40.0 112.415 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HD1' ' A' ' 140' ' ' PHE . . . 49.57 60.4 6.4 Favored Glycine 0 N--CA 1.51 3.604 0 CA-C-N 119.994 1.897 . . . . 40.0 109.074 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.562 ' CZ ' HD22 ' B' ' 77' ' ' LEU . 1.0 OUTLIER -173.73 124.94 0.37 Allowed 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 118.848 -1.141 . . . . 40.0 108.877 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.682 HD13 ' N ' ' A' ' 145' ' ' TYR . 1.1 tp -64.48 157.63 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.331 -0.856 . . . . 40.0 111.89 -177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 1.082 HD23 HG23 ' B' ' 71' ' ' THR 0.254 24.6 tp . . . . . 0 C--N 1.292 -1.904 0 C-N-CA 119.238 -0.985 . . . . 40.0 110.725 -178.268 . . . . . . . . 2 2 . 1 stop_ save_